data_1mtx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mtx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 34' ' ' CYS . 4.3 pt . . . . . 0 C--O 1.214 -0.763 0 CA-C-O 121.269 0.557 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -88.4 31.93 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 16.7 t -74.72 159.01 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 108.911 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.416 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -87.47 156.11 19.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.53 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.59 158.04 36.38 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.174 0.988 . . . . 0.0 111.727 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -113.7 -12.1 12.85 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.8 p -168.43 138.22 1.99 Allowed Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 5.7 Cg_exo -58.82 -14.61 22.95 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.633 1.555 . . . . 0.0 110.103 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -42.61 93.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.157 -0.964 . . . . 0.0 108.774 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 42.0 mt-30 -75.34 -5.05 42.8 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.39 -0.818 . . . . 0.0 109.349 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 94.4 m -85.06 -26.38 27.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.345 -0.847 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -69.87 -46.58 23.81 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.359 -0.838 . . . . 0.0 112.279 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.01 -53.26 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.358 1.372 . . . . 0.0 110.449 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.95 -44.27 10.3 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.602 1.535 . . . . 0.0 108.863 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 10.2 t -75.27 -3.79 35.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.4 ttpt -100.26 -9.64 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.235 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.48 -10.18 28.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.339 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -95.38 -56.67 2.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 8.8 m-85 -86.98 -61.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 108.895 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.16 -160.62 34.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.525 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 16.2 tt0 -83.71 7.63 17.05 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.11 -1.229 . . . . 0.0 109.428 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -108.29 -16.19 14.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.468 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -54.67 113.42 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.069 -1.02 . . . . 0.0 109.651 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.09 121.0 6.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -133.54 160.19 38.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.099 -1.236 . . . . 0.0 110.678 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 4.7 mmtp -144.51 -178.28 5.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.53 121.98 7.92 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.987 -1.07 . . . . 0.0 110.851 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -85.35 98.52 10.59 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.8 OUTLIER 4.82 65.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.338 0.589 . . . . 0.0 111.452 -177.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.39 -44.14 0.18 Allowed Glycine 0 N--CA 1.483 1.804 0 C-N-CA 119.746 -1.216 . . . . 0.0 111.3 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.5 mttt -153.26 160.48 42.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.477 -1.602 . . . . 0.0 109.929 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 71.9 m -88.04 178.81 6.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.65 0.738 . . . . 0.0 110.126 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 16.8 ttmt -150.4 124.09 9.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.9 m -102.75 127.12 50.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 111.354 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.473 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 27.6 m-85 -119.67 96.91 49.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.95 138.22 77.35 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.107 1.871 . . . . 0.0 110.24 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.545 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.534 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -113.75 56.94 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 3' ' ' ILE . 96.6 t -139.2 153.31 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 109.731 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -88.44 164.19 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.093 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.12 156.88 35.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 111.178 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.4 p -112.5 -10.23 13.74 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.463 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 64.6 p -168.16 137.19 1.97 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.2 Cg_exo -59.32 -14.27 23.94 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.534 1.49 . . . . 0.0 109.878 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -66.31 -45.83 79.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 108.616 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 4.8 mt-30 -72.5 -4.76 32.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.434 -0.791 . . . . 0.0 109.027 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 96.8 m -89.26 -23.37 22.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.385 -0.822 . . . . 0.0 110.463 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -58.48 -46.15 99.63 Favored Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 112.148 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.2 Cg_exo -58.94 -56.28 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.626 1.551 . . . . 0.0 111.868 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.68 -51.28 2.53 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.936 1.757 . . . . 0.0 110.586 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.546 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.98 -17.05 64.32 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.465 -0.772 . . . . 0.0 109.401 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 14' ' ' LEU . 12.4 ttmm -81.01 -10.87 59.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.388 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.11 33.22 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.756 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.81 -61.18 0.9 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.401 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.2 m-85 -84.91 -65.76 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 178.41 -168.67 39.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.533 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 2.6 tt0 -69.67 -10.73 59.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.329 . . . . 0.0 109.393 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -89.84 -8.4 52.09 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.194 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.556 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -54.93 122.06 10.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.012 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.88 120.55 6.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.546 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -128.45 157.27 41.56 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.952 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -139.01 -177.16 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.508 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.89 122.27 7.87 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.064 -1.022 . . . . 0.0 110.953 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.598 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -85.55 97.98 10.37 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.598 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.3 p30 4.81 65.84 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.348 0.594 . . . . 0.0 111.518 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.55 -44.12 0.18 Allowed Glycine 0 N--CA 1.484 1.892 0 C-N-CA 119.748 -1.215 . . . . 0.0 111.323 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 76.7 mttt -153.44 159.9 42.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.424 -1.633 . . . . 0.0 109.764 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 55.5 m -88.21 178.28 6.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.608 -0.683 . . . . 0.0 110.236 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.47 132.58 15.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.325 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.99 119.61 35.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 32.4 m-85 -121.37 97.49 47.24 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.462 -0.774 . . . . 0.0 109.338 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.8 Cg_endo -61.55 140.92 89.61 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.089 1.859 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.6 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.437 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.534 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.534 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p30 -111.08 78.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 108.976 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 72.4 t -158.5 152.47 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HG2' ' N ' ' A' ' 7' ' ' CYS . 32.7 tttm -91.77 162.13 14.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 108.798 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.531 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -156.02 158.59 38.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.949 -1.094 . . . . 0.0 111.353 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -113.49 -10.75 13.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 p -168.16 139.27 2.26 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -59.78 -14.11 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 121.606 1.538 . . . . 0.0 109.919 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -63.76 -45.13 91.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.314 -0.867 . . . . 0.0 109.106 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 2.2 mt-30 -74.84 -5.03 41.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 92.5 m -88.68 -27.56 21.17 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.419 -0.801 . . . . 0.0 110.052 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.609 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -67.91 -45.2 42.64 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.227 -0.92 . . . . 0.0 112.225 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.66 -52.9 6.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.327 1.352 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.73 -44.63 10.19 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.768 1.645 . . . . 0.0 109.341 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 11.8 t -73.46 -8.65 56.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.79 -0.569 . . . . 0.0 109.776 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.529 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 3.1 ttpt -95.57 -9.58 31.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.71 -9.33 29.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -92.61 -58.73 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 9.1 m-85 -85.66 -60.95 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 168.44 -161.09 34.81 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.529 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 42.5 tt0 -84.72 10.05 12.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.246 . . . . 0.0 109.465 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -111.73 -15.55 13.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.337 -0.852 . . . . 0.0 109.79 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.487 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -55.31 123.23 13.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 109.787 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.69 117.14 5.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -125.88 165.46 18.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 110.412 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.9 mttp -154.7 179.32 9.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.243 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.32 124.75 9.58 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.888 -1.133 . . . . 0.0 110.948 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -88.94 98.67 11.88 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 7.1 m120 4.66 66.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.412 0.625 . . . . 0.0 111.542 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.47 -46.84 0.17 Allowed Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 2.5 mtmp? -153.33 160.44 42.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.561 -1.552 . . . . 0.0 109.522 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 57.2 m -88.13 -178.73 6.02 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 110.284 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.74 134.96 16.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.1 m -114.27 120.43 40.39 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.239 -0.913 . . . . 0.0 111.018 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -113.23 98.99 47.94 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.57 141.48 95.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.146 1.898 . . . . 0.0 110.382 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.396 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.511 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 23.7 t30 -106.9 81.72 1.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.086 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG11 ' N ' ' A' ' 6' ' ' LYS . 79.9 t -159.18 151.59 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.514 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -97.68 165.83 11.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 108.685 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.43 164.01 38.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.915 -1.116 . . . . 0.0 111.373 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.4 p -112.83 -10.71 13.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.49 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 31.8 p -167.33 141.87 3.16 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 1.9 Cg_endo -61.99 -10.24 17.06 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.793 1.662 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -77.17 -40.08 46.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.147 -0.971 . . . . 0.0 109.117 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 19.2 mt-30 -75.78 -4.71 42.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 56.4 m -89.55 -19.98 24.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.326 -0.859 . . . . 0.0 109.853 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.597 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -58.2 -44.41 99.22 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 112.37 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 6.2 Cg_exo -57.35 -56.31 1.91 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.633 1.555 . . . . 0.0 111.759 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -63.09 -49.82 4.46 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.71 1.607 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -70.18 -12.58 61.7 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.693 -0.629 . . . . 0.0 109.519 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -85.46 -9.93 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.439 -0.788 . . . . 0.0 109.071 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.65 41.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.264 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -106.88 -62.94 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-30 -84.22 -63.36 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.62 -156.72 18.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.7 tt0 -80.18 -9.99 59.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.037 -1.272 . . . . 0.0 109.346 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -95.75 -12.15 25.86 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.561 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -44.21 111.67 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -88.93 117.79 4.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -126.79 145.95 50.43 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 109.609 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.0 mttm -119.05 -168.3 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.547 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 6.0 t -150.61 123.98 8.96 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.282 -0.887 . . . . 0.0 109.658 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -95.18 -141.38 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.399 -0.813 . . . . 0.0 110.044 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.9 m-20 -38.43 -30.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 0.0 110.143 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 163.46 53.99 0.02 OUTLIER Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.344 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 29.1 mttt -152.62 144.39 23.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.023 -1.281 . . . . 0.0 108.628 178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.482 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 73.0 m -85.82 159.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 109.526 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.3 mttt -140.41 129.69 23.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 69.2 m -95.06 117.19 29.76 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.304 -0.872 . . . . 0.0 110.058 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.538 ' CZ ' ' HD3' ' A' ' 35' ' ' LYS . 32.5 m-85 -120.88 99.99 46.56 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.507 -0.745 . . . . 0.0 109.041 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -60.55 141.95 96.65 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.008 1.805 . . . . 0.0 110.258 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.52 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.526 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.526 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.5 t30 -108.45 83.38 1.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.063 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 96.7 t -158.65 149.0 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -86.89 158.48 19.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.47 157.91 37.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.978 -1.076 . . . . 0.0 111.24 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.6 p -113.45 -9.87 13.28 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.0 p -168.01 138.51 2.22 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.0 Cg_exo -59.59 -14.08 24.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 121.726 1.617 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.508 ' O ' ' CD ' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -62.93 -46.79 86.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 108.981 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.497 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 5.0 mt-30 -72.28 -4.79 31.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.271 -0.893 . . . . 0.0 109.301 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.0 m -88.82 -29.2 19.89 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.382 -0.824 . . . . 0.0 109.985 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mp -67.64 -45.35 45.73 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.903 . . . . 0.0 112.188 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.1 Cg_exo -55.69 -53.08 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.565 1.51 . . . . 0.0 110.727 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -63.03 -47.77 7.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.611 1.541 . . . . 0.0 109.349 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.66 -11.18 60.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.665 -0.647 . . . . 0.0 109.449 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 15.0 ttpp -89.39 -9.88 48.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.294 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.15 4.88 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -106.9 -61.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.619 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 m-30 -84.71 -56.86 3.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 108.762 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 171.87 -155.24 23.48 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 28.8 tt0 -90.37 7.01 40.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.24 . . . . 0.0 109.521 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -110.82 -12.24 14.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.124 -0.985 . . . . 0.0 109.869 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -50.27 122.31 6.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.81 115.66 5.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -126.59 156.26 41.18 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.239 -1.154 . . . . 0.0 110.267 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.7 mtmt -145.11 -179.89 6.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.96 124.76 9.14 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.997 -1.064 . . . . 0.0 110.856 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.596 ' O ' ' C ' ' A' ' 31' ' ' ASN . 37.1 mtp -89.17 98.52 11.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.0 t30 4.89 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 121.341 0.591 . . . . 0.0 111.426 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.26 -46.45 0.16 Allowed Glycine 0 N--CA 1.483 1.83 0 C-N-CA 119.799 -1.191 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 10.2 mtmm -153.51 160.15 42.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.587 -1.537 . . . . 0.0 109.556 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 65.0 m -88.18 -179.18 6.11 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.644 0.735 . . . . 0.0 110.338 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -150.46 140.8 22.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.579 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 29.4 m -118.28 124.66 48.39 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 111.075 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.35 102.51 48.12 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.92 107.69 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.97 1.78 . . . . 0.0 110.141 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.54 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.541 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.541 ' N ' HG13 ' A' ' 3' ' ' ILE . 42.9 t-20 -107.49 81.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 86.7 t -159.72 151.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.86 162.48 16.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.175 -0.953 . . . . 0.0 108.928 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.8 155.65 33.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 111.243 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -111.62 -10.27 14.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.448 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 88.5 p -167.99 139.24 2.33 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.0 Cg_exo -60.11 -12.98 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.648 1.566 . . . . 0.0 110.122 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -69.43 -44.42 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 108.861 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.448 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 7.2 mt-30 -73.59 -4.78 36.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.102 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 90.3 m -86.83 -22.73 25.64 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 109.969 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 mp -67.64 -45.52 45.85 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.334 -0.854 . . . . 0.0 112.27 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.69 -53.23 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.495 1.464 . . . . 0.0 110.612 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -64.34 -43.55 14.04 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.731 1.621 . . . . 0.0 109.068 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 11.7 t -75.2 -6.88 52.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.723 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.513 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.7 ttpt -98.58 -9.83 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.422 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.4 11.28 37.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.281 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.72 -57.89 2.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 7.8 m-85 -85.86 -61.86 1.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 108.77 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.08 -160.0 29.59 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 4.4 tt0 -88.06 9.75 21.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.048 -1.266 . . . . 0.0 109.364 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -111.62 -15.84 13.38 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -49.79 122.7 6.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.018 . . . . 0.0 109.66 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.42 122.52 7.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -130.91 169.65 15.49 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.236 . . . . 0.0 110.687 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 42.6 mttp -151.02 176.5 11.07 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.71 124.76 9.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.815 -1.178 . . . . 0.0 110.899 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.597 ' O ' ' C ' ' A' ' 31' ' ' ASN . 6.4 mtt -89.8 99.52 12.51 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 30' ' ' MET . 1.0 OUTLIER 4.99 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.337 0.589 . . . . 0.0 111.507 -177.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.19 -44.35 0.19 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 25.8 mttt -153.41 158.87 42.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.376 -1.661 . . . . 0.0 109.792 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 55.7 m -87.99 178.56 6.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.634 0.73 . . . . 0.0 110.154 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -147.64 125.05 11.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.7 m -104.09 122.13 44.64 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.29 -0.882 . . . . 0.0 111.222 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -117.65 99.59 52.35 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.24 159.82 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.06 1.84 . . . . 0.0 110.353 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.463 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.524 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -112.18 66.85 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.073 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 6' ' ' LYS . 74.3 t -146.77 152.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 14.2 ptmt -87.57 165.85 15.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.95 . . . . 0.0 109.005 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 3.1 p -155.98 151.79 27.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.973 -1.08 . . . . 0.0 111.666 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.44 -10.72 14.55 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -167.92 136.55 1.98 Allowed Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 6.3 Cg_exo -58.39 -15.05 22.72 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.547 1.498 . . . . 0.0 109.943 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -63.6 -44.09 95.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.2 -4.89 41.5 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 87.4 m -88.28 -25.31 22.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.338 -0.851 . . . . 0.0 110.479 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.578 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -58.01 -46.29 99.7 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.888 -1.132 . . . . 0.0 112.543 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.12 -55.94 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.436 1.424 . . . . 0.0 111.844 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.96 -52.18 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.914 1.743 . . . . 0.0 110.719 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.589 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.72 -15.95 63.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.511 -0.743 . . . . 0.0 109.881 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 14' ' ' LEU . 8.1 ttmm -90.4 -24.54 20.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 0.0 109.788 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.9 -3.66 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.763 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.14 -49.41 5.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 4.8 m-85 -96.65 -65.35 0.97 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.255 -0.903 . . . . 0.0 108.862 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.88 -172.42 42.01 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.539 ' HA ' ' HG3' ' A' ' 18' ' ' LYS . 5.6 tt0 -67.83 -6.81 23.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.987 -1.302 . . . . 0.0 109.621 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -90.64 -10.38 43.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.118 -0.988 . . . . 0.0 109.866 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . . . -77.97 131.1 37.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 109.598 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -104.67 133.87 11.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.589 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -136.14 158.12 45.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.253 . . . . 0.0 109.791 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mmmt -142.25 -176.3 4.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.461 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -149.09 129.81 14.12 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 24.5 mtm -154.31 40.28 0.47 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 30' ' ' MET . 64.0 t30 179.87 39.73 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.98 21.24 69.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 40.2 mttt -153.08 152.2 31.06 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.256 -1.144 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 28' ' ' LYS . 57.7 m -88.45 -177.22 5.57 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.361 0.601 . . . . 0.0 109.933 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 7.7 ttmt -150.82 128.12 11.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 40.4 m -95.31 124.46 39.36 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 58.3 m-85 -119.83 95.12 49.06 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.345 -0.847 . . . . 0.0 108.871 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 2.7 Cg_endo -60.1 131.67 40.34 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.186 1.924 . . . . 0.0 110.261 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.5 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.532 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 11.5 m120 -104.68 82.83 1.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 63.2 t -159.32 148.3 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 109.594 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.65 159.2 20.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.263 -0.898 . . . . 0.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.9 p -156.0 154.58 31.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.014 -1.054 . . . . 0.0 111.388 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -113.8 -8.45 13.19 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.2 p -168.14 136.15 1.85 Allowed Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.513 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.7 Cg_exo -60.03 -13.95 25.79 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.567 1.511 . . . . 0.0 109.858 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' ' CD ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -64.83 -37.44 87.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 108.913 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 7.5 mt-30 -80.83 -5.14 56.87 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.9 m -87.87 -30.37 20.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 109.98 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.603 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -69.2 -44.64 27.79 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 112.251 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.7 Cg_exo -55.11 -52.57 7.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.322 1.348 . . . . 0.0 110.624 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.9 Cg_endo -64.15 -47.22 6.64 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.669 1.58 . . . . 0.0 109.359 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 t -71.55 -8.12 52.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.609 -0.682 . . . . 0.0 109.586 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.4 ttpt -92.86 -11.29 33.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.6 2.18 44.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -105.19 -57.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 m-30 -84.86 -67.08 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 108.586 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -176.35 -156.56 15.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 3.8 tt0 -90.48 5.82 46.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.034 -1.274 . . . . 0.0 109.582 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 25' ' ' ALA . 6.8 p -108.94 -15.45 14.37 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.149 -0.97 . . . . 0.0 109.725 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.501 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -44.45 123.76 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.693 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.12 5.77 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -126.43 163.26 23.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.176 -1.19 . . . . 0.0 110.402 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.6 mttp -153.41 177.75 10.55 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.0 122.58 8.56 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.086 -1.009 . . . . 0.0 110.986 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -86.08 98.31 10.79 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.5 p30 4.77 65.89 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 121.289 0.566 . . . . 0.0 111.473 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.66 -43.84 0.18 Allowed Glycine 0 N--CA 1.485 1.931 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.228 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 22.4 mttt -153.55 160.59 42.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.536 -1.567 . . . . 0.0 109.579 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 83.0 m -88.24 -177.47 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.7 0.762 . . . . 0.0 110.482 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 4.4 mttt -150.19 142.5 24.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 27.4 m -122.19 123.64 41.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 111.011 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -117.78 97.55 50.86 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.73 131.98 40.44 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.126 1.884 . . . . 0.0 110.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.323 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.513 ' N ' HG13 ' A' ' 3' ' ' ILE . 2.4 m120 -105.07 78.44 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 55.0 t -157.74 148.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.575 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 162.31 18.98 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.238 -0.914 . . . . 0.0 109.219 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 156.0 32.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.113 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 p -114.65 -7.84 12.72 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.5 p -167.83 136.57 2.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.507 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.1 Cg_exo -59.8 -14.44 27.08 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.562 1.508 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -66.13 -45.83 79.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 108.731 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -72.27 -4.8 31.72 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.381 -0.824 . . . . 0.0 109.047 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 87.5 m -89.39 -26.21 21.15 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 110.224 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -57.2 -46.5 99.83 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.421 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -57.97 -56.39 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.67 1.58 . . . . 0.0 111.854 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.77 -51.36 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.778 1.652 . . . . 0.0 110.259 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.575 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -67.91 -15.01 63.42 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.428 -0.795 . . . . 0.0 109.273 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 14.4 ttpp -86.29 -10.82 53.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.887 . . . . 0.0 109.264 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.71 15.12 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -61.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 109.476 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 1.7 m-30 -84.86 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.137 -0.977 . . . . 0.0 108.681 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -178.28 -166.19 34.2 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -73.33 -11.53 60.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.079 -1.248 . . . . 0.0 109.398 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -88.81 -21.56 23.68 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.269 -0.895 . . . . 0.0 109.45 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.58 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -44.79 129.56 7.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -108.1 125.95 8.08 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.575 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -132.12 153.89 50.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.296 . . . . 0.0 110.226 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 11.3 mttp -134.96 -177.14 4.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 109.496 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 122.89 8.46 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.024 -1.047 . . . . 0.0 110.795 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 2.5 mtp -85.0 97.55 9.88 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.7 OUTLIER 5.05 65.71 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 CA-C-O 121.336 0.589 . . . . 0.0 111.472 -177.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.28 -43.34 0.19 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 96.3 mttt -152.97 157.73 41.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.484 -1.597 . . . . 0.0 109.724 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 57.9 m -87.75 178.1 6.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.568 -0.707 . . . . 0.0 110.074 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.8 128.13 11.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.498 -0.751 . . . . 0.0 109.28 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 m -93.25 119.69 32.7 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.481 -0.762 . . . . 0.0 109.469 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.501 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.9 m-85 -115.87 100.04 53.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.279 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.7 Cg_exo -60.04 158.08 31.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.115 1.876 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.6 p80 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.481 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.543 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.258 0.551 . . . . 0.0 109.659 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -85.41 49.01 1.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.11 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 95.2 t -110.67 153.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.052 . . . . 0.0 109.464 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.78 157.96 20.84 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.162 -0.962 . . . . 0.0 109.457 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.5 p -156.54 155.7 32.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 111.188 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.1 p -112.49 -9.66 13.78 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.4 p -168.28 138.58 2.1 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -59.81 -14.32 26.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.52 1.48 . . . . 0.0 109.892 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -46.01 84.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.923 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -4.74 34.33 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 87.5 m -87.46 -25.37 23.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.316 -0.865 . . . . 0.0 110.295 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -57.7 -46.39 99.75 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.024 -1.047 . . . . 0.0 112.333 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -57.23 -55.92 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.606 1.537 . . . . 0.0 111.78 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.2 Cg_endo -61.69 -47.57 10.92 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.755 1.637 . . . . 0.0 109.999 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -73.51 -11.13 60.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.3 ttpp -97.92 -13.67 21.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.291 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.38 8.92 12.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -115.98 -56.74 2.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.492 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 6.4 m-85 -85.94 -65.82 0.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -0.946 . . . . 0.0 108.676 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.51 -168.66 40.17 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -73.82 -6.22 45.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.989 -1.3 . . . . 0.0 109.407 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.7 p -89.5 -23.08 22.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.211 -0.931 . . . . 0.0 109.747 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . . . -61.2 133.74 56.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -105.47 130.57 10.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -134.88 153.41 52.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.27 . . . . 0.0 109.677 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 18.2 mttt -138.25 -176.81 4.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.226 -0.921 . . . . 0.0 109.585 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.17 121.38 7.8 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.05 -1.031 . . . . 0.0 110.898 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.18 99.27 10.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 24.1 t30 4.76 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.288 0.566 . . . . 0.0 111.535 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.18 -44.51 0.19 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.349 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.2 mtmt -153.45 160.14 42.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.603 -1.528 . . . . 0.0 109.781 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.543 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.0 m -87.97 179.7 6.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.598 -0.689 . . . . 0.0 110.191 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -150.52 127.82 11.34 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.455 -0.778 . . . . 0.0 109.357 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.61 122.26 39.34 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.466 -0.772 . . . . 0.0 109.867 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.1 m-85 -119.38 94.5 48.43 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.64 164.7 10.94 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.126 1.884 . . . . 0.0 110.299 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.277 0.56 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -104.53 39.08 1.74 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 67.0 t -99.42 150.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.2 pttt -84.64 158.98 20.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.905 -1.122 . . . . 0.0 108.938 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.08 156.42 34.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 110.881 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 p -107.43 -3.94 19.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.1 p -166.36 140.7 3.54 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 1.2 Cg_endo -63.42 -9.93 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.962 1.775 . . . . 0.0 110.269 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 13.9 tttt -75.71 -40.34 55.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.61 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.403 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 19.4 mt-30 -72.27 -4.64 30.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.515 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 72.0 m -88.85 -29.3 19.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.255 -0.903 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 1.3 mp -66.94 -44.43 51.26 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 112.513 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -56.22 -53.33 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.403 1.402 . . . . 0.0 111.014 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -65.4 -45.43 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.744 1.629 . . . . 0.0 109.61 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.4 t -67.75 -16.59 64.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 110.0 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 32.5 ttmt -82.04 -9.55 59.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.142 -0.974 . . . . 0.0 109.43 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.14 21.44 2.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.36 -55.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.611 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.4 m-30 -85.01 -65.96 0.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 0.0 108.726 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 163.61 -170.63 39.04 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.54 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 7.4 tt0 -68.66 -6.38 25.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.073 -1.251 . . . . 0.0 109.637 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -90.26 -8.84 49.98 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -59.27 124.28 19.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.891 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -112.92 118.55 4.61 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -128.6 166.47 18.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.368 -1.078 . . . . 0.0 109.687 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 49.1 mtmt -136.03 -169.51 2.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.865 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 27.3 t -151.44 115.64 5.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' GLY . 4.8 mmt -85.38 -140.07 0.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 109.609 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.6 m120 -41.22 -27.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.938 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 161.98 53.41 0.02 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 4.8 mtpp -153.39 139.68 18.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.083 -1.245 . . . . 0.0 108.167 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.469 ' O ' HG13 ' A' ' 3' ' ' ILE . 71.2 m -85.2 159.57 20.08 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 110.594 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -139.42 122.97 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.516 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 32.9 m -92.75 122.33 35.04 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 111.127 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.593 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.7 m-85 -122.18 93.35 48.6 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.43 147.67 93.31 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.063 1.842 . . . . 0.0 110.131 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.51 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 3.9 t-20 -105.1 80.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 75.7 t -159.53 153.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -90.13 160.61 16.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -155.96 157.95 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 110.797 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -9.45 13.17 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.4 p -168.06 137.72 2.08 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.6 Cg_exo -59.46 -14.42 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.672 1.581 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.4 -45.21 80.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.924 . . . . 0.0 108.779 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -73.92 -5.21 39.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.391 -0.818 . . . . 0.0 109.029 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 96.0 m -89.19 -22.09 22.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 110.117 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.588 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -57.75 -46.45 99.74 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 120.992 -1.067 . . . . 0.0 112.202 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.22 -56.28 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.73 -51.26 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.861 1.707 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -68.93 -14.62 63.15 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.487 -0.758 . . . . 0.0 109.219 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.5 ttpp -83.48 -9.8 58.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.352 -0.842 . . . . 0.0 109.205 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.58 15.6 13.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.945 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -109.26 -64.96 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.862 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-85 -84.2 -66.8 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 108.531 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -171.95 -157.22 13.35 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.549 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 29.1 tt0 -81.56 -12.52 58.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.284 . . . . 0.0 109.57 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.1 p -92.71 -13.09 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.345 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.491 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -43.5 118.13 1.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -90.12 122.06 6.43 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -128.47 161.17 30.14 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.155 -1.203 . . . . 0.0 110.234 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -144.78 178.06 8.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.837 . . . . 0.0 109.657 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.15 123.06 8.73 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.242 -0.911 . . . . 0.0 110.876 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.587 ' O ' ' C ' ' A' ' 31' ' ' ASN . 3.9 mtp -87.04 96.97 10.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.587 ' C ' ' O ' ' A' ' 30' ' ' MET . 11.2 m120 4.82 65.54 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.395 0.617 . . . . 0.0 111.505 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.5 -41.38 0.18 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 39.5 mttt -153.53 157.69 40.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.511 -1.582 . . . . 0.0 109.766 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' HG22 ' A' ' 3' ' ' ILE . 59.4 m -87.36 179.53 6.58 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 110.075 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 8.5 mttt -150.62 134.34 16.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 41.9 m -103.04 117.44 34.58 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.3 m-85 -118.9 106.1 44.22 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 Cg_exo -59.86 130.11 33.45 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.986 1.791 . . . . 0.0 110.223 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.537 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.24 33.19 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.121 -0.987 . . . . 0.0 109.818 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 50.4 t -82.46 162.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 109.116 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.452 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -84.12 153.6 23.64 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.133 -0.979 . . . . 0.0 109.08 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.552 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 165.22 37.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.092 -1.005 . . . . 0.0 111.557 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.1 p -122.31 -7.86 8.71 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -168.24 143.81 3.05 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -60.57 -16.13 40.84 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.899 1.733 . . . . 0.0 109.896 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.05 -43.2 88.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.26 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' O ' ' CD ' ' A' ' 16' ' ' PRO . 92.5 mt-30 -71.84 -4.68 29.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.238 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 73.5 m -84.84 -29.17 25.54 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.361 -0.837 . . . . 0.0 109.972 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.608 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mp -69.41 -45.17 27.22 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.343 -0.848 . . . . 0.0 112.584 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.1 Cg_exo -55.25 -54.28 4.58 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.429 1.419 . . . . 0.0 110.745 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -66.91 -44.18 5.78 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.543 1.495 . . . . 0.0 108.859 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.8 t -73.52 -5.03 37.52 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.189 0.519 . . . . 0.0 109.727 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.539 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.7 ttpp -98.64 -9.51 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.06 14.75 26.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.78 -57.03 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 9.2 m-85 -85.53 -35.75 20.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 108.713 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 139.46 -160.32 25.96 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.539 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 8.1 tt0 -86.69 8.66 21.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -1.231 . . . . 0.0 109.362 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 p -107.46 -18.15 13.93 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -53.61 119.72 5.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -101.04 117.12 5.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -125.01 169.9 11.67 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 110.638 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.2 mttt -155.09 177.23 11.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -149.61 128.2 12.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.98 -1.075 . . . . 0.0 110.515 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.601 ' O ' ' C ' ' A' ' 31' ' ' ASN . 38.3 mtt -95.61 104.03 15.92 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 30' ' ' MET . 35.8 m-20 4.86 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.321 0.581 . . . . 0.0 111.338 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 175.6 -54.98 0.12 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.248 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.552 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mppt? -152.99 165.33 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.753 -1.439 . . . . 0.0 109.968 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 68.4 m -88.35 177.59 6.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.634 0.73 . . . . 0.0 110.365 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.45 128.8 12.08 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 30.9 m -102.99 122.3 44.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 111.117 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.566 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.0 m-85 -113.41 98.56 46.94 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.99 90.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.983 1.789 . . . . 0.0 110.163 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.468 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 12.6 pt . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 121.201 0.524 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.24 51.77 2.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 53.5 t -116.23 153.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.184 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.6 pttt -99.68 157.63 16.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 109.629 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -156.02 159.67 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.7 p -107.83 -6.22 16.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -166.74 140.02 3.12 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 2.7 Cg_endo -60.33 -13.94 27.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.565 1.51 . . . . 0.0 109.733 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -73.41 -41.19 63.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.18 -4.95 38.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.282 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' CB ' ' A' ' 7' ' ' CYS . 69.5 m -91.15 -22.85 20.46 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.413 -0.805 . . . . 0.0 109.99 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -67.74 -45.16 44.51 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.162 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -56.98 -53.81 4.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.446 1.43 . . . . 0.0 111.022 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -65.17 -44.92 8.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.756 1.638 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 24.6 t -67.28 -16.68 64.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.8 -0.562 . . . . 0.0 109.922 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.585 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 29.6 ttmt -85.75 -9.98 56.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.35 15.69 15.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.434 ' NE2' ' CZ ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -118.13 -59.72 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.86 . . . . 0.0 109.61 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 7.0 m-85 -87.01 -67.69 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 108.908 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 177.07 -169.03 41.21 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.585 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 19.5 tt0 -69.72 -4.87 21.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -1.234 . . . . 0.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 p -95.82 -8.23 34.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -59.39 123.85 18.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.015 -1.053 . . . . 0.0 109.689 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.11 127.36 7.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -137.22 158.79 43.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.24 . . . . 0.0 110.381 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 68.0 mttm -123.1 -168.92 1.84 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.42 -0.8 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.568 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 36.1 t -151.08 117.23 5.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' GLY . 8.9 mtm -84.56 -140.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.495 -0.753 . . . . 0.0 109.283 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m-80 -41.7 -28.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . 162.13 54.69 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 25.5 mttm -152.69 135.98 15.81 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.157 -1.202 . . . . 0.0 108.239 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 31.7 m -85.07 148.69 26.02 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.042 -1.036 . . . . 0.0 111.005 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.4 ttpm? -123.47 117.39 25.03 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.6 m -94.06 123.31 37.35 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.628 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.522 ' OH ' ' CE ' ' A' ' 35' ' ' LYS . 13.1 m-85 -117.99 104.7 48.34 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.96 140.2 91.63 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.077 1.851 . . . . 0.0 110.221 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.413 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.512 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.512 ' N ' HG13 ' A' ' 3' ' ' ILE . 39.4 t-20 -109.45 76.2 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.244 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 71.9 t -153.64 151.8 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.837 . . . . 0.0 109.428 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -85.02 164.4 18.28 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 154.94 32.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 0.0 111.72 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -114.27 -10.66 12.68 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -168.08 141.75 2.72 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.6 Cg_exo -60.41 -17.27 46.6 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.728 1.619 . . . . 0.0 109.849 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' O ' ' CD ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.82 -44.89 91.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.074 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 47.6 mt-30 -71.31 -4.81 28.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.283 -0.886 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 10' ' ' PRO . 74.1 m -85.86 -26.7 25.51 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.235 -0.915 . . . . 0.0 109.982 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.6 mm? -71.89 -45.77 11.93 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.458 -0.776 . . . . 0.0 112.017 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -54.84 -53.4 6.09 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.329 1.353 . . . . 0.0 110.437 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -66.67 -44.38 6.06 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.661 1.574 . . . . 0.0 109.041 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 12.7 t -73.31 -5.06 37.18 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.179 0.514 . . . . 0.0 109.832 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 9.5 ttpt -99.9 -9.43 22.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.986 -1.071 . . . . 0.0 109.341 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.1 11.89 38.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -120.13 -54.65 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.133 -0.979 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 8.4 m-85 -87.21 -46.33 9.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 108.702 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 154.53 -159.79 29.15 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -88.14 9.52 22.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.247 . . . . 0.0 109.46 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -108.4 -17.84 13.89 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.778 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -54.39 112.01 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -95.42 119.74 6.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -126.52 170.7 11.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.074 -1.25 . . . . 0.0 110.859 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 7.4 mttt -155.31 -177.81 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -149.79 131.95 15.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' CYS . 27.8 mtp -155.39 28.86 0.39 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.992 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -167.53 43.43 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 63.85 19.66 63.45 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.0 mtpt -153.21 155.81 37.33 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.17 -1.194 . . . . 0.0 109.604 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 28' ' ' LYS . 93.5 m -89.27 -178.91 5.75 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.513 0.673 . . . . 0.0 109.871 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.0 tmtt? -150.89 128.25 11.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 33.0 m -103.42 125.59 50.1 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 111.338 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.486 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 62.9 m-85 -114.89 96.59 45.14 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.66 154.2 56.49 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.062 1.841 . . . . 0.0 110.385 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.283 0.563 . . . . 0.0 109.647 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -91.76 64.43 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.456 ' HB ' HD12 ' A' ' 3' ' ' ILE . 72.8 t -145.72 148.71 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 1.9 ptpp? -95.6 162.12 13.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.231 -0.918 . . . . 0.0 109.45 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -155.71 158.14 37.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 111.113 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -8.38 16.51 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.446 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 73.8 p -166.6 139.83 3.18 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 3.9 Cg_exo -59.87 -14.35 27.0 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.747 1.631 . . . . 0.0 109.97 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -75.17 -39.83 60.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.295 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 2.4 mt-30 -73.5 -5.84 42.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 95.4 m -91.65 -21.51 20.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 109.89 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.602 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -64.89 -44.78 73.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 112.467 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.5 Cg_exo -55.86 -53.87 4.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.441 1.427 . . . . 0.0 110.875 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -63.79 -46.24 9.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.628 1.552 . . . . 0.0 109.372 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.1 t -70.71 -10.68 59.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.75 -0.594 . . . . 0.0 109.622 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 7.0 ttpt -91.9 -10.39 39.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 109.334 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.23 4.19 44.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -104.47 -61.7 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.6 m-30 -84.45 -52.71 5.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.704 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.15 -155.6 26.47 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 1.7 tt0 -90.18 7.37 38.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.09 -1.241 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -110.76 -14.02 14.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.089 -1.007 . . . . 0.0 109.928 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -46.68 126.96 9.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.701 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.22 120.13 6.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -131.72 176.47 8.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -1.186 . . . . 0.0 110.274 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 33.4 mmtm -150.24 -166.49 2.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 109.214 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.565 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 25.0 t -151.08 103.56 3.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.042 -1.036 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -103.78 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 1.7 t-20 -80.96 67.02 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.544 -0.722 . . . . 0.0 110.06 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.13 46.1 94.81 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.6 mttp -154.12 137.33 15.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.109 -1.23 . . . . 0.0 108.399 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 32.8 m -85.79 149.61 25.14 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.584 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 17.4 mtmt -123.6 124.37 42.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.1 m -103.23 122.88 45.67 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.247 -0.908 . . . . 0.0 111.165 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.63 104.85 46.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -58.8 148.93 81.01 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.896 1.731 . . . . 0.0 109.999 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.561 -179.778 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.516 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -110.8 65.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.833 . . . . 0.0 109.354 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.435 ' HB ' HD12 ' A' ' 3' ' ' ILE . 89.2 t -142.34 150.61 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 109.333 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -89.93 163.46 14.96 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.128 -0.982 . . . . 0.0 109.107 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 160.89 39.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.672 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 p -110.68 -4.6 15.29 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.4 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 66.6 p -166.47 140.94 3.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 1.5 Cg_endo -62.12 -12.19 25.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.798 1.665 . . . . 0.0 109.967 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -77.98 -38.57 44.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.426 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 6.0 mt-30 -73.09 -4.97 35.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -0.916 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.446 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 84.6 m -91.88 -27.19 18.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.358 -0.839 . . . . 0.0 110.041 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -65.56 -44.79 66.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.237 -0.914 . . . . 0.0 112.27 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.8 -53.5 5.47 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.492 1.462 . . . . 0.0 110.956 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 3.1 Cg_exo -62.21 -46.51 12.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.742 1.628 . . . . 0.0 109.638 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.11 -14.65 63.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.554 -0.716 . . . . 0.0 109.482 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.576 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.4 ttmp? -81.3 -9.69 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.167 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.72 14.31 19.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.46 -0.775 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tt0 -126.65 -57.27 1.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.627 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.583 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.7 m-30 -84.67 -66.76 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 108.739 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 169.05 -169.69 42.03 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.576 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.13 -4.59 22.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.015 -1.286 . . . . 0.0 109.728 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 p -94.23 -8.07 40.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.226 -0.922 . . . . 0.0 109.587 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -58.34 122.2 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.941 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.54 121.11 6.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -131.85 157.16 44.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.98 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -126.39 -168.21 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.614 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 28.0 t -151.42 120.19 6.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.963 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' GLY . 28.9 mtp -84.72 -143.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.368 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 30' ' ' MET . 28.4 t-20 -43.7 -26.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 33' ' ' LYS . . . 164.38 55.24 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 27.0 mttt -152.9 138.51 17.78 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.103 -1.234 . . . . 0.0 108.358 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 81.5 m -85.11 156.17 21.17 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 110.702 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 12.3 mttm -135.1 127.44 30.28 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.544 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 30.4 m -100.62 124.48 46.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.874 0.845 . . . . 0.0 111.452 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -125.82 96.53 37.61 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.48 147.45 94.25 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.116 1.877 . . . . 0.0 110.081 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 4.9 pt . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.14 63.1 5.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.41 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 3' ' ' ILE . 72.6 t -143.48 151.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.609 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 5.8 mtpp -95.31 166.77 11.73 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.305 -0.872 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.21 159.96 39.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 110.66 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.464 ' OG1' ' OE1' ' A' ' 12' ' ' GLN . 13.3 p -111.77 -8.71 14.14 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 p -167.06 137.93 2.54 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 4.3 Cg_exo -59.38 -14.66 25.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.71 1.607 . . . . 0.0 109.939 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -70.9 -42.03 70.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.295 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.464 ' OE1' ' OG1' ' A' ' 8' ' ' THR . 63.8 mt-30 -74.16 -4.63 36.92 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 68.8 m -91.47 -23.78 19.88 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.275 -0.89 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -66.77 -44.54 53.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.319 -0.863 . . . . 0.0 112.402 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.71 -53.51 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.483 1.455 . . . . 0.0 110.951 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.59 -46.39 7.18 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.643 1.562 . . . . 0.0 109.251 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.22 -10.72 59.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.725 -0.61 . . . . 0.0 109.725 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.532 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 16.2 ttpp -91.71 -9.91 42.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.424 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.16 -6.32 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.288 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -93.93 -61.86 1.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.609 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 1.7 m-30 -84.34 -66.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 108.85 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -179.57 -155.87 16.25 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 2.6 tt0 -88.49 5.97 40.02 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.086 -1.244 . . . . 0.0 109.524 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.0 p -109.34 -13.1 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.177 -0.952 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -45.25 123.9 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.29 116.73 5.63 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -132.53 172.29 12.7 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.094 -1.239 . . . . 0.0 110.666 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 38.9 mttp -154.09 -167.03 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.557 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 6.6 t -151.14 121.07 7.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.88 -1.138 . . . . 0.0 109.721 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.507 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.5 mmt -98.52 -135.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.108 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m120 -35.28 -31.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.9 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 158.37 49.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.499 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.1 mtpp -153.61 150.38 28.58 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.972 -1.311 . . . . 0.0 108.147 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 58.3 m -86.76 152.25 22.67 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 110.132 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 5.8 mmtm -122.98 121.63 36.58 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 28.8 m -104.09 119.45 38.97 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.102 -0.999 . . . . 0.0 111.159 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 35.3 m-85 -110.85 93.98 18.76 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 2.5 Cg_endo -61.56 152.19 75.11 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.122 1.881 . . . . 0.0 110.303 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 p80 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.505 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p-10 -103.22 77.3 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 21.5 t -157.46 145.24 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 7.7 mttm -84.8 164.06 18.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.046 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.4 159.76 39.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.11 -0.994 . . . . 0.0 111.384 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -111.98 -12.51 13.73 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p -168.32 139.3 2.19 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 5.3 Cg_exo -59.01 -14.29 22.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.642 1.561 . . . . 0.0 109.893 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -64.57 -46.87 80.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.249 -0.907 . . . . 0.0 108.823 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 mt-30 -72.71 -4.98 34.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.112 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 92.6 m -89.06 -26.71 21.25 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.88 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.6 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -65.95 -44.98 63.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 112.537 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.9 Cg_exo -55.21 -53.23 6.18 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.356 1.37 . . . . 0.0 110.751 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.39 -44.15 12.34 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.702 1.601 . . . . 0.0 109.614 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 10.4 t -72.74 -10.39 59.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.71 -0.618 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.539 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.3 ttpt -96.9 -9.58 28.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.523 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.4 8.86 44.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.33 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.31 -58.09 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 8.7 m-85 -84.88 -62.81 1.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 108.575 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.27 -159.73 29.01 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.539 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 61.0 tt0 -86.91 4.77 40.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.265 . . . . 0.0 109.366 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -107.83 -13.89 14.9 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.166 -0.959 . . . . 0.0 110.191 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -52.06 119.32 4.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.563 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.29 117.85 5.28 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -126.63 163.39 23.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.127 -1.22 . . . . 0.0 110.563 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.9 mtmt -153.64 178.97 9.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 0.0 109.272 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -150.6 124.55 9.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.011 -1.055 . . . . 0.0 110.861 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 5.8 mtp -90.53 98.45 11.78 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.8 OUTLIER 4.93 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.393 -177.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.84 -47.45 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.153 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 19.7 mtmm -153.86 161.97 41.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.543 -1.563 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.464 ' O ' HG21 ' A' ' 3' ' ' ILE . 55.9 m -88.52 -179.96 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 110.393 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.5 mttt -150.57 140.41 21.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 36.2 m -119.71 131.08 55.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.229 -0.92 . . . . 0.0 110.806 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -122.0 95.17 47.73 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.79 148.67 91.3 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.147 1.898 . . . . 0.0 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.368 179.86 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.525 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 1.1 t-20 -105.25 78.78 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 61.8 t -158.7 148.46 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.633 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -84.58 161.02 20.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.201 -0.937 . . . . 0.0 109.184 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -155.78 156.11 34.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 111.084 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -8.05 12.65 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.463 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 80.2 p -167.91 138.87 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 Cg_endo -61.35 -13.3 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.704 1.603 . . . . 0.0 109.813 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -44.84 76.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.768 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 10.9 mt-30 -74.29 -4.55 36.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.416 -0.802 . . . . 0.0 109.273 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 94.6 m -88.84 -23.95 22.68 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.589 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -57.44 -46.96 99.75 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.404 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.3 Cg_exo -57.33 -56.21 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 121.665 1.577 . . . . 0.0 111.799 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.4 Cg_endo -61.24 -49.98 6.79 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.657 1.572 . . . . 0.0 110.032 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.581 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -70.34 -12.38 61.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 14' ' ' LEU . 16.6 ttpp -94.94 -9.81 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.36 11.79 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -119.46 -56.81 2.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.747 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 6.1 m-85 -85.15 -66.2 0.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 108.723 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.05 -172.25 42.08 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.517 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 15.8 tt0 -69.91 -4.9 22.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.016 -1.285 . . . . 0.0 109.55 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 p -92.25 -21.49 20.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 109.794 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.532 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . . . -62.0 133.91 55.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.988 . . . . 0.0 109.568 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -106.41 129.96 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.581 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -133.95 147.02 51.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.968 -1.313 . . . . 0.0 109.867 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.4 mttt -129.44 -176.16 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 123.18 8.62 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.072 -1.017 . . . . 0.0 110.764 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.589 ' O ' ' C ' ' A' ' 31' ' ' ASN . 82.2 mtp -86.28 99.8 11.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 30' ' ' MET . 4.9 m120 4.6 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.222 0.534 . . . . 0.0 111.516 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 170.82 -44.84 0.19 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.423 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 11.2 mtmm -153.34 159.9 42.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.49 -1.594 . . . . 0.0 109.715 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 57.3 m -87.72 179.61 6.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.518 0.675 . . . . 0.0 110.238 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 3.1 ttpt -150.63 128.86 11.96 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.426 -0.796 . . . . 0.0 109.26 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 38.6 m -95.3 120.11 34.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 30.2 m-85 -115.16 94.08 37.62 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.405 -0.809 . . . . 0.0 108.99 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -61.45 140.97 90.42 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.205 1.937 . . . . 0.0 110.043 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.483 -179.96 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.522 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.522 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.7 m-20 -109.45 69.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 0.0 109.215 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 49.5 t -143.56 146.87 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -86.32 159.95 19.26 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.219 -0.926 . . . . 0.0 109.596 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.5 p -156.06 145.6 20.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.141 -0.974 . . . . 0.0 110.575 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.33 -5.44 40.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.6 p -167.05 140.48 3.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.583 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 2.3 Cg_endo -62.22 -11.26 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -41.45 62.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.365 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 5.4 mt-30 -74.46 -4.72 38.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 90.4 m -88.56 -21.14 24.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.6 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.1 mm? -70.71 -45.15 17.01 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 111.892 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -55.24 -52.46 7.75 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.303 1.336 . . . . 0.0 110.627 -178.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.8 Cg_endo -67.47 -44.23 4.86 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.724 1.616 . . . . 0.0 109.229 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.22 -7.53 49.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.797 -0.565 . . . . 0.0 109.886 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.522 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.1 ttpt -97.26 -9.35 27.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.96 5.84 45.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.917 . . . . 0.0 109.54 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.95 -54.48 2.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 6.7 m-85 -89.47 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.44 -156.63 18.81 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.522 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.8 tt0 -90.16 4.69 49.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.17 -1.194 . . . . 0.0 109.376 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -106.72 -16.35 14.51 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.105 -0.997 . . . . 0.0 109.953 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.83 119.43 2.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.984 -1.072 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.81 124.0 8.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -135.54 166.73 22.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.257 . . . . 0.0 110.683 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 3.5 mtmp? -139.94 -166.2 2.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.341 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.583 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 29.9 t -150.49 116.7 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 32' ' ' GLY . 5.1 mtp -84.67 -140.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.1 OUTLIER -41.09 -27.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.111 -179.637 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 162.11 52.7 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -153.13 140.98 20.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.038 -1.272 . . . . 0.0 108.185 178.35 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' HG21 ' A' ' 3' ' ' ILE . 56.4 m -85.15 151.04 24.41 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.091 -1.005 . . . . 0.0 110.296 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.577 ' HG2' ' CE2' ' A' ' 37' ' ' TYR . 10.9 tttt -126.7 118.74 25.34 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 43.2 m -97.26 124.92 41.5 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.37 -0.831 . . . . 0.0 111.133 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.577 ' CE2' ' HG2' ' A' ' 35' ' ' LYS . 29.1 m-85 -116.15 99.57 52.77 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.02 104.61 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.054 1.836 . . . . 0.0 110.034 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.486 -179.794 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.194 0.521 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -132.09 40.35 3.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 41.6 t -106.91 156.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' N ' HG11 ' A' ' 5' ' ' VAL . 10.9 pttp -85.02 158.16 20.55 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.08 156.07 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 111.33 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.2 p -112.78 -10.44 13.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 p -168.27 137.87 2.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 5.4 Cg_exo -58.95 -15.12 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 121.505 1.47 . . . . 0.0 109.843 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -45.58 84.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 108.732 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 62.8 mm-40 -72.47 -5.61 37.94 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.336 -0.853 . . . . 0.0 109.192 179.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 92.5 m -89.62 -25.77 21.12 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.32 -0.863 . . . . 0.0 110.337 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.59 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -57.72 -46.12 99.77 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 112.356 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.4 Cg_exo -57.53 -56.06 2.03 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.547 1.498 . . . . 0.0 111.654 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -61.45 -50.18 6.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.682 1.588 . . . . 0.0 109.945 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.551 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -69.11 -13.43 62.42 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.521 -0.737 . . . . 0.0 109.138 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.0 ttpt -95.58 -10.6 29.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.352 -0.842 . . . . 0.0 109.524 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.04 16.88 5.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -123.07 -55.87 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 7.2 m-85 -85.92 -63.37 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 108.855 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.13 -171.83 42.0 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 24.4 tt0 -73.21 -1.68 18.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.958 -1.319 . . . . 0.0 109.592 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -95.58 -21.01 18.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.919 . . . . 0.0 109.814 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . . . -60.92 129.04 39.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -101.83 129.46 9.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -131.2 159.34 38.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.101 -1.235 . . . . 0.0 109.748 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.3 mttm -143.57 -176.77 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.39 122.25 8.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.969 -1.082 . . . . 0.0 110.678 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.07 97.54 9.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.058 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 5.1 p-10 4.99 65.62 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.472 0.653 . . . . 0.0 111.449 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.12 -44.05 0.18 Allowed Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.8 -1.191 . . . . 0.0 111.162 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 38.3 mttt -153.42 160.41 42.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.509 -1.583 . . . . 0.0 109.828 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.2 m -87.69 177.77 6.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.619 -0.675 . . . . 0.0 110.123 -179.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 5.6 mtmt -150.95 131.04 13.46 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.5 m -98.21 118.55 35.09 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.459 -0.775 . . . . 0.0 109.896 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.5 m-85 -116.59 90.55 31.37 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 108.927 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 3.4 Cg_exo -59.9 105.71 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.331 2.021 . . . . 0.0 110.23 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.471 -179.988 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.2 pt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.49 23.18 14.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.492 HG11 ' N ' ' A' ' 6' ' ' LYS . 53.6 t -74.83 158.2 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 0.0 109.123 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.492 ' N ' HG11 ' A' ' 5' ' ' VAL . 50.4 tttp -84.39 158.59 21.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.132 -0.98 . . . . 0.0 109.075 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.17 159.91 39.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 111.619 -178.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -115.53 -9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -168.02 138.3 2.18 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 3.6 Cg_exo -60.26 -13.23 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.524 1.482 . . . . 0.0 109.958 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 3.8 tptm -65.56 -46.2 80.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.218 -0.926 . . . . 0.0 108.74 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 29.6 mt-30 -72.5 -4.53 30.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.436 -0.79 . . . . 0.0 109.132 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.4 m -87.47 -27.81 22.44 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.296 -0.877 . . . . 0.0 110.336 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -69.68 -44.75 24.51 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 112.437 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.79 -53.33 5.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.361 1.374 . . . . 0.0 110.636 -178.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -67.0 -43.58 6.39 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.708 1.605 . . . . 0.0 109.261 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 43.2 t -71.13 -10.59 60.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.862 -0.524 . . . . 0.0 110.129 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 25.8 ttmt -95.47 -9.51 32.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 0.0 109.639 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.16 10.97 8.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.97 -56.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.63 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 6.2 m-85 -84.92 -63.13 1.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 108.816 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 158.3 -171.68 35.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.547 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 3.8 tm0? -67.98 -6.11 20.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.078 -1.248 . . . . 0.0 109.725 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -92.91 -9.12 41.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.578 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -70.37 122.72 20.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.41 122.38 7.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -127.43 161.89 27.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -1.156 . . . . 0.0 109.893 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 13.4 mttt -146.53 177.91 8.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.58 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.58 124.56 9.29 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -179.775 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.7 100.14 13.05 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.103 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.593 ' C ' ' O ' ' A' ' 30' ' ' MET . 33.2 m-20 4.88 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.398 0.618 . . . . 0.0 111.349 -177.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 174.28 -49.59 0.14 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.233 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 2.3 mptt -153.38 162.54 41.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.568 -1.548 . . . . 0.0 109.776 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 62.8 m -88.49 179.81 6.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.672 0.749 . . . . 0.0 110.655 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -150.38 133.36 16.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.878 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.8 m -108.08 120.49 42.48 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.391 -0.818 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -118.36 101.53 51.05 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.11 108.26 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.953 1.768 . . . . 0.0 110.242 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.495 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.493 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.408 HG23 ' HG3' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -47.5 119.16 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.229 -0.919 . . . . 0.0 109.199 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 34' ' ' CYS . 4.3 pt -103.38 138.74 26.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 110.118 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -88.4 31.93 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 16.7 t -74.72 159.01 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 108.911 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -87.47 156.11 19.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.59 158.04 36.38 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.174 0.988 . . . . 0.0 111.727 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -113.7 -12.1 12.85 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.8 p -168.43 138.22 1.99 Allowed Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 5.7 Cg_exo -58.82 -14.61 22.95 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.633 1.555 . . . . 0.0 110.103 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -42.61 93.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.157 -0.964 . . . . 0.0 108.774 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 42.0 mt-30 -75.34 -5.05 42.8 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.39 -0.818 . . . . 0.0 109.349 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 94.4 m -85.06 -26.38 27.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.345 -0.847 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -69.87 -46.58 23.81 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.359 -0.838 . . . . 0.0 112.279 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.01 -53.26 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.358 1.372 . . . . 0.0 110.449 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.95 -44.27 10.3 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.602 1.535 . . . . 0.0 108.863 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 10.2 t -75.27 -3.79 35.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.4 ttpt -100.26 -9.64 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.235 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.48 -10.18 28.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.339 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -95.38 -56.67 2.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 8.8 m-85 -86.98 -61.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 108.895 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.16 -160.62 34.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.525 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 16.2 tt0 -83.71 7.63 17.05 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.11 -1.229 . . . . 0.0 109.428 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -108.29 -16.19 14.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.468 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -54.67 113.42 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.069 -1.02 . . . . 0.0 109.651 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.09 121.0 6.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -133.54 160.19 38.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.099 -1.236 . . . . 0.0 110.678 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 4.7 mmtp -144.51 -178.28 5.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.53 121.98 7.92 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.987 -1.07 . . . . 0.0 110.851 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -85.35 98.52 10.59 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.8 OUTLIER 4.82 65.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.338 0.589 . . . . 0.0 111.452 -177.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.39 -44.14 0.18 Allowed Glycine 0 N--CA 1.483 1.804 0 C-N-CA 119.746 -1.216 . . . . 0.0 111.3 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.5 mttt -153.26 160.48 42.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.477 -1.602 . . . . 0.0 109.929 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 71.9 m -88.04 178.81 6.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.65 0.738 . . . . 0.0 110.126 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 16.8 ttmt -150.4 124.09 9.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 1' ' ' THR . 33.9 m -102.75 127.12 50.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 111.354 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.473 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 27.6 m-85 -119.67 96.91 49.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 1' ' ' THR . 3.1 Cg_exo -60.95 138.22 77.35 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.107 1.871 . . . . 0.0 110.24 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 33' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 35' ' ' LYS . 44.9 mt -107.42 -56.68 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.545 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -85.01 171.74 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.154 -0.966 . . . . 0.0 109.215 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.534 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -113.75 56.94 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 3' ' ' ILE . 96.6 t -139.2 153.31 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 109.731 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -88.44 164.19 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.093 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.12 156.88 35.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 111.178 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.4 p -112.5 -10.23 13.74 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.463 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 64.6 p -168.16 137.19 1.97 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.2 Cg_exo -59.32 -14.27 23.94 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.534 1.49 . . . . 0.0 109.878 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -66.31 -45.83 79.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 108.616 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 4.8 mt-30 -72.5 -4.76 32.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.434 -0.791 . . . . 0.0 109.027 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 96.8 m -89.26 -23.37 22.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.385 -0.822 . . . . 0.0 110.463 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -58.48 -46.15 99.63 Favored Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 112.148 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.2 Cg_exo -58.94 -56.28 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.626 1.551 . . . . 0.0 111.868 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.68 -51.28 2.53 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.936 1.757 . . . . 0.0 110.586 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.546 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.98 -17.05 64.32 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.465 -0.772 . . . . 0.0 109.401 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 14' ' ' LEU . 12.4 ttmm -81.01 -10.87 59.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.388 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.11 33.22 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.756 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.81 -61.18 0.9 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.401 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.2 m-85 -84.91 -65.76 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 178.41 -168.67 39.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.533 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 2.6 tt0 -69.67 -10.73 59.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.329 . . . . 0.0 109.393 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -89.84 -8.4 52.09 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.194 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.556 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -54.93 122.06 10.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.012 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.88 120.55 6.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.546 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -128.45 157.27 41.56 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.952 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -139.01 -177.16 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.508 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.89 122.27 7.87 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.064 -1.022 . . . . 0.0 110.953 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.598 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -85.55 97.98 10.37 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.598 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.3 p30 4.81 65.84 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.348 0.594 . . . . 0.0 111.518 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.55 -44.12 0.18 Allowed Glycine 0 N--CA 1.484 1.892 0 C-N-CA 119.748 -1.215 . . . . 0.0 111.323 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 76.7 mttt -153.44 159.9 42.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.424 -1.633 . . . . 0.0 109.764 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 55.5 m -88.21 178.28 6.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.608 -0.683 . . . . 0.0 110.236 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.47 132.58 15.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.325 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.99 119.61 35.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 32.4 m-85 -121.37 97.49 47.24 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.462 -0.774 . . . . 0.0 109.338 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.8 Cg_endo -61.55 140.92 89.61 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.089 1.859 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.6 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.437 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.29 0.567 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.411 ' CD1' ' CE1' ' A' ' 37' ' ' TYR . 96.7 mt -88.8 -49.12 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.551 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.534 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -105.48 154.09 6.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.099 -1.0 . . . . 0.0 108.746 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.534 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p30 -111.08 78.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 108.976 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 72.4 t -158.5 152.47 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HG2' ' N ' ' A' ' 7' ' ' CYS . 32.7 tttm -91.77 162.13 14.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 108.798 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.531 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -156.02 158.59 38.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.949 -1.094 . . . . 0.0 111.353 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -113.49 -10.75 13.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 p -168.16 139.27 2.26 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -59.78 -14.11 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 121.606 1.538 . . . . 0.0 109.919 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -63.76 -45.13 91.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.314 -0.867 . . . . 0.0 109.106 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 2.2 mt-30 -74.84 -5.03 41.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 92.5 m -88.68 -27.56 21.17 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.419 -0.801 . . . . 0.0 110.052 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.609 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -67.91 -45.2 42.64 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.227 -0.92 . . . . 0.0 112.225 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.66 -52.9 6.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.327 1.352 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.73 -44.63 10.19 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.768 1.645 . . . . 0.0 109.341 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 11.8 t -73.46 -8.65 56.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.79 -0.569 . . . . 0.0 109.776 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.529 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 3.1 ttpt -95.57 -9.58 31.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.71 -9.33 29.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -92.61 -58.73 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 9.1 m-85 -85.66 -60.95 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 168.44 -161.09 34.81 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.529 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 42.5 tt0 -84.72 10.05 12.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.246 . . . . 0.0 109.465 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -111.73 -15.55 13.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.337 -0.852 . . . . 0.0 109.79 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.487 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -55.31 123.23 13.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 109.787 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.69 117.14 5.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -125.88 165.46 18.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 110.412 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.9 mttp -154.7 179.32 9.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.243 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.32 124.75 9.58 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.888 -1.133 . . . . 0.0 110.948 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -88.94 98.67 11.88 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 7.1 m120 4.66 66.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.412 0.625 . . . . 0.0 111.542 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.47 -46.84 0.17 Allowed Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 2.5 mtmp? -153.33 160.44 42.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.561 -1.552 . . . . 0.0 109.522 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 57.2 m -88.13 -178.73 6.02 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 110.284 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.74 134.96 16.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.1 m -114.27 120.43 40.39 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.239 -0.913 . . . . 0.0 111.018 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.411 ' CE1' ' CD1' ' A' ' 2' ' ' ILE . 19.6 m-85 -113.23 98.99 47.94 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.57 141.48 95.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.146 1.898 . . . . 0.0 110.382 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.396 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.57 -41.82 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 109.462 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -101.01 155.03 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.031 -1.043 . . . . 0.0 108.913 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.511 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 23.7 t30 -106.9 81.72 1.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.086 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG11 ' N ' ' A' ' 6' ' ' LYS . 79.9 t -159.18 151.59 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.514 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -97.68 165.83 11.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 108.685 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.43 164.01 38.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.915 -1.116 . . . . 0.0 111.373 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.4 p -112.83 -10.71 13.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.49 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 31.8 p -167.33 141.87 3.16 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 1.9 Cg_endo -61.99 -10.24 17.06 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.793 1.662 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.541 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -77.17 -40.08 46.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.147 -0.971 . . . . 0.0 109.117 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.49 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 19.2 mt-30 -75.78 -4.71 42.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 56.4 m -89.55 -19.98 24.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.326 -0.859 . . . . 0.0 109.853 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.597 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -58.2 -44.41 99.22 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 112.37 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 6.2 Cg_exo -57.35 -56.31 1.91 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.633 1.555 . . . . 0.0 111.759 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -63.09 -49.82 4.46 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.71 1.607 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -70.18 -12.58 61.7 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.693 -0.629 . . . . 0.0 109.519 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -85.46 -9.93 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.439 -0.788 . . . . 0.0 109.071 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.65 41.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.264 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -106.88 -62.94 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-30 -84.22 -63.36 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.62 -156.72 18.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.7 tt0 -80.18 -9.99 59.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.037 -1.272 . . . . 0.0 109.346 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -95.75 -12.15 25.86 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.561 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -44.21 111.67 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -88.93 117.79 4.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -126.79 145.95 50.43 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 109.609 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.0 mttm -119.05 -168.3 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.547 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 6.0 t -150.61 123.98 8.96 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.282 -0.887 . . . . 0.0 109.658 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -95.18 -141.38 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.399 -0.813 . . . . 0.0 110.044 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.9 m-20 -38.43 -30.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 0.0 110.143 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 163.46 53.99 0.02 OUTLIER Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.344 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 29.1 mttt -152.62 144.39 23.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.023 -1.281 . . . . 0.0 108.628 178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.482 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 73.0 m -85.82 159.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 109.526 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.3 mttt -140.41 129.69 23.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.644 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 69.2 m -95.06 117.19 29.76 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.304 -0.872 . . . . 0.0 110.058 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.538 ' CZ ' ' HD3' ' A' ' 35' ' ' LYS . 32.5 m-85 -120.88 99.99 46.56 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.507 -0.745 . . . . 0.0 109.041 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -60.55 141.95 96.65 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.008 1.805 . . . . 0.0 110.258 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.52 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 9.9 mt -75.45 -28.07 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.511 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.526 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -103.55 154.0 5.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.095 -1.003 . . . . 0.0 108.721 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.526 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.5 t30 -108.45 83.38 1.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.063 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 96.7 t -158.65 149.0 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -86.89 158.48 19.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.47 157.91 37.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.978 -1.076 . . . . 0.0 111.24 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.6 p -113.45 -9.87 13.28 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.0 p -168.01 138.51 2.22 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.0 Cg_exo -59.59 -14.08 24.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 121.726 1.617 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.508 ' O ' ' CD ' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -62.93 -46.79 86.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 108.981 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.497 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 5.0 mt-30 -72.28 -4.79 31.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.271 -0.893 . . . . 0.0 109.301 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.0 m -88.82 -29.2 19.89 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.382 -0.824 . . . . 0.0 109.985 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mp -67.64 -45.35 45.73 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.903 . . . . 0.0 112.188 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.1 Cg_exo -55.69 -53.08 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.565 1.51 . . . . 0.0 110.727 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -63.03 -47.77 7.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.611 1.541 . . . . 0.0 109.349 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.66 -11.18 60.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.665 -0.647 . . . . 0.0 109.449 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 15.0 ttpp -89.39 -9.88 48.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.294 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.15 4.88 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -106.9 -61.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.619 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 m-30 -84.71 -56.86 3.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 108.762 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 171.87 -155.24 23.48 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 28.8 tt0 -90.37 7.01 40.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.24 . . . . 0.0 109.521 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -110.82 -12.24 14.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.124 -0.985 . . . . 0.0 109.869 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.554 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -50.27 122.31 6.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.81 115.66 5.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -126.59 156.26 41.18 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.239 -1.154 . . . . 0.0 110.267 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.7 mtmt -145.11 -179.89 6.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.96 124.76 9.14 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.997 -1.064 . . . . 0.0 110.856 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.596 ' O ' ' C ' ' A' ' 31' ' ' ASN . 37.1 mtp -89.17 98.52 11.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.0 t30 4.89 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 121.341 0.591 . . . . 0.0 111.426 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.26 -46.45 0.16 Allowed Glycine 0 N--CA 1.483 1.83 0 C-N-CA 119.799 -1.191 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 10.2 mtmm -153.51 160.15 42.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.587 -1.537 . . . . 0.0 109.556 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 65.0 m -88.18 -179.18 6.11 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.644 0.735 . . . . 0.0 110.338 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -150.46 140.8 22.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.579 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 29.4 m -118.28 124.66 48.39 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 111.075 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.35 102.51 48.12 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.92 107.69 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.97 1.78 . . . . 0.0 110.141 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.54 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.534 HG22 HD11 ' A' ' 2' ' ' ILE . 39.9 mm -73.89 -38.91 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.541 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -109.31 155.2 10.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.253 -0.904 . . . . 0.0 108.922 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.541 ' N ' HG13 ' A' ' 3' ' ' ILE . 42.9 t-20 -107.49 81.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 86.7 t -159.72 151.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.86 162.48 16.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.175 -0.953 . . . . 0.0 108.928 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.8 155.65 33.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 111.243 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -111.62 -10.27 14.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.448 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 88.5 p -167.99 139.24 2.33 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.0 Cg_exo -60.11 -12.98 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.648 1.566 . . . . 0.0 110.122 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -69.43 -44.42 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 108.861 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 7.2 mt-30 -73.59 -4.78 36.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.102 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 90.3 m -86.83 -22.73 25.64 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 109.969 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.5 mp -67.64 -45.52 45.85 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.334 -0.854 . . . . 0.0 112.27 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.69 -53.23 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.495 1.464 . . . . 0.0 110.612 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -64.34 -43.55 14.04 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.731 1.621 . . . . 0.0 109.068 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 11.7 t -75.2 -6.88 52.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.723 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.513 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.7 ttpt -98.58 -9.83 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.422 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.4 11.28 37.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.281 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.72 -57.89 2.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 7.8 m-85 -85.86 -61.86 1.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 108.77 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.08 -160.0 29.59 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 4.4 tt0 -88.06 9.75 21.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.048 -1.266 . . . . 0.0 109.364 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -111.62 -15.84 13.38 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -49.79 122.7 6.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.018 . . . . 0.0 109.66 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.42 122.52 7.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -130.91 169.65 15.49 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.236 . . . . 0.0 110.687 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 42.6 mttp -151.02 176.5 11.07 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.71 124.76 9.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.815 -1.178 . . . . 0.0 110.899 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.597 ' O ' ' C ' ' A' ' 31' ' ' ASN . 6.4 mtt -89.8 99.52 12.51 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 30' ' ' MET . 1.0 OUTLIER 4.99 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.337 0.589 . . . . 0.0 111.507 -177.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.19 -44.35 0.19 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 25.8 mttt -153.41 158.87 42.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.376 -1.661 . . . . 0.0 109.792 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 55.7 m -87.99 178.56 6.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.634 0.73 . . . . 0.0 110.154 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -147.64 125.05 11.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.7 m -104.09 122.13 44.64 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.29 -0.882 . . . . 0.0 111.222 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -117.65 99.59 52.35 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.24 159.82 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.06 1.84 . . . . 0.0 110.353 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.463 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.509 ' CG2' ' HB2' ' A' ' 36' ' ' CYS . 4.8 mt -96.32 -35.23 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.27 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -104.53 154.75 6.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.257 -0.902 . . . . 0.0 108.766 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.524 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -112.18 66.85 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.073 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 6' ' ' LYS . 74.3 t -146.77 152.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 14.2 ptmt -87.57 165.85 15.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.95 . . . . 0.0 109.005 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 3.1 p -155.98 151.79 27.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.973 -1.08 . . . . 0.0 111.666 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.44 -10.72 14.55 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -167.92 136.55 1.98 Allowed Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 6.3 Cg_exo -58.39 -15.05 22.72 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.547 1.498 . . . . 0.0 109.943 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -63.6 -44.09 95.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.2 -4.89 41.5 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 87.4 m -88.28 -25.31 22.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.338 -0.851 . . . . 0.0 110.479 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.578 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -58.01 -46.29 99.7 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.888 -1.132 . . . . 0.0 112.543 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.12 -55.94 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.436 1.424 . . . . 0.0 111.844 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.96 -52.18 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.914 1.743 . . . . 0.0 110.719 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.589 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.72 -15.95 63.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.511 -0.743 . . . . 0.0 109.881 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 14' ' ' LEU . 8.1 ttmm -90.4 -24.54 20.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 0.0 109.788 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.9 -3.66 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.763 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.14 -49.41 5.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 4.8 m-85 -96.65 -65.35 0.97 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.255 -0.903 . . . . 0.0 108.862 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.88 -172.42 42.01 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.539 ' HA ' ' HG3' ' A' ' 18' ' ' LYS . 5.6 tt0 -67.83 -6.81 23.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.987 -1.302 . . . . 0.0 109.621 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -90.64 -10.38 43.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.118 -0.988 . . . . 0.0 109.866 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . . . -77.97 131.1 37.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 109.598 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -104.67 133.87 11.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.589 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -136.14 158.12 45.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.253 . . . . 0.0 109.791 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mmmt -142.25 -176.3 4.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.461 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -149.09 129.81 14.12 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' A' ' 31' ' ' ASN . 24.5 mtm -154.31 40.28 0.47 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 30' ' ' MET . 64.0 t30 179.87 39.73 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.98 21.24 69.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 40.2 mttt -153.08 152.2 31.06 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.256 -1.144 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 28' ' ' LYS . 57.7 m -88.45 -177.22 5.57 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.361 0.601 . . . . 0.0 109.933 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 7.7 ttmt -150.82 128.12 11.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 40.4 m -95.31 124.46 39.36 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 58.3 m-85 -119.83 95.12 49.06 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.345 -0.847 . . . . 0.0 108.871 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 2.7 Cg_endo -60.1 131.67 40.34 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.186 1.924 . . . . 0.0 110.261 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.5 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.429 ' CG2' ' HD3' ' A' ' 33' ' ' LYS . 5.7 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.343 0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.427 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 35.2 mt -59.08 -53.66 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 0.0 109.386 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -102.22 155.47 4.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.193 -0.942 . . . . 0.0 108.621 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.532 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 11.5 m120 -104.68 82.83 1.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 63.2 t -159.32 148.3 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 109.594 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.65 159.2 20.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.263 -0.898 . . . . 0.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.9 p -156.0 154.58 31.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.014 -1.054 . . . . 0.0 111.388 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -113.8 -8.45 13.19 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.2 p -168.14 136.15 1.85 Allowed Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.513 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.7 Cg_exo -60.03 -13.95 25.79 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.567 1.511 . . . . 0.0 109.858 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' ' CD ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -64.83 -37.44 87.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 108.913 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 7.5 mt-30 -80.83 -5.14 56.87 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.9 m -87.87 -30.37 20.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 109.98 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.603 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -69.2 -44.64 27.79 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 112.251 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.7 Cg_exo -55.11 -52.57 7.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.322 1.348 . . . . 0.0 110.624 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.9 Cg_endo -64.15 -47.22 6.64 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.669 1.58 . . . . 0.0 109.359 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 t -71.55 -8.12 52.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.609 -0.682 . . . . 0.0 109.586 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.4 ttpt -92.86 -11.29 33.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.6 2.18 44.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -105.19 -57.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 m-30 -84.86 -67.08 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 108.586 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -176.35 -156.56 15.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 3.8 tt0 -90.48 5.82 46.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.034 -1.274 . . . . 0.0 109.582 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 25' ' ' ALA . 6.8 p -108.94 -15.45 14.37 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.149 -0.97 . . . . 0.0 109.725 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.501 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -44.45 123.76 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.693 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.12 5.77 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -126.43 163.26 23.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.176 -1.19 . . . . 0.0 110.402 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.6 mttp -153.41 177.75 10.55 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.0 122.58 8.56 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.086 -1.009 . . . . 0.0 110.986 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -86.08 98.31 10.79 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.5 p30 4.77 65.89 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 121.289 0.566 . . . . 0.0 111.473 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.66 -43.84 0.18 Allowed Glycine 0 N--CA 1.485 1.931 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.228 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 22.4 mttt -153.55 160.59 42.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.536 -1.567 . . . . 0.0 109.579 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 83.0 m -88.24 -177.47 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.7 0.762 . . . . 0.0 110.482 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 4.4 mttt -150.19 142.5 24.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 27.4 m -122.19 123.64 41.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 111.011 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -117.78 97.55 50.86 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.73 131.98 40.44 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.126 1.884 . . . . 0.0 110.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.323 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.499 HG13 ' CG ' ' A' ' 35' ' ' LYS . 3.5 mt -119.21 -33.68 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.613 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -101.27 154.63 4.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.126 -0.984 . . . . 0.0 108.844 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.513 ' N ' HG13 ' A' ' 3' ' ' ILE . 2.4 m120 -105.07 78.44 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 55.0 t -157.74 148.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.575 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 162.31 18.98 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.238 -0.914 . . . . 0.0 109.219 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 156.0 32.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.113 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 p -114.65 -7.84 12.72 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.5 p -167.83 136.57 2.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.507 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.1 Cg_exo -59.8 -14.44 27.08 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.562 1.508 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -66.13 -45.83 79.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 108.731 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -72.27 -4.8 31.72 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.381 -0.824 . . . . 0.0 109.047 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 87.5 m -89.39 -26.21 21.15 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 110.224 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -57.2 -46.5 99.83 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.421 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -57.97 -56.39 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.67 1.58 . . . . 0.0 111.854 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.77 -51.36 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.778 1.652 . . . . 0.0 110.259 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.575 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -67.91 -15.01 63.42 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.428 -0.795 . . . . 0.0 109.273 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 14.4 ttpp -86.29 -10.82 53.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.887 . . . . 0.0 109.264 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.71 15.12 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -61.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 109.476 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 1.7 m-30 -84.86 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.137 -0.977 . . . . 0.0 108.681 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -178.28 -166.19 34.2 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -73.33 -11.53 60.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.079 -1.248 . . . . 0.0 109.398 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -88.81 -21.56 23.68 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.269 -0.895 . . . . 0.0 109.45 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.58 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -44.79 129.56 7.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -108.1 125.95 8.08 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.575 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -132.12 153.89 50.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.296 . . . . 0.0 110.226 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 11.3 mttp -134.96 -177.14 4.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 109.496 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 122.89 8.46 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.024 -1.047 . . . . 0.0 110.795 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 2.5 mtp -85.0 97.55 9.88 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.7 OUTLIER 5.05 65.71 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 CA-C-O 121.336 0.589 . . . . 0.0 111.472 -177.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.28 -43.34 0.19 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 96.3 mttt -152.97 157.73 41.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.484 -1.597 . . . . 0.0 109.724 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 57.9 m -87.75 178.1 6.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.568 -0.707 . . . . 0.0 110.074 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.8 128.13 11.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.498 -0.751 . . . . 0.0 109.28 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 m -93.25 119.69 32.7 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.481 -0.762 . . . . 0.0 109.469 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.501 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.9 m-85 -115.87 100.04 53.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.279 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.7 Cg_exo -60.04 158.08 31.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.115 1.876 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.6 p80 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.481 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.467 ' O ' HG12 ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.545 HG22 ' CE ' ' A' ' 35' ' ' LYS . 3.5 mt -154.2 154.89 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.865 . . . . 0.0 109.346 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.543 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -124.55 138.22 54.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.103 -0.998 . . . . 0.0 109.659 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -85.41 49.01 1.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.11 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 95.2 t -110.67 153.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.052 . . . . 0.0 109.464 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.78 157.96 20.84 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.162 -0.962 . . . . 0.0 109.457 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.5 p -156.54 155.7 32.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 111.188 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.1 p -112.49 -9.66 13.78 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.4 p -168.28 138.58 2.1 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -59.81 -14.32 26.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.52 1.48 . . . . 0.0 109.892 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -46.01 84.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.923 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -4.74 34.33 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 87.5 m -87.46 -25.37 23.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.316 -0.865 . . . . 0.0 110.295 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -57.7 -46.39 99.75 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.024 -1.047 . . . . 0.0 112.333 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -57.23 -55.92 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.606 1.537 . . . . 0.0 111.78 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.2 Cg_endo -61.69 -47.57 10.92 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.755 1.637 . . . . 0.0 109.999 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -73.51 -11.13 60.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.3 ttpp -97.92 -13.67 21.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.291 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.38 8.92 12.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -115.98 -56.74 2.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.492 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 6.4 m-85 -85.94 -65.82 0.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -0.946 . . . . 0.0 108.676 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.51 -168.66 40.17 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -73.82 -6.22 45.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.989 -1.3 . . . . 0.0 109.407 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.7 p -89.5 -23.08 22.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.211 -0.931 . . . . 0.0 109.747 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . . . -61.2 133.74 56.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -105.47 130.57 10.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -134.88 153.41 52.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.27 . . . . 0.0 109.677 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 18.2 mttt -138.25 -176.81 4.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.226 -0.921 . . . . 0.0 109.585 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.17 121.38 7.8 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.05 -1.031 . . . . 0.0 110.898 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.18 99.27 10.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 24.1 t30 4.76 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.288 0.566 . . . . 0.0 111.535 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.18 -44.51 0.19 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.349 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.2 mtmt -153.45 160.14 42.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.603 -1.528 . . . . 0.0 109.781 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.543 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.0 m -87.97 179.7 6.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.598 -0.689 . . . . 0.0 110.191 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' CE ' HG22 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -150.52 127.82 11.34 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.455 -0.778 . . . . 0.0 109.357 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.61 122.26 39.34 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.466 -0.772 . . . . 0.0 109.867 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.1 m-85 -119.38 94.5 48.43 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.64 164.7 10.94 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.126 1.884 . . . . 0.0 110.299 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.464 ' O ' HG12 ' A' ' 2' ' ' ILE . 4.9 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 35' ' ' LYS . 13.9 mt -156.28 160.3 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.373 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -125.89 144.67 35.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.183 -0.948 . . . . 0.0 109.493 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -104.53 39.08 1.74 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 67.0 t -99.42 150.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.2 pttt -84.64 158.98 20.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.905 -1.122 . . . . 0.0 108.938 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.08 156.42 34.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 110.881 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 p -107.43 -3.94 19.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.1 p -166.36 140.7 3.54 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 1.2 Cg_endo -63.42 -9.93 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.962 1.775 . . . . 0.0 110.269 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 13.9 tttt -75.71 -40.34 55.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.61 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.403 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 19.4 mt-30 -72.27 -4.64 30.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.515 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 72.0 m -88.85 -29.3 19.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.255 -0.903 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.593 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 1.3 mp -66.94 -44.43 51.26 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 112.513 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -56.22 -53.33 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.403 1.402 . . . . 0.0 111.014 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -65.4 -45.43 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.744 1.629 . . . . 0.0 109.61 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.4 t -67.75 -16.59 64.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 110.0 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 32.5 ttmt -82.04 -9.55 59.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.142 -0.974 . . . . 0.0 109.43 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.14 21.44 2.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.36 -55.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.611 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.4 m-30 -85.01 -65.96 0.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 0.0 108.726 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 163.61 -170.63 39.04 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.54 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 7.4 tt0 -68.66 -6.38 25.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.073 -1.251 . . . . 0.0 109.637 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -90.26 -8.84 49.98 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -59.27 124.28 19.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.891 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -112.92 118.55 4.61 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -128.6 166.47 18.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.368 -1.078 . . . . 0.0 109.687 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 49.1 mtmt -136.03 -169.51 2.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.865 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 27.3 t -151.44 115.64 5.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' GLY . 4.8 mmt -85.38 -140.07 0.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 109.609 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.6 m120 -41.22 -27.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.938 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 161.98 53.41 0.02 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.591 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 4.8 mtpp -153.39 139.68 18.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.083 -1.245 . . . . 0.0 108.167 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.469 ' O ' HG13 ' A' ' 3' ' ' ILE . 71.2 m -85.2 159.57 20.08 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 110.594 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -139.42 122.97 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.516 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 32.9 m -92.75 122.33 35.04 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 111.127 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.593 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.7 m-85 -122.18 93.35 48.6 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.43 147.67 93.31 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.063 1.842 . . . . 0.0 110.131 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.486 ' N ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.295 0.569 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.425 HD13 ' CE1' ' A' ' 37' ' ' TYR . 77.5 mt -121.44 -31.9 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -102.2 156.43 4.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.15 -0.969 . . . . 0.0 108.675 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.51 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 3.9 t-20 -105.1 80.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 75.7 t -159.53 153.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -90.13 160.61 16.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -155.96 157.95 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 110.797 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -9.45 13.17 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.4 p -168.06 137.72 2.08 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.6 Cg_exo -59.46 -14.42 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.672 1.581 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.4 -45.21 80.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.924 . . . . 0.0 108.779 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -73.92 -5.21 39.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.391 -0.818 . . . . 0.0 109.029 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 96.0 m -89.19 -22.09 22.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 110.117 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.588 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -57.75 -46.45 99.74 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 120.992 -1.067 . . . . 0.0 112.202 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.22 -56.28 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.73 -51.26 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.861 1.707 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -68.93 -14.62 63.15 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.487 -0.758 . . . . 0.0 109.219 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.5 ttpp -83.48 -9.8 58.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.352 -0.842 . . . . 0.0 109.205 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.58 15.6 13.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.945 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -109.26 -64.96 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.862 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-85 -84.2 -66.8 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 108.531 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -171.95 -157.22 13.35 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.549 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 29.1 tt0 -81.56 -12.52 58.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.284 . . . . 0.0 109.57 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.1 p -92.71 -13.09 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.345 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.491 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -43.5 118.13 1.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -90.12 122.06 6.43 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -128.47 161.17 30.14 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.155 -1.203 . . . . 0.0 110.234 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.503 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -144.78 178.06 8.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.837 . . . . 0.0 109.657 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.15 123.06 8.73 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.242 -0.911 . . . . 0.0 110.876 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.587 ' O ' ' C ' ' A' ' 31' ' ' ASN . 3.9 mtp -87.04 96.97 10.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.587 ' C ' ' O ' ' A' ' 30' ' ' MET . 11.2 m120 4.82 65.54 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.395 0.617 . . . . 0.0 111.505 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.5 -41.38 0.18 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 39.5 mttt -153.53 157.69 40.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.511 -1.582 . . . . 0.0 109.766 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' HG22 ' A' ' 3' ' ' ILE . 59.4 m -87.36 179.53 6.58 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 110.075 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 8.5 mttt -150.62 134.34 16.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 41.9 m -103.04 117.44 34.58 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.3 m-85 -118.9 106.1 44.22 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 Cg_exo -59.86 130.11 33.45 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.986 1.791 . . . . 0.0 110.223 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.537 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.466 ' O ' HG13 ' A' ' 2' ' ' ILE . 23.6 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -149.44 151.74 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.1 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -123.8 147.01 28.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.44 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.24 33.19 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.121 -0.987 . . . . 0.0 109.818 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 50.4 t -82.46 162.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 109.116 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -84.12 153.6 23.64 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.133 -0.979 . . . . 0.0 109.08 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.552 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 165.22 37.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.092 -1.005 . . . . 0.0 111.557 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.1 p -122.31 -7.86 8.71 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -168.24 143.81 3.05 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -60.57 -16.13 40.84 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.899 1.733 . . . . 0.0 109.896 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.05 -43.2 88.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.26 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' O ' ' CD ' ' A' ' 16' ' ' PRO . 92.5 mt-30 -71.84 -4.68 29.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.238 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 73.5 m -84.84 -29.17 25.54 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.361 -0.837 . . . . 0.0 109.972 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.608 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mp -69.41 -45.17 27.22 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.343 -0.848 . . . . 0.0 112.584 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.1 Cg_exo -55.25 -54.28 4.58 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.429 1.419 . . . . 0.0 110.745 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -66.91 -44.18 5.78 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.543 1.495 . . . . 0.0 108.859 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.8 t -73.52 -5.03 37.52 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.189 0.519 . . . . 0.0 109.727 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.539 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.7 ttpp -98.64 -9.51 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.06 14.75 26.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.78 -57.03 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 9.2 m-85 -85.53 -35.75 20.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 108.713 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 139.46 -160.32 25.96 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.539 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 8.1 tt0 -86.69 8.66 21.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -1.231 . . . . 0.0 109.362 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 p -107.46 -18.15 13.93 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -53.61 119.72 5.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -101.04 117.12 5.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -125.01 169.9 11.67 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 110.638 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.2 mttt -155.09 177.23 11.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' HB2' ' HA ' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -149.61 128.2 12.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.98 -1.075 . . . . 0.0 110.515 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.601 ' O ' ' C ' ' A' ' 31' ' ' ASN . 38.3 mtt -95.61 104.03 15.92 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 30' ' ' MET . 35.8 m-20 4.86 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.321 0.581 . . . . 0.0 111.338 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 175.6 -54.98 0.12 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.248 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mppt? -152.99 165.33 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.753 -1.439 . . . . 0.0 109.968 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 68.4 m -88.35 177.59 6.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.634 0.73 . . . . 0.0 110.365 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.45 128.8 12.08 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 30.9 m -102.99 122.3 44.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 111.117 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.566 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.0 m-85 -113.41 98.56 46.94 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.99 90.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.983 1.789 . . . . 0.0 110.163 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.468 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 36' ' ' CYS . 9.0 t . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.596 ' N ' ' CD1' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -152.88 145.88 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 0.0 108.9 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 12.6 pt -95.07 150.87 3.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.222 -0.924 . . . . 0.0 109.65 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.24 51.77 2.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 53.5 t -116.23 153.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.184 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.6 pttt -99.68 157.63 16.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 109.629 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -156.02 159.67 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.7 p -107.83 -6.22 16.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -166.74 140.02 3.12 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 2.7 Cg_endo -60.33 -13.94 27.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.565 1.51 . . . . 0.0 109.733 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -73.41 -41.19 63.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.18 -4.95 38.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.282 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' CB ' ' A' ' 7' ' ' CYS . 69.5 m -91.15 -22.85 20.46 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.413 -0.805 . . . . 0.0 109.99 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -67.74 -45.16 44.51 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.162 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -56.98 -53.81 4.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.446 1.43 . . . . 0.0 111.022 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -65.17 -44.92 8.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.756 1.638 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 24.6 t -67.28 -16.68 64.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.8 -0.562 . . . . 0.0 109.922 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.585 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 29.6 ttmt -85.75 -9.98 56.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.35 15.69 15.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.434 ' NE2' ' CZ ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -118.13 -59.72 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.86 . . . . 0.0 109.61 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 7.0 m-85 -87.01 -67.69 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 108.908 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.491 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 177.07 -169.03 41.21 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.585 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 19.5 tt0 -69.72 -4.87 21.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -1.234 . . . . 0.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 p -95.82 -8.23 34.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -59.39 123.85 18.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.015 -1.053 . . . . 0.0 109.689 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.11 127.36 7.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -137.22 158.79 43.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.24 . . . . 0.0 110.381 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 68.0 mttm -123.1 -168.92 1.84 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.42 -0.8 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.568 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 36.1 t -151.08 117.23 5.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' GLY . 8.9 mtm -84.56 -140.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.495 -0.753 . . . . 0.0 109.283 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m-80 -41.7 -28.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . 162.13 54.69 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 25.5 mttm -152.69 135.98 15.81 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.157 -1.202 . . . . 0.0 108.239 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.503 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 31.7 m -85.07 148.69 26.02 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.042 -1.036 . . . . 0.0 111.005 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.4 ttpm? -123.47 117.39 25.03 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.6 m -94.06 123.31 37.35 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.628 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.522 ' OH ' ' CE ' ' A' ' 35' ' ' LYS . 13.1 m-85 -117.99 104.7 48.34 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.96 140.2 91.63 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.077 1.851 . . . . 0.0 110.221 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.413 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.514 HG21 ' N ' ' A' ' 3' ' ' ILE . 3.5 tt -124.02 -38.6 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 109.445 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.514 ' N ' HG21 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -87.68 153.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.512 ' N ' HG13 ' A' ' 3' ' ' ILE . 39.4 t-20 -109.45 76.2 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.244 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 71.9 t -153.64 151.8 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.837 . . . . 0.0 109.428 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -85.02 164.4 18.28 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 154.94 32.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 0.0 111.72 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -114.27 -10.66 12.68 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -168.08 141.75 2.72 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.6 Cg_exo -60.41 -17.27 46.6 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.728 1.619 . . . . 0.0 109.849 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' O ' ' CD ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.82 -44.89 91.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.074 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 47.6 mt-30 -71.31 -4.81 28.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.283 -0.886 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 10' ' ' PRO . 74.1 m -85.86 -26.7 25.51 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.235 -0.915 . . . . 0.0 109.982 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.595 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.6 mm? -71.89 -45.77 11.93 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.458 -0.776 . . . . 0.0 112.017 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -54.84 -53.4 6.09 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.329 1.353 . . . . 0.0 110.437 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -66.67 -44.38 6.06 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.661 1.574 . . . . 0.0 109.041 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 12.7 t -73.31 -5.06 37.18 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.179 0.514 . . . . 0.0 109.832 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 9.5 ttpt -99.9 -9.43 22.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.986 -1.071 . . . . 0.0 109.341 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.1 11.89 38.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -120.13 -54.65 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.133 -0.979 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 8.4 m-85 -87.21 -46.33 9.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 108.702 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 154.53 -159.79 29.15 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -88.14 9.52 22.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.247 . . . . 0.0 109.46 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -108.4 -17.84 13.89 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.778 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -54.39 112.01 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -95.42 119.74 6.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -126.52 170.7 11.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.074 -1.25 . . . . 0.0 110.859 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 7.4 mttt -155.31 -177.81 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -149.79 131.95 15.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 29' ' ' CYS . 27.8 mtp -155.39 28.86 0.39 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.992 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -167.53 43.43 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 63.85 19.66 63.45 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.0 mtpt -153.21 155.81 37.33 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.17 -1.194 . . . . 0.0 109.604 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 28' ' ' LYS . 93.5 m -89.27 -178.91 5.75 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.513 0.673 . . . . 0.0 109.871 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.0 tmtt? -150.89 128.25 11.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 33.0 m -103.42 125.59 50.1 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 111.338 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.486 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 62.9 m-85 -114.89 96.59 45.14 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.66 154.2 56.49 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.062 1.841 . . . . 0.0 110.385 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.443 ' HB ' ' HA ' ' A' ' 35' ' ' LYS . 22.2 mm -117.79 -55.92 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.0 OUTLIER -84.26 158.74 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.017 -1.052 . . . . 0.0 109.647 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -91.76 64.43 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.456 ' HB ' HD12 ' A' ' 3' ' ' ILE . 72.8 t -145.72 148.71 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 1.9 ptpp? -95.6 162.12 13.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.231 -0.918 . . . . 0.0 109.45 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -155.71 158.14 37.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 111.113 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -8.38 16.51 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.446 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 73.8 p -166.6 139.83 3.18 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 3.9 Cg_exo -59.87 -14.35 27.0 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.747 1.631 . . . . 0.0 109.97 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -75.17 -39.83 60.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.295 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 2.4 mt-30 -73.5 -5.84 42.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 95.4 m -91.65 -21.51 20.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 109.89 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.602 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.1 mp -64.89 -44.78 73.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 112.467 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.5 Cg_exo -55.86 -53.87 4.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.441 1.427 . . . . 0.0 110.875 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -63.79 -46.24 9.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.628 1.552 . . . . 0.0 109.372 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.1 t -70.71 -10.68 59.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.75 -0.594 . . . . 0.0 109.622 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 7.0 ttpt -91.9 -10.39 39.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 109.334 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.23 4.19 44.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -104.47 -61.7 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.6 m-30 -84.45 -52.71 5.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.704 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.15 -155.6 26.47 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 1.7 tt0 -90.18 7.37 38.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.09 -1.241 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -110.76 -14.02 14.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.089 -1.007 . . . . 0.0 109.928 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.563 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -46.68 126.96 9.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.701 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.22 120.13 6.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -131.72 176.47 8.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -1.186 . . . . 0.0 110.274 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 33.4 mmtm -150.24 -166.49 2.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 109.214 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.565 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 25.0 t -151.08 103.56 3.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.042 -1.036 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -103.78 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 1.7 t-20 -80.96 67.02 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.544 -0.722 . . . . 0.0 110.06 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.13 46.1 94.81 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.6 mttp -154.12 137.33 15.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.109 -1.23 . . . . 0.0 108.399 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 32.8 m -85.79 149.61 25.14 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.584 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 17.4 mtmt -123.6 124.37 42.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.1 m -103.23 122.88 45.67 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.247 -0.908 . . . . 0.0 111.165 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.63 104.85 46.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -58.8 148.93 81.01 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.896 1.731 . . . . 0.0 109.999 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.561 -179.778 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.52 -33.7 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.93 . . . . 0.0 109.544 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -101.02 155.01 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.195 -0.941 . . . . 0.0 108.646 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.516 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -110.8 65.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.833 . . . . 0.0 109.354 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.435 ' HB ' HD12 ' A' ' 3' ' ' ILE . 89.2 t -142.34 150.61 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 109.333 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -89.93 163.46 14.96 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.128 -0.982 . . . . 0.0 109.107 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 160.89 39.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.672 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 p -110.68 -4.6 15.29 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.4 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 66.6 p -166.47 140.94 3.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 1.5 Cg_endo -62.12 -12.19 25.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.798 1.665 . . . . 0.0 109.967 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -77.98 -38.57 44.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.426 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 6.0 mt-30 -73.09 -4.97 35.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -0.916 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.446 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 84.6 m -91.88 -27.19 18.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.358 -0.839 . . . . 0.0 110.041 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -65.56 -44.79 66.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.237 -0.914 . . . . 0.0 112.27 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.8 -53.5 5.47 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.492 1.462 . . . . 0.0 110.956 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 3.1 Cg_exo -62.21 -46.51 12.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.742 1.628 . . . . 0.0 109.638 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.11 -14.65 63.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.554 -0.716 . . . . 0.0 109.482 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.576 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.4 ttmp? -81.3 -9.69 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.167 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.72 14.31 19.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.46 -0.775 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tt0 -126.65 -57.27 1.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.627 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.583 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 1.7 m-30 -84.67 -66.76 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 108.739 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 169.05 -169.69 42.03 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.576 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.13 -4.59 22.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.015 -1.286 . . . . 0.0 109.728 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 p -94.23 -8.07 40.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.226 -0.922 . . . . 0.0 109.587 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -58.34 122.2 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.941 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.54 121.11 6.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -131.85 157.16 44.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.98 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -126.39 -168.21 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.614 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 28.0 t -151.42 120.19 6.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.963 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' GLY . 28.9 mtp -84.72 -143.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.368 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 30' ' ' MET . 28.4 t-20 -43.7 -26.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 33' ' ' LYS . . . 164.38 55.24 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 27.0 mttt -152.9 138.51 17.78 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.103 -1.234 . . . . 0.0 108.358 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 81.5 m -85.11 156.17 21.17 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 110.702 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 12.3 mttm -135.1 127.44 30.28 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.544 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 30.4 m -100.62 124.48 46.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.874 0.845 . . . . 0.0 111.452 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -125.82 96.53 37.61 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.48 147.45 94.25 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.116 1.877 . . . . 0.0 110.081 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.508 ' CG2' ' N ' ' A' ' 2' ' ' ILE . 16.3 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.54 ' N ' ' CD1' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -148.7 147.34 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 109.232 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 4.9 pt -100.27 160.5 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.21 -0.931 . . . . 0.0 109.433 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.14 63.1 5.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.41 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 3' ' ' ILE . 72.6 t -143.48 151.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.609 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 5.8 mtpp -95.31 166.77 11.73 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.305 -0.872 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.21 159.96 39.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 110.66 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.464 ' OG1' ' OE1' ' A' ' 12' ' ' GLN . 13.3 p -111.77 -8.71 14.14 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 p -167.06 137.93 2.54 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 4.3 Cg_exo -59.38 -14.66 25.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.71 1.607 . . . . 0.0 109.939 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -70.9 -42.03 70.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.295 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.464 ' OE1' ' OG1' ' A' ' 8' ' ' THR . 63.8 mt-30 -74.16 -4.63 36.92 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 68.8 m -91.47 -23.78 19.88 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.275 -0.89 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -66.77 -44.54 53.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.319 -0.863 . . . . 0.0 112.402 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.71 -53.51 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.483 1.455 . . . . 0.0 110.951 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.59 -46.39 7.18 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.643 1.562 . . . . 0.0 109.251 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.5 t -70.22 -10.72 59.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.725 -0.61 . . . . 0.0 109.725 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.532 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 16.2 ttpp -91.71 -9.91 42.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.424 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.16 -6.32 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.288 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -93.93 -61.86 1.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.609 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 1.7 m-30 -84.34 -66.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 108.85 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -179.57 -155.87 16.25 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 2.6 tt0 -88.49 5.97 40.02 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.086 -1.244 . . . . 0.0 109.524 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.0 p -109.34 -13.1 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.177 -0.952 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . . . -45.25 123.9 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.29 116.73 5.63 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -132.53 172.29 12.7 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.094 -1.239 . . . . 0.0 110.666 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 38.9 mttp -154.09 -167.03 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.557 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 6.6 t -151.14 121.07 7.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.88 -1.138 . . . . 0.0 109.721 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.507 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.5 mmt -98.52 -135.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.108 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m120 -35.28 -31.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.9 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 158.37 49.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.499 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.1 mtpp -153.61 150.38 28.58 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.972 -1.311 . . . . 0.0 108.147 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 58.3 m -86.76 152.25 22.67 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 110.132 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 5.8 mmtm -122.98 121.63 36.58 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 28.8 m -104.09 119.45 38.97 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.102 -0.999 . . . . 0.0 111.159 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 35.3 m-85 -110.85 93.98 18.76 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 2.5 Cg_endo -61.56 152.19 75.11 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.122 1.881 . . . . 0.0 110.303 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 p80 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 3' ' ' ILE . 46.2 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.1 mt -97.33 -42.01 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.902 . . . . 0.0 109.611 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -100.82 154.5 4.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.173 -0.954 . . . . 0.0 108.7 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.505 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p-10 -103.22 77.3 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 21.5 t -157.46 145.24 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 7.7 mttm -84.8 164.06 18.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.046 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.4 159.76 39.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.11 -0.994 . . . . 0.0 111.384 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -111.98 -12.51 13.73 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p -168.32 139.3 2.19 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 5.3 Cg_exo -59.01 -14.29 22.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.642 1.561 . . . . 0.0 109.893 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -64.57 -46.87 80.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.249 -0.907 . . . . 0.0 108.823 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 mt-30 -72.71 -4.98 34.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.112 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 92.6 m -89.06 -26.71 21.25 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.88 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.6 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -65.95 -44.98 63.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 112.537 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.9 Cg_exo -55.21 -53.23 6.18 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.356 1.37 . . . . 0.0 110.751 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.39 -44.15 12.34 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.702 1.601 . . . . 0.0 109.614 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 10.4 t -72.74 -10.39 59.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.71 -0.618 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.539 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.3 ttpt -96.9 -9.58 28.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.523 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.4 8.86 44.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.33 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.31 -58.09 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 8.7 m-85 -84.88 -62.81 1.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 108.575 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.27 -159.73 29.01 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.539 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 61.0 tt0 -86.91 4.77 40.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.265 . . . . 0.0 109.366 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -107.83 -13.89 14.9 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.166 -0.959 . . . . 0.0 110.191 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -52.06 119.32 4.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.563 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.29 117.85 5.28 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -126.63 163.39 23.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.127 -1.22 . . . . 0.0 110.563 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.9 mtmt -153.64 178.97 9.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 0.0 109.272 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -150.6 124.55 9.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.011 -1.055 . . . . 0.0 110.861 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 5.8 mtp -90.53 98.45 11.78 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.8 OUTLIER 4.93 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.393 -177.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.84 -47.45 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.153 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 19.7 mtmm -153.86 161.97 41.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.543 -1.563 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.464 ' O ' HG21 ' A' ' 3' ' ' ILE . 55.9 m -88.52 -179.96 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 110.393 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.5 mttt -150.57 140.41 21.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 36.2 m -119.71 131.08 55.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.229 -0.92 . . . . 0.0 110.806 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -122.0 95.17 47.73 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.79 148.67 91.3 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.147 1.898 . . . . 0.0 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.368 179.86 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 2' ' ' ILE . 37.5 mt -73.59 -36.44 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -101.59 155.08 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.141 -0.975 . . . . 0.0 108.747 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.525 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 1.1 t-20 -105.25 78.78 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 61.8 t -158.7 148.46 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.633 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -84.58 161.02 20.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.201 -0.937 . . . . 0.0 109.184 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -155.78 156.11 34.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 111.084 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -8.05 12.65 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.463 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 80.2 p -167.91 138.87 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.526 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 2.7 Cg_endo -61.35 -13.3 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.704 1.603 . . . . 0.0 109.813 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -44.84 76.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.768 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 10.9 mt-30 -74.29 -4.55 36.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.416 -0.802 . . . . 0.0 109.273 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 94.6 m -88.84 -23.95 22.68 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.589 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -57.44 -46.96 99.75 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.404 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.3 Cg_exo -57.33 -56.21 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 121.665 1.577 . . . . 0.0 111.799 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.4 Cg_endo -61.24 -49.98 6.79 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.657 1.572 . . . . 0.0 110.032 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.581 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -70.34 -12.38 61.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 14' ' ' LEU . 16.6 ttpp -94.94 -9.81 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.36 11.79 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -119.46 -56.81 2.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.747 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 6.1 m-85 -85.15 -66.2 0.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 108.723 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.05 -172.25 42.08 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.517 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 15.8 tt0 -69.91 -4.9 22.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.016 -1.285 . . . . 0.0 109.55 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 p -92.25 -21.49 20.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 109.794 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.532 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . . . -62.0 133.91 55.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.988 . . . . 0.0 109.568 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -106.41 129.96 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.581 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -133.95 147.02 51.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.968 -1.313 . . . . 0.0 109.867 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.4 mttt -129.44 -176.16 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 123.18 8.62 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.072 -1.017 . . . . 0.0 110.764 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.589 ' O ' ' C ' ' A' ' 31' ' ' ASN . 82.2 mtp -86.28 99.8 11.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 30' ' ' MET . 4.9 m120 4.6 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.222 0.534 . . . . 0.0 111.516 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 170.82 -44.84 0.19 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.423 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 11.2 mtmm -153.34 159.9 42.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.49 -1.594 . . . . 0.0 109.715 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 57.3 m -87.72 179.61 6.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.518 0.675 . . . . 0.0 110.238 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.586 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 3.1 ttpt -150.63 128.86 11.96 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.426 -0.796 . . . . 0.0 109.26 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 38.6 m -95.3 120.11 34.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.586 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 30.2 m-85 -115.16 94.08 37.62 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.405 -0.809 . . . . 0.0 108.99 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -61.45 140.97 90.42 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.205 1.937 . . . . 0.0 110.043 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.483 -179.96 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 89.1 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.512 ' CD1' ' HE2' ' A' ' 35' ' ' LYS . 2.7 mp -100.3 -41.17 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.315 -0.865 . . . . 0.0 109.463 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.522 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -102.61 154.52 5.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 O-C-N 121.091 -1.006 . . . . 0.0 108.836 179.78 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.522 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.7 m-20 -109.45 69.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 0.0 109.215 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 49.5 t -143.56 146.87 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -86.32 159.95 19.26 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.219 -0.926 . . . . 0.0 109.596 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.5 p -156.06 145.6 20.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.141 -0.974 . . . . 0.0 110.575 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.33 -5.44 40.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.6 p -167.05 140.48 3.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.583 ' HB3' ' N ' ' A' ' 29' ' ' CYS . 2.3 Cg_endo -62.22 -11.26 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -41.45 62.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.365 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 5.4 mt-30 -74.46 -4.72 38.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 90.4 m -88.56 -21.14 24.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.6 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.1 mm? -70.71 -45.15 17.01 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 111.892 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -55.24 -52.46 7.75 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.303 1.336 . . . . 0.0 110.627 -178.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.8 Cg_endo -67.47 -44.23 4.86 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.724 1.616 . . . . 0.0 109.229 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.22 -7.53 49.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.797 -0.565 . . . . 0.0 109.886 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.522 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.1 ttpt -97.26 -9.35 27.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.96 5.84 45.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.917 . . . . 0.0 109.54 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.95 -54.48 2.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 6.7 m-85 -89.47 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.44 -156.63 18.81 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.522 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.8 tt0 -90.16 4.69 49.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.17 -1.194 . . . . 0.0 109.376 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -106.72 -16.35 14.51 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.105 -0.997 . . . . 0.0 109.953 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.83 119.43 2.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.984 -1.072 . . . . 0.0 109.445 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.81 124.0 8.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -135.54 166.73 22.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.257 . . . . 0.0 110.683 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 3.5 mtmp? -139.94 -166.2 2.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.341 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.583 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 29.9 t -150.49 116.7 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 32' ' ' GLY . 5.1 mtp -84.67 -140.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.1 OUTLIER -41.09 -27.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.111 -179.637 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 162.11 52.7 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -153.13 140.98 20.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.038 -1.272 . . . . 0.0 108.185 178.35 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' HG21 ' A' ' 3' ' ' ILE . 56.4 m -85.15 151.04 24.41 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.091 -1.005 . . . . 0.0 110.296 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.577 ' HG2' ' CE2' ' A' ' 37' ' ' TYR . 10.9 tttt -126.7 118.74 25.34 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 43.2 m -97.26 124.92 41.5 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.37 -0.831 . . . . 0.0 111.133 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.577 ' CE2' ' HG2' ' A' ' 35' ' ' LYS . 29.1 m-85 -116.15 99.57 52.77 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.02 104.61 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.054 1.836 . . . . 0.0 110.034 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.486 -179.794 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.503 ' OG1' ' CD ' ' A' ' 38' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.483 ' CG1' ' C ' ' A' ' 1' ' ' THR . 1.3 mt -156.88 148.63 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.16 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -118.99 -176.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.253 -0.904 . . . . 0.0 109.604 -179.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -132.09 40.35 3.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 41.6 t -106.91 156.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' N ' HG11 ' A' ' 5' ' ' VAL . 10.9 pttp -85.02 158.16 20.55 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.08 156.07 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 111.33 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.2 p -112.78 -10.44 13.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 p -168.27 137.87 2.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 5.4 Cg_exo -58.95 -15.12 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 121.505 1.47 . . . . 0.0 109.843 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -45.58 84.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 108.732 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 62.8 mm-40 -72.47 -5.61 37.94 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.336 -0.853 . . . . 0.0 109.192 179.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 92.5 m -89.62 -25.77 21.12 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.32 -0.863 . . . . 0.0 110.337 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.59 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -57.72 -46.12 99.77 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 112.356 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.4 Cg_exo -57.53 -56.06 2.03 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.547 1.498 . . . . 0.0 111.654 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -61.45 -50.18 6.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.682 1.588 . . . . 0.0 109.945 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.551 ' CB ' ' CB ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -69.11 -13.43 62.42 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.521 -0.737 . . . . 0.0 109.138 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.0 ttpt -95.58 -10.6 29.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.352 -0.842 . . . . 0.0 109.524 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.04 16.88 5.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -123.07 -55.87 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 7.2 m-85 -85.92 -63.37 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 108.855 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.13 -171.83 42.0 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.536 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 24.4 tt0 -73.21 -1.68 18.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.958 -1.319 . . . . 0.0 109.592 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -95.58 -21.01 18.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.919 . . . . 0.0 109.814 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' A' ' 21' ' ' PHE . . . -60.92 129.04 39.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -101.83 129.46 9.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' CB ' ' CB ' ' A' ' 17' ' ' CYS . . . -131.2 159.34 38.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.101 -1.235 . . . . 0.0 109.748 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.52 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.3 mttm -143.57 -176.77 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.39 122.25 8.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.969 -1.082 . . . . 0.0 110.678 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.07 97.54 9.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.058 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 5.1 p-10 4.99 65.62 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.472 0.653 . . . . 0.0 111.449 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.12 -44.05 0.18 Allowed Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.8 -1.191 . . . . 0.0 111.162 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 38.3 mttt -153.42 160.41 42.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.509 -1.583 . . . . 0.0 109.828 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.2 m -87.69 177.77 6.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.619 -0.675 . . . . 0.0 110.123 -179.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 5.6 mtmt -150.95 131.04 13.46 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.5 m -98.21 118.55 35.09 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.459 -0.775 . . . . 0.0 109.896 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.5 m-85 -116.59 90.55 31.37 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 108.927 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.503 ' CD ' ' OG1' ' A' ' 1' ' ' THR . 3.4 Cg_exo -59.9 105.71 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.331 2.021 . . . . 0.0 110.23 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.471 -179.988 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.483 ' C ' ' CG1' ' A' ' 2' ' ' ILE . 2.4 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.483 ' CG1' ' C ' ' A' ' 1' ' ' THR . 1.2 mt -157.78 147.6 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 109.024 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 1.2 pt -111.8 149.39 14.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.49 23.18 14.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.492 HG11 ' N ' ' A' ' 6' ' ' LYS . 53.6 t -74.83 158.2 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 0.0 109.123 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.492 ' N ' HG11 ' A' ' 5' ' ' VAL . 50.4 tttp -84.39 158.59 21.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.132 -0.98 . . . . 0.0 109.075 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.17 159.91 39.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 111.619 -178.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -115.53 -9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -168.02 138.3 2.18 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 3.6 Cg_exo -60.26 -13.23 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.524 1.482 . . . . 0.0 109.958 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 3.8 tptm -65.56 -46.2 80.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.218 -0.926 . . . . 0.0 108.74 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 29.6 mt-30 -72.5 -4.53 30.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.436 -0.79 . . . . 0.0 109.132 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.4 m -87.47 -27.81 22.44 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.296 -0.877 . . . . 0.0 110.336 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -69.68 -44.75 24.51 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 112.437 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.79 -53.33 5.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.361 1.374 . . . . 0.0 110.636 -178.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -67.0 -43.58 6.39 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.708 1.605 . . . . 0.0 109.261 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 27' ' ' ALA . 43.2 t -71.13 -10.59 60.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.862 -0.524 . . . . 0.0 110.129 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 25.8 ttmt -95.47 -9.51 32.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 0.0 109.639 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.16 10.97 8.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.97 -56.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.63 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CD1' ' HB3' ' A' ' 25' ' ' ALA . 6.2 m-85 -84.92 -63.13 1.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 108.816 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 158.3 -171.68 35.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.547 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 3.8 tm0? -67.98 -6.11 20.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.078 -1.248 . . . . 0.0 109.725 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -92.91 -9.12 41.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.578 ' HB3' ' CD1' ' A' ' 21' ' ' PHE . . . -70.37 122.72 20.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.41 122.38 7.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -127.43 161.89 27.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -1.156 . . . . 0.0 109.893 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 13.4 mttt -146.53 177.91 8.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.58 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.58 124.56 9.29 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -179.775 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.7 100.14 13.05 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.103 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.593 ' C ' ' O ' ' A' ' 30' ' ' MET . 33.2 m-20 4.88 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.398 0.618 . . . . 0.0 111.349 -177.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 174.28 -49.59 0.14 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.233 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 2.3 mptt -153.38 162.54 41.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.568 -1.548 . . . . 0.0 109.776 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 62.8 m -88.49 179.81 6.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.672 0.749 . . . . 0.0 110.655 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -150.38 133.36 16.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.878 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.8 m -108.08 120.49 42.48 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.391 -0.818 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -118.36 101.53 51.05 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.11 108.26 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.953 1.768 . . . . 0.0 110.242 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.495 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 34' ' ' CYS . 4.3 pt . . . . . 0 C--O 1.214 -0.763 0 CA-C-O 121.269 0.557 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -88.4 31.93 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 16.7 t -74.72 159.01 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 108.911 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.416 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -87.47 156.11 19.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.53 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.59 158.04 36.38 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.174 0.988 . . . . 0.0 111.727 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -113.7 -12.1 12.85 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.8 p -168.43 138.22 1.99 Allowed Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.696 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.7 Cg_exo -58.82 -14.61 22.95 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.633 1.555 . . . . 0.0 110.103 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -42.61 93.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.157 -0.964 . . . . 0.0 108.774 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 42.0 mt-30 -75.34 -5.05 42.8 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.39 -0.818 . . . . 0.0 109.349 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 94.4 m -85.06 -26.38 27.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.345 -0.847 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.87 -46.58 23.81 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.359 -0.838 . . . . 0.0 112.279 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.01 -53.26 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.358 1.372 . . . . 0.0 110.449 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.95 -44.27 10.3 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.602 1.535 . . . . 0.0 108.863 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 10.2 t -75.27 -3.79 35.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.4 ttpt -100.26 -9.64 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.235 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.48 -10.18 28.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.339 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -95.38 -56.67 2.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.871 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.8 m-85 -86.98 -61.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 108.895 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.16 -160.62 34.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.534 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 16.2 tt0 -83.71 7.63 17.05 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.11 -1.229 . . . . 0.0 109.428 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -108.29 -16.19 14.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -54.67 113.42 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.069 -1.02 . . . . 0.0 109.651 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.09 121.0 6.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -133.54 160.19 38.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.099 -1.236 . . . . 0.0 110.678 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 4.7 mmtp -144.51 -178.28 5.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.53 121.98 7.92 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.987 -1.07 . . . . 0.0 110.851 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -85.35 98.52 10.59 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 6.4 m-20 4.82 65.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.338 0.589 . . . . 0.0 111.452 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.39 -44.14 0.18 Allowed Glycine 0 N--CA 1.483 1.804 0 C-N-CA 119.746 -1.216 . . . . 0.0 111.3 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.5 mttt -153.26 160.48 42.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.477 -1.602 . . . . 0.0 109.929 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.565 ' HB2' HD11 ' A' ' 3' ' ' ILE . 71.9 m -88.04 178.81 6.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.65 0.738 . . . . 0.0 110.126 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 16.8 ttmt -150.4 124.09 9.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.9 m -102.75 127.12 50.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 111.354 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.498 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 27.6 m-85 -119.67 96.91 49.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.95 138.22 77.35 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.107 1.871 . . . . 0.0 110.24 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.846 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.545 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -113.75 56.94 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.846 ' HB ' HD11 ' A' ' 3' ' ' ILE . 96.6 t -139.2 153.31 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 109.731 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -88.44 164.19 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.093 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.12 156.88 35.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 111.178 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.4 p -112.5 -10.23 13.74 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.48 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 64.6 p -168.16 137.19 1.97 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.703 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.2 Cg_exo -59.32 -14.27 23.94 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.534 1.49 . . . . 0.0 109.878 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -66.31 -45.83 79.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 108.616 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 4.8 mt-30 -72.5 -4.76 32.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.434 -0.791 . . . . 0.0 109.027 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.8 m -89.26 -23.37 22.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.385 -0.822 . . . . 0.0 110.463 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -58.48 -46.15 99.63 Favored Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 112.148 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.2 Cg_exo -58.94 -56.28 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.626 1.551 . . . . 0.0 111.868 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.68 -51.28 2.53 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.936 1.757 . . . . 0.0 110.586 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.98 -17.05 64.32 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.465 -0.772 . . . . 0.0 109.401 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 12.4 ttmm -81.01 -10.87 59.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.388 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.11 33.22 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.756 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.81 -61.18 0.9 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.401 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.2 m-85 -84.91 -65.76 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.546 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 178.41 -168.67 39.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 2.6 tt0 -69.67 -10.73 59.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.329 . . . . 0.0 109.393 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -89.84 -8.4 52.09 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.194 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . . . -54.93 122.06 10.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.012 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.88 120.55 6.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -128.45 157.27 41.56 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.952 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -139.01 -177.16 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.508 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.89 122.27 7.87 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.064 -1.022 . . . . 0.0 110.953 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.598 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -85.55 97.98 10.37 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.598 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.3 p30 4.81 65.84 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.348 0.594 . . . . 0.0 111.518 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.55 -44.12 0.18 Allowed Glycine 0 N--CA 1.484 1.892 0 C-N-CA 119.748 -1.215 . . . . 0.0 111.323 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 76.7 mttt -153.44 159.9 42.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.424 -1.633 . . . . 0.0 109.764 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.675 ' HB2' HD13 ' A' ' 3' ' ' ILE . 55.5 m -88.21 178.28 6.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.608 -0.683 . . . . 0.0 110.236 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.594 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.47 132.58 15.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.325 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.99 119.61 35.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.484 ' OH ' ' HD2' ' A' ' 35' ' ' LYS . 32.4 m-85 -121.37 97.49 47.24 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.462 -0.774 . . . . 0.0 109.338 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.8 Cg_endo -61.55 140.92 89.61 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.089 1.859 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.6 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.437 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.549 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p30 -111.08 78.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 108.976 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 4' ' ' ASN . 72.4 t -158.5 152.47 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG2' ' N ' ' A' ' 7' ' ' CYS . 32.7 tttm -91.77 162.13 14.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 108.798 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.531 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -156.02 158.59 38.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.949 -1.094 . . . . 0.0 111.353 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -113.49 -10.75 13.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 p -168.16 139.27 2.26 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.904 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.4 Cg_exo -59.78 -14.11 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 121.606 1.538 . . . . 0.0 109.919 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -63.76 -45.13 91.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.314 -0.867 . . . . 0.0 109.106 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 2.2 mt-30 -74.84 -5.03 41.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.5 m -88.68 -27.56 21.17 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.419 -0.801 . . . . 0.0 110.052 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -67.91 -45.2 42.64 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.227 -0.92 . . . . 0.0 112.225 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.66 -52.9 6.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.327 1.352 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.73 -44.63 10.19 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.768 1.645 . . . . 0.0 109.341 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 11.8 t -73.46 -8.65 56.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.79 -0.569 . . . . 0.0 109.776 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 3.1 ttpt -95.57 -9.58 31.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.71 -9.33 29.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -92.61 -58.73 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.904 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 9.1 m-85 -85.66 -60.95 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 168.44 -161.09 34.81 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 42.5 tt0 -84.72 10.05 12.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.246 . . . . 0.0 109.465 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -111.73 -15.55 13.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.337 -0.852 . . . . 0.0 109.79 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -55.31 123.23 13.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 109.787 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.69 117.14 5.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.733 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -125.88 165.46 18.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 110.412 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.9 mttp -154.7 179.32 9.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.243 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -150.32 124.75 9.58 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.888 -1.133 . . . . 0.0 110.948 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -88.94 98.67 11.88 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 7.1 m120 4.66 66.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.412 0.625 . . . . 0.0 111.542 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.47 -46.84 0.17 Allowed Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 2.5 mtmp? -153.33 160.44 42.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.561 -1.552 . . . . 0.0 109.522 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.613 ' HB2' HD13 ' A' ' 3' ' ' ILE . 57.2 m -88.13 -178.73 6.02 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 110.284 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.74 134.96 16.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.1 m -114.27 120.43 40.39 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.239 -0.913 . . . . 0.0 111.018 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -113.23 98.99 47.94 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.57 141.48 95.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.146 1.898 . . . . 0.0 110.382 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.396 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.548 ' O ' HG23 ' A' ' 5' ' ' VAL . 23.7 t30 -106.9 81.72 1.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.086 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 4' ' ' ASN . 79.9 t -159.18 151.59 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -97.68 165.83 11.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 108.685 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.43 164.01 38.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.915 -1.116 . . . . 0.0 111.373 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.4 p -112.83 -10.71 13.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.494 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 31.8 p -167.33 141.87 3.16 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.614 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.9 Cg_endo -61.99 -10.24 17.06 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.793 1.662 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -77.17 -40.08 46.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.147 -0.971 . . . . 0.0 109.117 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.494 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 43.4 mt-30 -75.78 -4.71 42.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 56.4 m -89.55 -19.98 24.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.326 -0.859 . . . . 0.0 109.853 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.625 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -58.2 -44.41 99.22 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 112.37 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 6.2 Cg_exo -57.35 -56.31 1.91 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.633 1.555 . . . . 0.0 111.759 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -63.09 -49.82 4.46 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.71 1.607 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -70.18 -12.58 61.7 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.693 -0.629 . . . . 0.0 109.519 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.553 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -85.46 -9.93 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.439 -0.788 . . . . 0.0 109.071 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.65 41.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.264 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -106.88 -62.94 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-30 -84.22 -63.36 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.62 -156.72 18.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.553 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.7 tt0 -80.18 -9.99 59.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.037 -1.272 . . . . 0.0 109.346 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -95.75 -12.15 25.86 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.21 111.67 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -88.93 117.79 4.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.577 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.79 145.95 50.43 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 109.609 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.0 mttm -119.05 -168.3 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 6.0 t -150.61 123.98 8.96 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.282 -0.887 . . . . 0.0 109.658 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -95.18 -141.38 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.399 -0.813 . . . . 0.0 110.044 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.9 m-20 -38.43 -30.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 0.0 110.143 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 163.46 53.99 0.02 OUTLIER Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.344 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 29.1 mttt -152.62 144.39 23.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.023 -1.281 . . . . 0.0 108.628 178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.532 ' O ' HG23 ' A' ' 3' ' ' ILE . 73.0 m -85.82 159.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 109.526 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.577 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.3 mttt -140.41 129.69 23.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 69.2 m -95.06 117.19 29.76 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.304 -0.872 . . . . 0.0 110.058 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CZ ' ' HD3' ' A' ' 35' ' ' LYS . 32.5 m-85 -120.88 99.99 46.56 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.507 -0.745 . . . . 0.0 109.041 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -60.55 141.95 96.65 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.008 1.805 . . . . 0.0 110.258 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.52 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.542 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.542 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.5 t30 -108.45 83.38 1.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.063 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 96.7 t -158.65 149.0 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -86.89 158.48 19.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.47 157.91 37.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.978 -1.076 . . . . 0.0 111.24 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.6 p -113.45 -9.87 13.28 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.0 p -168.01 138.51 2.22 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.867 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.0 Cg_exo -59.59 -14.08 24.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 121.726 1.617 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -62.93 -46.79 86.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 108.981 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.497 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 15.2 mt-30 -72.28 -4.79 31.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.271 -0.893 . . . . 0.0 109.301 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.0 m -88.82 -29.2 19.89 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.382 -0.824 . . . . 0.0 109.985 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.3 mp -67.64 -45.35 45.73 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.903 . . . . 0.0 112.188 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.1 Cg_exo -55.69 -53.08 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.565 1.51 . . . . 0.0 110.727 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -63.03 -47.77 7.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.611 1.541 . . . . 0.0 109.349 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.2 t -69.66 -11.18 60.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.665 -0.647 . . . . 0.0 109.449 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 15.0 ttpp -89.39 -9.88 48.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.294 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.15 4.88 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -106.9 -61.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.626 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.5 m-30 -84.71 -56.86 3.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 108.762 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 171.87 -155.24 23.48 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.546 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 28.8 tt0 -90.37 7.01 40.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.24 . . . . 0.0 109.521 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -110.82 -12.24 14.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.124 -0.985 . . . . 0.0 109.869 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -50.27 122.31 6.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.81 115.66 5.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.59 156.26 41.18 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.239 -1.154 . . . . 0.0 110.267 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.7 mtmt -145.11 -179.89 6.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -150.96 124.76 9.14 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.997 -1.064 . . . . 0.0 110.856 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.596 ' O ' ' C ' ' A' ' 31' ' ' ASN . 37.1 mtp -89.17 98.52 11.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.0 t30 4.89 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 121.341 0.591 . . . . 0.0 111.426 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.26 -46.45 0.16 Allowed Glycine 0 N--CA 1.483 1.83 0 C-N-CA 119.799 -1.191 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 10.2 mtmm -153.51 160.15 42.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.587 -1.537 . . . . 0.0 109.556 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 65.0 m -88.18 -179.18 6.11 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.644 0.735 . . . . 0.0 110.338 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.564 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -150.46 140.8 22.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 29.4 m -118.28 124.66 48.39 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 111.075 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.35 102.51 48.12 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.92 107.69 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.97 1.78 . . . . 0.0 110.141 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.54 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.552 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.552 ' N ' HG13 ' A' ' 3' ' ' ILE . 42.9 t-20 -107.49 81.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 86.7 t -159.72 151.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.86 162.48 16.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.175 -0.953 . . . . 0.0 108.928 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.8 155.65 33.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 111.243 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -111.62 -10.27 14.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 88.5 p -167.99 139.24 2.33 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.788 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.0 Cg_exo -60.11 -12.98 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.648 1.566 . . . . 0.0 110.122 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -69.43 -44.42 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 108.861 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.467 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 9.4 mt-30 -73.59 -4.78 36.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.102 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 90.3 m -86.83 -22.73 25.64 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 109.969 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.5 mp -67.64 -45.52 45.85 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.334 -0.854 . . . . 0.0 112.27 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.69 -53.23 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.495 1.464 . . . . 0.0 110.612 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -64.34 -43.55 14.04 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.731 1.621 . . . . 0.0 109.068 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 11.7 t -75.2 -6.88 52.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.723 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.7 ttpt -98.58 -9.83 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.422 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.4 11.28 37.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.281 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.72 -57.89 2.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 7.8 m-85 -85.86 -61.86 1.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 108.77 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.08 -160.0 29.59 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.525 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 4.4 tt0 -88.06 9.75 21.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.048 -1.266 . . . . 0.0 109.364 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -111.62 -15.84 13.38 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -49.79 122.7 6.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.018 . . . . 0.0 109.66 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.42 122.52 7.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.602 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -130.91 169.65 15.49 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.236 . . . . 0.0 110.687 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 42.6 mttp -151.02 176.5 11.07 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.71 124.76 9.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.815 -1.178 . . . . 0.0 110.899 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.597 ' O ' ' C ' ' A' ' 31' ' ' ASN . 6.4 mtt -89.8 99.52 12.51 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 30' ' ' MET . 1.0 OUTLIER 4.99 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.337 0.589 . . . . 0.0 111.507 -177.36 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.19 -44.35 0.19 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 25.8 mttt -153.41 158.87 42.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.376 -1.661 . . . . 0.0 109.792 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 55.7 m -87.99 178.56 6.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.634 0.73 . . . . 0.0 110.154 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.568 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -147.64 125.05 11.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.7 m -104.09 122.13 44.64 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.29 -0.882 . . . . 0.0 111.222 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -117.65 99.59 52.35 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.24 159.82 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.06 1.84 . . . . 0.0 110.353 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.463 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.757 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.539 ' N ' HG13 ' A' ' 3' ' ' ILE . 14.1 t-20 -112.18 66.85 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.073 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.757 ' HB ' HD11 ' A' ' 3' ' ' ILE . 74.3 t -146.77 152.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 14.2 ptmt -87.57 165.85 15.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.95 . . . . 0.0 109.005 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 3.1 p -155.98 151.79 27.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.973 -1.08 . . . . 0.0 111.666 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.44 -10.72 14.55 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -167.92 136.55 1.98 Allowed Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.7 ' O ' HD12 ' A' ' 14' ' ' LEU . 6.3 Cg_exo -58.39 -15.05 22.72 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.547 1.498 . . . . 0.0 109.943 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -63.6 -44.09 95.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.2 -4.89 41.5 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 87.4 m -88.28 -25.31 22.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.338 -0.851 . . . . 0.0 110.479 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -58.01 -46.29 99.7 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.888 -1.132 . . . . 0.0 112.543 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.12 -55.94 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.436 1.424 . . . . 0.0 111.844 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.96 -52.18 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.914 1.743 . . . . 0.0 110.719 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.72 -15.95 63.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.511 -0.743 . . . . 0.0 109.881 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 8.1 ttmm -90.4 -24.54 20.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 0.0 109.788 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.9 -3.66 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.763 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.14 -49.41 5.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.963 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 4.8 m-85 -96.65 -65.35 0.97 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.255 -0.903 . . . . 0.0 108.862 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.88 -172.42 42.01 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.564 ' HA ' ' HG3' ' A' ' 18' ' ' LYS . 5.6 tt0 -67.83 -6.81 23.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.987 -1.302 . . . . 0.0 109.621 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -90.64 -10.38 43.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.118 -0.988 . . . . 0.0 109.866 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.963 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -77.97 131.1 37.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 109.598 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -104.67 133.87 11.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -136.14 158.12 45.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.253 . . . . 0.0 109.791 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mmmt -142.25 -176.3 4.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.502 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -149.09 129.81 14.12 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.5 mtm -154.31 40.28 0.47 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.0 t30 179.87 39.73 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.98 21.24 69.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 40.2 mttt -153.08 152.2 31.06 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.256 -1.144 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.672 ' HB2' HD13 ' A' ' 3' ' ' ILE . 57.7 m -88.45 -177.22 5.57 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.361 0.601 . . . . 0.0 109.933 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 7.7 ttmt -150.82 128.12 11.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 40.4 m -95.31 124.46 39.36 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.482 ' OH ' ' HD2' ' A' ' 35' ' ' LYS . 58.3 m-85 -119.83 95.12 49.06 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.345 -0.847 . . . . 0.0 108.871 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.1 131.67 40.34 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.186 1.924 . . . . 0.0 110.261 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.5 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.539 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.539 ' N ' HG13 ' A' ' 3' ' ' ILE . 11.5 m120 -104.68 82.83 1.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 63.2 t -159.32 148.3 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 109.594 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.65 159.2 20.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.263 -0.898 . . . . 0.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.9 p -156.0 154.58 31.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.014 -1.054 . . . . 0.0 111.388 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -113.8 -8.45 13.19 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.2 p -168.14 136.15 1.85 Allowed Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.791 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.7 Cg_exo -60.03 -13.95 25.79 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.567 1.511 . . . . 0.0 109.858 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -64.83 -37.44 87.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 108.913 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 7.5 mt-30 -80.83 -5.14 56.87 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.9 m -87.87 -30.37 20.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 109.98 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.791 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.2 -44.64 27.79 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 112.251 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.7 Cg_exo -55.11 -52.57 7.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.322 1.348 . . . . 0.0 110.624 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.9 Cg_endo -64.15 -47.22 6.64 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.669 1.58 . . . . 0.0 109.359 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 t -71.55 -8.12 52.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.609 -0.682 . . . . 0.0 109.586 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' HD2' ' CG ' ' A' ' 23' ' ' GLN . 1.4 ttpt -92.86 -11.29 33.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.6 2.18 44.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -105.19 -57.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.5 m-30 -84.86 -67.08 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 108.586 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -176.35 -156.56 15.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.559 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 3.8 tt0 -90.48 5.82 46.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.034 -1.274 . . . . 0.0 109.582 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 25' ' ' ALA . 6.8 p -108.94 -15.45 14.37 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.149 -0.97 . . . . 0.0 109.725 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.45 123.76 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.693 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.12 5.77 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.43 163.26 23.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.176 -1.19 . . . . 0.0 110.402 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.6 mttp -153.41 177.75 10.55 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.0 122.58 8.56 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.086 -1.009 . . . . 0.0 110.986 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -86.08 98.31 10.79 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.5 p30 4.77 65.89 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 121.289 0.566 . . . . 0.0 111.473 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.66 -43.84 0.18 Allowed Glycine 0 N--CA 1.485 1.931 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.228 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 22.4 mttt -153.55 160.59 42.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.536 -1.567 . . . . 0.0 109.579 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.494 ' O ' HG23 ' A' ' 3' ' ' ILE . 83.0 m -88.24 -177.47 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.7 0.762 . . . . 0.0 110.482 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.548 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 4.4 mttt -150.19 142.5 24.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 27.4 m -122.19 123.64 41.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 111.011 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -117.78 97.55 50.86 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.73 131.98 40.44 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.126 1.884 . . . . 0.0 110.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.323 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.524 ' N ' HG13 ' A' ' 3' ' ' ILE . 2.4 m120 -105.07 78.44 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG23 ' C ' ' A' ' 4' ' ' ASN . 55.0 t -157.74 148.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.575 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 162.31 18.98 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.238 -0.914 . . . . 0.0 109.219 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 156.0 32.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.113 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 p -114.65 -7.84 12.72 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.5 p -167.83 136.57 2.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.771 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.1 Cg_exo -59.8 -14.44 27.08 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.562 1.508 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -66.13 -45.83 79.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 108.731 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -72.27 -4.8 31.72 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.381 -0.824 . . . . 0.0 109.047 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 87.5 m -89.39 -26.21 21.15 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 110.224 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.771 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.2 -46.5 99.83 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.421 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -57.97 -56.39 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.67 1.58 . . . . 0.0 111.854 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.77 -51.36 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.778 1.652 . . . . 0.0 110.259 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.641 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -67.91 -15.01 63.42 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.428 -0.795 . . . . 0.0 109.273 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.57 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 14.4 ttpp -86.29 -10.82 53.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.887 . . . . 0.0 109.264 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.71 15.12 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -61.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 109.476 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.697 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.7 m-30 -84.86 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.137 -0.977 . . . . 0.0 108.681 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -178.28 -166.19 34.2 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.57 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -73.33 -11.53 60.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.079 -1.248 . . . . 0.0 109.398 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -88.81 -21.56 23.68 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.269 -0.895 . . . . 0.0 109.45 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.79 129.56 7.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -108.1 125.95 8.08 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -132.12 153.89 50.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.296 . . . . 0.0 110.226 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 11.3 mttp -134.96 -177.14 4.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 109.496 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 122.89 8.46 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.024 -1.047 . . . . 0.0 110.795 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 2.5 mtp -85.0 97.55 9.88 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.7 OUTLIER 5.05 65.71 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 CA-C-O 121.336 0.589 . . . . 0.0 111.472 -177.207 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.28 -43.34 0.19 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 96.3 mttt -152.97 157.73 41.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.484 -1.597 . . . . 0.0 109.724 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' O ' HG23 ' A' ' 3' ' ' ILE . 57.9 m -87.75 178.1 6.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.568 -0.707 . . . . 0.0 110.074 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.8 128.13 11.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.498 -0.751 . . . . 0.0 109.28 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 m -93.25 119.69 32.7 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.481 -0.762 . . . . 0.0 109.469 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.9 m-85 -115.87 100.04 53.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.279 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.7 Cg_exo -60.04 158.08 31.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.115 1.876 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.481 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.579 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.258 0.551 . . . . 0.0 109.659 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 23.6 p-10 -85.41 49.01 1.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.11 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 95.2 t -110.67 153.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.052 . . . . 0.0 109.464 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.78 157.96 20.84 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.162 -0.962 . . . . 0.0 109.457 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.5 p -156.54 155.7 32.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 111.188 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.1 p -112.49 -9.66 13.78 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.4 p -168.28 138.58 2.1 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.65 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.4 Cg_exo -59.81 -14.32 26.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.52 1.48 . . . . 0.0 109.892 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -46.01 84.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.923 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -4.74 34.33 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 87.5 m -87.46 -25.37 23.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.316 -0.865 . . . . 0.0 110.295 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -57.7 -46.39 99.75 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.024 -1.047 . . . . 0.0 112.333 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -57.23 -55.92 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.606 1.537 . . . . 0.0 111.78 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.2 Cg_endo -61.69 -47.57 10.92 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.755 1.637 . . . . 0.0 109.999 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.557 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -73.51 -11.13 60.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.3 ttpp -97.92 -13.67 21.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.291 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.38 8.92 12.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -115.98 -56.74 2.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.492 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.966 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.4 m-85 -85.94 -65.82 0.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -0.946 . . . . 0.0 108.676 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.51 -168.66 40.17 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -73.82 -6.22 45.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.989 -1.3 . . . . 0.0 109.407 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.7 p -89.5 -23.08 22.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.211 -0.931 . . . . 0.0 109.747 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.966 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -61.2 133.74 56.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -105.47 130.57 10.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -134.88 153.41 52.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.27 . . . . 0.0 109.677 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 18.2 mttt -138.25 -176.81 4.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.226 -0.921 . . . . 0.0 109.585 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.17 121.38 7.8 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.05 -1.031 . . . . 0.0 110.898 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.18 99.27 10.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.032 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 24.1 t30 4.76 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.288 0.566 . . . . 0.0 111.535 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.18 -44.51 0.19 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.349 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.2 mtmt -153.45 160.14 42.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.603 -1.528 . . . . 0.0 109.781 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.0 m -87.97 179.7 6.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.598 -0.689 . . . . 0.0 110.191 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -150.52 127.82 11.34 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.455 -0.778 . . . . 0.0 109.357 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.61 122.26 39.34 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.466 -0.772 . . . . 0.0 109.867 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.1 m-85 -119.38 94.5 48.43 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.64 164.7 10.94 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.126 1.884 . . . . 0.0 110.299 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.504 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.277 0.56 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -104.53 39.08 1.74 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 67.0 t -99.42 150.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.2 pttt -84.64 158.98 20.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.905 -1.122 . . . . 0.0 108.938 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.08 156.42 34.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 110.881 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 p -107.43 -3.94 19.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.1 p -166.36 140.7 3.54 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.713 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.2 Cg_endo -63.42 -9.93 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.962 1.775 . . . . 0.0 110.269 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 13.9 tttt -75.71 -40.34 55.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.61 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 19.4 mt-30 -72.27 -4.64 30.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.515 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 72.0 m -88.85 -29.3 19.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.255 -0.903 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.3 mp -66.94 -44.43 51.26 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 112.513 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -56.22 -53.33 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.403 1.402 . . . . 0.0 111.014 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -65.4 -45.43 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.744 1.629 . . . . 0.0 109.61 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.4 t -67.75 -16.59 64.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 110.0 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 32.5 ttmt -82.04 -9.55 59.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.142 -0.974 . . . . 0.0 109.43 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.14 21.44 2.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.36 -55.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.621 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.4 m-30 -85.01 -65.96 0.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 0.0 108.726 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.589 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 163.61 -170.63 39.04 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 18' ' ' LYS . 7.4 tt0 -68.66 -6.38 25.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.073 -1.251 . . . . 0.0 109.637 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -90.26 -8.84 49.98 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -59.27 124.28 19.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.891 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -112.92 118.55 4.61 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -128.6 166.47 18.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.368 -1.078 . . . . 0.0 109.687 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 49.1 mtmt -136.03 -169.51 2.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.865 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 27.3 t -151.44 115.64 5.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' GLY . 4.8 mmt -85.38 -140.07 0.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 109.609 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.6 m120 -41.22 -27.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.938 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 161.98 53.41 0.02 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.8 mtpp -153.39 139.68 18.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.083 -1.245 . . . . 0.0 108.167 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.485 ' O ' HG13 ' A' ' 3' ' ' ILE . 71.2 m -85.2 159.57 20.08 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 110.594 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -139.42 122.97 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 32.9 m -92.75 122.33 35.04 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 111.127 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.7 m-85 -122.18 93.35 48.6 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.43 147.67 93.31 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.063 1.842 . . . . 0.0 110.131 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.522 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 5' ' ' VAL . 3.9 t-20 -105.1 80.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 4' ' ' ASN . 75.7 t -159.53 153.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -90.13 160.61 16.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -155.96 157.95 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 110.797 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -9.45 13.17 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.4 p -168.06 137.72 2.08 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.754 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.6 Cg_exo -59.46 -14.42 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.672 1.581 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.4 -45.21 80.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.924 . . . . 0.0 108.779 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -73.92 -5.21 39.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.391 -0.818 . . . . 0.0 109.029 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.0 m -89.19 -22.09 22.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 110.117 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -57.75 -46.45 99.74 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 120.992 -1.067 . . . . 0.0 112.202 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.22 -56.28 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.73 -51.26 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.861 1.707 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -68.93 -14.62 63.15 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.487 -0.758 . . . . 0.0 109.219 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.558 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.5 ttpp -83.48 -9.8 58.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.352 -0.842 . . . . 0.0 109.205 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.58 15.6 13.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.945 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -109.26 -64.96 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.862 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-85 -84.2 -66.8 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 108.531 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -171.95 -157.22 13.35 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 29.1 tt0 -81.56 -12.52 58.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.284 . . . . 0.0 109.57 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.1 p -92.71 -13.09 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.345 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -43.5 118.13 1.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -90.12 122.06 6.43 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -128.47 161.17 30.14 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.155 -1.203 . . . . 0.0 110.234 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -144.78 178.06 8.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.837 . . . . 0.0 109.657 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.15 123.06 8.73 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.242 -0.911 . . . . 0.0 110.876 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.587 ' O ' ' C ' ' A' ' 31' ' ' ASN . 3.9 mtp -87.04 96.97 10.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.587 ' C ' ' O ' ' A' ' 30' ' ' MET . 11.2 m120 4.82 65.54 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.395 0.617 . . . . 0.0 111.505 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.5 -41.38 0.18 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 39.5 mttt -153.53 157.69 40.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.511 -1.582 . . . . 0.0 109.766 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' HG23 ' A' ' 3' ' ' ILE . 59.4 m -87.36 179.53 6.58 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 110.075 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.629 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 8.5 mttt -150.62 134.34 16.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 41.9 m -103.04 117.44 34.58 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.3 m-85 -118.9 106.1 44.22 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 Cg_exo -59.86 130.11 33.45 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.986 1.791 . . . . 0.0 110.223 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.537 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.547 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.24 33.19 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.121 -0.987 . . . . 0.0 109.818 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 6' ' ' LYS . 50.4 t -82.46 162.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 109.116 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -84.12 153.6 23.64 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.133 -0.979 . . . . 0.0 109.08 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.552 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 165.22 37.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.092 -1.005 . . . . 0.0 111.557 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.1 p -122.31 -7.86 8.71 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -168.24 143.81 3.05 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -60.57 -16.13 40.84 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.899 1.733 . . . . 0.0 109.896 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.05 -43.2 88.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.26 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' O ' ' CD ' ' A' ' 16' ' ' PRO . 92.5 mt-30 -71.84 -4.68 29.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.238 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 73.5 m -84.84 -29.17 25.54 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.361 -0.837 . . . . 0.0 109.972 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.64 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mp -69.41 -45.17 27.22 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.343 -0.848 . . . . 0.0 112.584 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.1 Cg_exo -55.25 -54.28 4.58 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.429 1.419 . . . . 0.0 110.745 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -66.91 -44.18 5.78 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.543 1.495 . . . . 0.0 108.859 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.8 t -73.52 -5.03 37.52 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.189 0.519 . . . . 0.0 109.727 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.7 ttpp -98.64 -9.51 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.06 14.75 26.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.78 -57.03 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.059 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 9.2 m-85 -85.53 -35.75 20.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 108.713 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 139.46 -160.32 25.96 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.55 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 8.1 tt0 -86.69 8.66 21.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -1.231 . . . . 0.0 109.362 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 p -107.46 -18.15 13.93 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.059 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -53.61 119.72 5.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.04 117.12 5.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.556 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -125.01 169.9 11.67 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 110.638 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.2 mttt -155.09 177.23 11.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -149.61 128.2 12.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.98 -1.075 . . . . 0.0 110.515 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.601 ' O ' ' C ' ' A' ' 31' ' ' ASN . 38.3 mtt -95.61 104.03 15.92 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 30' ' ' MET . 35.8 m-20 4.86 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.321 0.581 . . . . 0.0 111.338 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 175.6 -54.98 0.12 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.248 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.552 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mppt? -152.99 165.33 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.753 -1.439 . . . . 0.0 109.968 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 68.4 m -88.35 177.59 6.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.634 0.73 . . . . 0.0 110.365 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.45 128.8 12.08 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.547 ' SG ' HD13 ' A' ' 3' ' ' ILE . 30.9 m -102.99 122.3 44.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 111.117 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.567 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.0 m-85 -113.41 98.56 46.94 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.99 90.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.983 1.789 . . . . 0.0 110.163 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.468 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.785 HD11 ' HB2' ' A' ' 34' ' ' CYS . 12.6 pt . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 121.201 0.524 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.24 51.77 2.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 53.5 t -116.23 153.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.184 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.6 pttt -99.68 157.63 16.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 109.629 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -156.02 159.67 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.7 p -107.83 -6.22 16.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -166.74 140.02 3.12 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.889 ' O ' HD12 ' A' ' 14' ' ' LEU . 2.7 Cg_endo -60.33 -13.94 27.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.565 1.51 . . . . 0.0 109.733 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -73.41 -41.19 63.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.18 -4.95 38.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.282 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' CB ' ' A' ' 7' ' ' CYS . 69.5 m -91.15 -22.85 20.46 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.413 -0.805 . . . . 0.0 109.99 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.889 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -67.74 -45.16 44.51 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.162 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -56.98 -53.81 4.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.446 1.43 . . . . 0.0 111.022 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -65.17 -44.92 8.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.756 1.638 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 24.6 t -67.28 -16.68 64.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.8 -0.562 . . . . 0.0 109.922 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.599 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 29.6 ttmt -85.75 -9.98 56.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.35 15.69 15.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -118.13 -59.72 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.86 . . . . 0.0 109.61 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 7.0 m-85 -87.01 -67.69 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 108.908 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 177.07 -169.03 41.21 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.599 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 19.5 tt0 -69.72 -4.87 21.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -1.234 . . . . 0.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 p -95.82 -8.23 34.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -59.39 123.85 18.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.015 -1.053 . . . . 0.0 109.689 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.11 127.36 7.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -137.22 158.79 43.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.24 . . . . 0.0 110.381 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 68.0 mttm -123.1 -168.92 1.84 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.42 -0.8 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 36.1 t -151.08 117.23 5.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' GLY . 8.9 mtm -84.56 -140.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.495 -0.753 . . . . 0.0 109.283 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m-80 -41.7 -28.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . 162.13 54.69 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 25.5 mttm -152.69 135.98 15.81 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.157 -1.202 . . . . 0.0 108.239 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.785 ' HB2' HD11 ' A' ' 3' ' ' ILE . 31.7 m -85.07 148.69 26.02 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.042 -1.036 . . . . 0.0 111.005 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.4 ttpm? -123.47 117.39 25.03 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.6 m -94.06 123.31 37.35 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.628 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.522 ' OH ' ' CE ' ' A' ' 35' ' ' LYS . 13.1 m-85 -117.99 104.7 48.34 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.96 140.2 91.63 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.077 1.851 . . . . 0.0 110.221 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.413 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.521 ' N ' HG13 ' A' ' 3' ' ' ILE . 39.4 t-20 -109.45 76.2 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.244 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 3' ' ' ILE . 71.9 t -153.64 151.8 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.837 . . . . 0.0 109.428 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -85.02 164.4 18.28 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 154.94 32.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 0.0 111.72 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -114.27 -10.66 12.68 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -168.08 141.75 2.72 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.6 Cg_exo -60.41 -17.27 46.6 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.728 1.619 . . . . 0.0 109.849 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.82 -44.89 91.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.074 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 47.6 mt-30 -71.31 -4.81 28.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.283 -0.886 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.491 ' SG ' ' HA ' ' A' ' 10' ' ' PRO . 74.1 m -85.86 -26.7 25.51 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.235 -0.915 . . . . 0.0 109.982 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.626 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.6 mm? -71.89 -45.77 11.93 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.458 -0.776 . . . . 0.0 112.017 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -54.84 -53.4 6.09 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.329 1.353 . . . . 0.0 110.437 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -66.67 -44.38 6.06 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.661 1.574 . . . . 0.0 109.041 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 12.7 t -73.31 -5.06 37.18 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.179 0.514 . . . . 0.0 109.832 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 9.5 ttpt -99.9 -9.43 22.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.986 -1.071 . . . . 0.0 109.341 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.1 11.89 38.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -120.13 -54.65 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.133 -0.979 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.4 m-85 -87.21 -46.33 9.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 108.702 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 154.53 -159.79 29.15 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -88.14 9.52 22.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.247 . . . . 0.0 109.46 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -108.4 -17.84 13.89 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.778 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.849 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -54.39 112.01 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -95.42 119.74 6.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.589 ' O ' HD21 ' A' ' 14' ' ' LEU . . . -126.52 170.7 11.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.074 -1.25 . . . . 0.0 110.859 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 7.4 mttt -155.31 -177.81 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -149.79 131.95 15.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' A' ' 29' ' ' CYS . 27.8 mtp -155.39 28.86 0.39 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.992 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -167.53 43.43 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 63.85 19.66 63.45 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.0 mtpt -153.21 155.81 37.33 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.17 -1.194 . . . . 0.0 109.604 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 28' ' ' LYS . 93.5 m -89.27 -178.91 5.75 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.513 0.673 . . . . 0.0 109.871 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.0 tmtt? -150.89 128.25 11.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 33.0 m -103.42 125.59 50.1 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 111.338 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 62.9 m-85 -114.89 96.59 45.14 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.66 154.2 56.49 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.062 1.841 . . . . 0.0 110.385 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.283 0.563 . . . . 0.0 109.647 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -91.76 64.43 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.572 ' HB ' HD11 ' A' ' 3' ' ' ILE . 72.8 t -145.72 148.71 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 1.9 ptpp? -95.6 162.12 13.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.231 -0.918 . . . . 0.0 109.45 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -155.71 158.14 37.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 111.113 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -8.38 16.51 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.462 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 73.8 p -166.6 139.83 3.18 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 14' ' ' LEU . 3.9 Cg_exo -59.87 -14.35 27.0 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.747 1.631 . . . . 0.0 109.97 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -75.17 -39.83 60.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.295 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 2.4 mt-30 -73.5 -5.84 42.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 95.4 m -91.65 -21.51 20.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 109.89 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -64.89 -44.78 73.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 112.467 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.5 Cg_exo -55.86 -53.87 4.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.441 1.427 . . . . 0.0 110.875 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -63.79 -46.24 9.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.628 1.552 . . . . 0.0 109.372 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.1 t -70.71 -10.68 59.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.75 -0.594 . . . . 0.0 109.622 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 7.0 ttpt -91.9 -10.39 39.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 109.334 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.23 4.19 44.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -104.47 -61.7 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.6 m-30 -84.45 -52.71 5.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.704 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.15 -155.6 26.47 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 1.7 tt0 -90.18 7.37 38.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.09 -1.241 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -110.76 -14.02 14.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.089 -1.007 . . . . 0.0 109.928 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -46.68 126.96 9.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.701 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.22 120.13 6.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -131.72 176.47 8.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -1.186 . . . . 0.0 110.274 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 33.4 mmtm -150.24 -166.49 2.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 109.214 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.555 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 25.0 t -151.08 103.56 3.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.042 -1.036 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -103.78 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.485 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 1.7 t-20 -80.96 67.02 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.544 -0.722 . . . . 0.0 110.06 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.13 46.1 94.81 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.6 mttp -154.12 137.33 15.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.109 -1.23 . . . . 0.0 108.399 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 32.8 m -85.79 149.61 25.14 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.584 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 17.4 mtmt -123.6 124.37 42.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.1 m -103.23 122.88 45.67 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.247 -0.908 . . . . 0.0 111.165 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.63 104.85 46.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -58.8 148.93 81.01 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.896 1.731 . . . . 0.0 109.999 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.561 -179.778 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.527 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -110.8 65.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.833 . . . . 0.0 109.354 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.712 ' HB ' HD11 ' A' ' 3' ' ' ILE . 89.2 t -142.34 150.61 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 109.333 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -89.93 163.46 14.96 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.128 -0.982 . . . . 0.0 109.107 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 160.89 39.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.672 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 p -110.68 -4.6 15.29 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 66.6 p -166.47 140.94 3.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.826 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.5 Cg_endo -62.12 -12.19 25.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.798 1.665 . . . . 0.0 109.967 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -77.98 -38.57 44.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.426 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.416 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 6.0 mt-30 -73.09 -4.97 35.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -0.916 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 84.6 m -91.88 -27.19 18.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.358 -0.839 . . . . 0.0 110.041 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -65.56 -44.79 66.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.237 -0.914 . . . . 0.0 112.27 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.8 -53.5 5.47 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.492 1.462 . . . . 0.0 110.956 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 3.1 Cg_exo -62.21 -46.51 12.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.742 1.628 . . . . 0.0 109.638 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.11 -14.65 63.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.554 -0.716 . . . . 0.0 109.482 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.4 ttmp? -81.3 -9.69 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.167 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.72 14.31 19.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.46 -0.775 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.408 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tt0 -126.65 -57.27 1.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.627 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.626 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.7 m-30 -84.67 -66.76 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 108.739 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 169.05 -169.69 42.03 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.589 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -70.13 -4.59 22.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.015 -1.286 . . . . 0.0 109.728 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.47 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 7.3 p -94.23 -8.07 40.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.226 -0.922 . . . . 0.0 109.587 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -58.34 122.2 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.941 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.54 121.11 6.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -131.85 157.16 44.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.98 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -126.39 -168.21 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.614 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 28.0 t -151.42 120.19 6.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.963 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' GLY . 28.9 mtp -84.72 -143.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.368 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 30' ' ' MET . 28.4 t-20 -43.7 -26.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' LYS . . . 164.38 55.24 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 27.0 mttt -152.9 138.51 17.78 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.103 -1.234 . . . . 0.0 108.358 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' O ' HG23 ' A' ' 3' ' ' ILE . 81.5 m -85.11 156.17 21.17 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 110.702 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 12.3 mttm -135.1 127.44 30.28 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 30.4 m -100.62 124.48 46.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.874 0.845 . . . . 0.0 111.452 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -125.82 96.53 37.61 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.48 147.45 94.25 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.116 1.877 . . . . 0.0 110.081 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.47 ' CD2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.549 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 4.9 pt . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.14 63.1 5.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.41 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' A' ' 3' ' ' ILE . 72.6 t -143.48 151.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.609 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 5.8 mtpp -95.31 166.77 11.73 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.305 -0.872 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.21 159.96 39.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 110.66 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.464 ' OG1' ' OE1' ' A' ' 12' ' ' GLN . 13.3 p -111.77 -8.71 14.14 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 p -167.06 137.93 2.54 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.926 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.3 Cg_exo -59.38 -14.66 25.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.71 1.607 . . . . 0.0 109.939 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -70.9 -42.03 70.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.295 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.464 ' OE1' ' OG1' ' A' ' 8' ' ' THR . 63.8 mt-30 -74.16 -4.63 36.92 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 68.8 m -91.47 -23.78 19.88 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.275 -0.89 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.926 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER -66.77 -44.54 53.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.319 -0.863 . . . . 0.0 112.402 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.71 -53.51 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.483 1.455 . . . . 0.0 110.951 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.59 -46.39 7.18 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.643 1.562 . . . . 0.0 109.251 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.5 t -70.22 -10.72 59.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.725 -0.61 . . . . 0.0 109.725 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 16.2 ttpp -91.71 -9.91 42.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.424 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.16 -6.32 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.288 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -93.93 -61.86 1.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.609 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 1.7 m-30 -84.34 -66.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 108.85 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -179.57 -155.87 16.25 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.54 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 2.6 tt0 -88.49 5.97 40.02 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.086 -1.244 . . . . 0.0 109.524 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.0 p -109.34 -13.1 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.177 -0.952 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -45.25 123.9 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.29 116.73 5.63 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -132.53 172.29 12.7 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.094 -1.239 . . . . 0.0 110.666 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 38.9 mttp -154.09 -167.03 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 6.6 t -151.14 121.07 7.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.88 -1.138 . . . . 0.0 109.721 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.507 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.5 mmt -98.52 -135.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.108 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m120 -35.28 -31.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.9 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 158.37 49.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.499 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.1 mtpp -153.61 150.38 28.58 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.972 -1.311 . . . . 0.0 108.147 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 58.3 m -86.76 152.25 22.67 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 110.132 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 5.8 mmtm -122.98 121.63 36.58 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 28.8 m -104.09 119.45 38.97 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.102 -0.999 . . . . 0.0 111.159 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 35.3 m-85 -110.85 93.98 18.76 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 2.5 Cg_endo -61.56 152.19 75.11 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.122 1.881 . . . . 0.0 110.303 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 p80 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.516 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p-10 -103.22 77.3 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.512 HG23 ' C ' ' A' ' 4' ' ' ASN . 21.5 t -157.46 145.24 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 7.7 mttm -84.8 164.06 18.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.046 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.4 159.76 39.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.11 -0.994 . . . . 0.0 111.384 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -111.98 -12.51 13.73 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p -168.32 139.3 2.19 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.943 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.3 Cg_exo -59.01 -14.29 22.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.642 1.561 . . . . 0.0 109.893 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -64.57 -46.87 80.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.249 -0.907 . . . . 0.0 108.823 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 mt-30 -72.71 -4.98 34.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.112 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.6 m -89.06 -26.71 21.25 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.88 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.943 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -65.95 -44.98 63.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 112.537 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.9 Cg_exo -55.21 -53.23 6.18 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.356 1.37 . . . . 0.0 110.751 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.39 -44.15 12.34 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.702 1.601 . . . . 0.0 109.614 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 10.4 t -72.74 -10.39 59.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.71 -0.618 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.3 ttpt -96.9 -9.58 28.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.523 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.4 8.86 44.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.33 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.31 -58.09 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.824 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.7 m-85 -84.88 -62.81 1.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 108.575 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.27 -159.73 29.01 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.55 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 61.0 tt0 -86.91 4.77 40.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.265 . . . . 0.0 109.366 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -107.83 -13.89 14.9 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.166 -0.959 . . . . 0.0 110.191 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.824 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -52.06 119.32 4.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.563 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.29 117.85 5.28 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.724 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -126.63 163.39 23.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.127 -1.22 . . . . 0.0 110.563 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.9 mtmt -153.64 178.97 9.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 0.0 109.272 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -150.6 124.55 9.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.011 -1.055 . . . . 0.0 110.861 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 5.8 mtp -90.53 98.45 11.78 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.8 OUTLIER 4.93 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.393 -177.208 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.84 -47.45 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.153 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 19.7 mtmm -153.86 161.97 41.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.543 -1.563 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' O ' HG23 ' A' ' 3' ' ' ILE . 55.9 m -88.52 -179.96 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 110.393 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.5 mttt -150.57 140.41 21.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 36.2 m -119.71 131.08 55.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.229 -0.92 . . . . 0.0 110.806 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -122.0 95.17 47.73 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.79 148.67 91.3 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.147 1.898 . . . . 0.0 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.368 179.86 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.525 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 1.1 t-20 -105.25 78.78 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 61.8 t -158.7 148.46 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.633 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -84.58 161.02 20.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.201 -0.937 . . . . 0.0 109.184 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -155.78 156.11 34.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 111.084 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -8.05 12.65 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.472 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 80.2 p -167.91 138.87 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.707 ' O ' HD12 ' A' ' 14' ' ' LEU . 2.7 Cg_endo -61.35 -13.3 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.704 1.603 . . . . 0.0 109.813 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -44.84 76.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.768 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.472 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 10.9 mt-30 -74.29 -4.55 36.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.416 -0.802 . . . . 0.0 109.273 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 94.6 m -88.84 -23.95 22.68 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.44 -46.96 99.75 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.404 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.3 Cg_exo -57.33 -56.21 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 121.665 1.577 . . . . 0.0 111.799 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.4 Cg_endo -61.24 -49.98 6.79 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.657 1.572 . . . . 0.0 110.032 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -70.34 -12.38 61.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 16.6 ttpp -94.94 -9.81 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.36 11.79 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -119.46 -56.81 2.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.747 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.1 m-85 -85.15 -66.2 0.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 108.723 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.05 -172.25 42.08 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.538 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 15.8 tt0 -69.91 -4.9 22.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.016 -1.285 . . . . 0.0 109.55 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 p -92.25 -21.49 20.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 109.794 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.977 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -62.0 133.91 55.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.988 . . . . 0.0 109.568 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -106.41 129.96 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -133.95 147.02 51.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.968 -1.313 . . . . 0.0 109.867 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.4 mttt -129.44 -176.16 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 123.18 8.62 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.072 -1.017 . . . . 0.0 110.764 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.589 ' O ' ' C ' ' A' ' 31' ' ' ASN . 82.2 mtp -86.28 99.8 11.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 30' ' ' MET . 4.9 m120 4.6 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.222 0.534 . . . . 0.0 111.516 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 170.82 -44.84 0.19 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.423 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 11.2 mtmm -153.34 159.9 42.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.49 -1.594 . . . . 0.0 109.715 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 57.3 m -87.72 179.61 6.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.518 0.675 . . . . 0.0 110.238 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 3.1 ttpt -150.63 128.86 11.96 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.426 -0.796 . . . . 0.0 109.26 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 38.6 m -95.3 120.11 34.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.59 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 30.2 m-85 -115.16 94.08 37.62 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.405 -0.809 . . . . 0.0 108.99 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -61.45 140.97 90.42 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.205 1.937 . . . . 0.0 110.043 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.483 -179.96 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.589 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.534 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.7 m-20 -109.45 69.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 0.0 109.215 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.589 ' HB ' HD11 ' A' ' 3' ' ' ILE . 49.5 t -143.56 146.87 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -86.32 159.95 19.26 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.219 -0.926 . . . . 0.0 109.596 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.5 p -156.06 145.6 20.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.141 -0.974 . . . . 0.0 110.575 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.33 -5.44 40.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.6 p -167.05 140.48 3.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.671 ' O ' HD23 ' A' ' 14' ' ' LEU . 2.3 Cg_endo -62.22 -11.26 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -41.45 62.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.365 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.429 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 5.4 mt-30 -74.46 -4.72 38.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 90.4 m -88.56 -21.14 24.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 10' ' ' PRO . 2.1 mm? -70.71 -45.15 17.01 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 111.892 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -55.24 -52.46 7.75 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.303 1.336 . . . . 0.0 110.627 -178.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.8 Cg_endo -67.47 -44.23 4.86 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.724 1.616 . . . . 0.0 109.229 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 14.6 t -72.22 -7.53 49.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.797 -0.565 . . . . 0.0 109.886 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.1 ttpt -97.26 -9.35 27.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.96 5.84 45.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.917 . . . . 0.0 109.54 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.95 -54.48 2.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.7 m-85 -89.47 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.44 -156.63 18.81 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.534 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.8 tt0 -90.16 4.69 49.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.17 -1.194 . . . . 0.0 109.376 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -106.72 -16.35 14.51 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.105 -0.997 . . . . 0.0 109.953 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -47.83 119.43 2.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.984 -1.072 . . . . 0.0 109.445 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.81 124.0 8.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -135.54 166.73 22.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.257 . . . . 0.0 110.683 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 3.5 mtmp? -139.94 -166.2 2.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.341 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 29.9 t -150.49 116.7 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 32' ' ' GLY . 5.1 mtp -84.67 -140.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.1 OUTLIER -41.09 -27.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.111 -179.637 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 162.11 52.7 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -153.13 140.98 20.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.038 -1.272 . . . . 0.0 108.185 178.35 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.52 ' O ' HG23 ' A' ' 3' ' ' ILE . 56.4 m -85.15 151.04 24.41 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.091 -1.005 . . . . 0.0 110.296 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.582 ' HG2' ' CE2' ' A' ' 37' ' ' TYR . 10.9 tttt -126.7 118.74 25.34 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 43.2 m -97.26 124.92 41.5 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.37 -0.831 . . . . 0.0 111.133 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.582 ' CE2' ' HG2' ' A' ' 35' ' ' LYS . 29.1 m-85 -116.15 99.57 52.77 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.02 104.61 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.054 1.836 . . . . 0.0 110.034 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.486 -179.794 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.194 0.521 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -132.09 40.35 3.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 41.6 t -106.91 156.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' N ' HG12 ' A' ' 5' ' ' VAL . 10.9 pttp -85.02 158.16 20.55 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.08 156.07 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 111.33 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.2 p -112.78 -10.44 13.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.53 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 p -168.27 137.87 2.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.809 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.4 Cg_exo -58.95 -15.12 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 121.505 1.47 . . . . 0.0 109.843 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -45.58 84.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 108.732 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 62.8 mm-40 -72.47 -5.61 37.94 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.336 -0.853 . . . . 0.0 109.192 179.304 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.5 m -89.62 -25.77 21.12 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.32 -0.863 . . . . 0.0 110.337 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.72 -46.12 99.77 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 112.356 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.4 Cg_exo -57.53 -56.06 2.03 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.547 1.498 . . . . 0.0 111.654 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.576 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -61.45 -50.18 6.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.682 1.588 . . . . 0.0 109.945 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -69.11 -13.43 62.42 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.521 -0.737 . . . . 0.0 109.138 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.0 ttpt -95.58 -10.6 29.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.352 -0.842 . . . . 0.0 109.524 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.04 16.88 5.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -123.07 -55.87 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.945 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 7.2 m-85 -85.92 -63.37 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 108.855 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.13 -171.83 42.0 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.546 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 24.4 tt0 -73.21 -1.68 18.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.958 -1.319 . . . . 0.0 109.592 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -95.58 -21.01 18.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.919 . . . . 0.0 109.814 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.945 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -60.92 129.04 39.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -101.83 129.46 9.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -131.2 159.34 38.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.101 -1.235 . . . . 0.0 109.748 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.3 mttm -143.57 -176.77 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.39 122.25 8.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.969 -1.082 . . . . 0.0 110.678 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.07 97.54 9.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.058 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 5.1 p-10 4.99 65.62 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.472 0.653 . . . . 0.0 111.449 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.12 -44.05 0.18 Allowed Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.8 -1.191 . . . . 0.0 111.162 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 38.3 mttt -153.42 160.41 42.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.509 -1.583 . . . . 0.0 109.828 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.556 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.2 m -87.69 177.77 6.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.619 -0.675 . . . . 0.0 110.123 -179.135 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.627 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 5.6 mtmt -150.95 131.04 13.46 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.5 m -98.21 118.55 35.09 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.459 -0.775 . . . . 0.0 109.896 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.5 m-85 -116.59 90.55 31.37 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 108.927 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 3.4 Cg_exo -59.9 105.71 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.331 2.021 . . . . 0.0 110.23 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.471 -179.988 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 34' ' ' CYS . 1.2 pt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.49 23.18 14.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 53.6 t -74.83 158.2 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 0.0 109.123 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.441 ' N ' HG12 ' A' ' 5' ' ' VAL . 50.4 tttp -84.39 158.59 21.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.132 -0.98 . . . . 0.0 109.075 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.17 159.91 39.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 111.619 -178.268 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -115.53 -9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -168.02 138.3 2.18 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.782 ' O ' HD12 ' A' ' 14' ' ' LEU . 3.6 Cg_exo -60.26 -13.23 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.524 1.482 . . . . 0.0 109.958 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 3.8 tptm -65.56 -46.2 80.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.218 -0.926 . . . . 0.0 108.74 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 29.6 mt-30 -72.5 -4.53 30.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.436 -0.79 . . . . 0.0 109.132 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.4 m -87.47 -27.81 22.44 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.296 -0.877 . . . . 0.0 110.336 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.68 -44.75 24.51 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 112.437 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.79 -53.33 5.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.361 1.374 . . . . 0.0 110.636 -178.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -67.0 -43.58 6.39 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.708 1.605 . . . . 0.0 109.261 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 43.2 t -71.13 -10.59 60.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.862 -0.524 . . . . 0.0 110.129 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 25.8 ttmt -95.47 -9.51 32.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 0.0 109.639 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.16 10.97 8.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.97 -56.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.63 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.036 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.2 m-85 -84.92 -63.13 1.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 108.816 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 158.3 -171.68 35.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -67.98 -6.11 20.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.078 -1.248 . . . . 0.0 109.725 179.848 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -92.91 -9.12 41.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.036 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -70.37 122.72 20.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.41 122.38 7.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.712 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -127.43 161.89 27.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -1.156 . . . . 0.0 109.893 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 13.4 mttt -146.53 177.91 8.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.58 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.58 124.56 9.29 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -179.775 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.7 100.14 13.05 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.103 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.593 ' C ' ' O ' ' A' ' 30' ' ' MET . 33.2 m-20 4.88 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.398 0.618 . . . . 0.0 111.349 -177.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 174.28 -49.59 0.14 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.233 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.3 mptt -153.38 162.54 41.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.568 -1.548 . . . . 0.0 109.776 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.627 ' HB2' HD12 ' A' ' 3' ' ' ILE . 62.8 m -88.49 179.81 6.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.672 0.749 . . . . 0.0 110.655 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.568 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -150.38 133.36 16.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.878 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.8 m -108.08 120.49 42.48 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.391 -0.818 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -118.36 101.53 51.05 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.11 108.26 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.953 1.768 . . . . 0.0 110.242 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.495 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.534 ' HG1' ' HZ ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.691 HG22 ' HG3' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -47.5 119.16 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.229 -0.919 . . . . 0.0 109.199 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 34' ' ' CYS . 4.3 pt -103.38 138.74 26.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 110.118 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -88.4 31.93 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 16.7 t -74.72 159.01 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 108.911 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -87.47 156.11 19.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.59 158.04 36.38 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.174 0.988 . . . . 0.0 111.727 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -113.7 -12.1 12.85 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.8 p -168.43 138.22 1.99 Allowed Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.696 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.7 Cg_exo -58.82 -14.61 22.95 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.633 1.555 . . . . 0.0 110.103 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -42.61 93.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.157 -0.964 . . . . 0.0 108.774 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 42.0 mt-30 -75.34 -5.05 42.8 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.39 -0.818 . . . . 0.0 109.349 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 94.4 m -85.06 -26.38 27.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.345 -0.847 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.87 -46.58 23.81 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.359 -0.838 . . . . 0.0 112.279 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.01 -53.26 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.358 1.372 . . . . 0.0 110.449 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.95 -44.27 10.3 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.602 1.535 . . . . 0.0 108.863 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 10.2 t -75.27 -3.79 35.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.4 ttpt -100.26 -9.64 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.235 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.48 -10.18 28.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.339 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -95.38 -56.67 2.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.871 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.8 m-85 -86.98 -61.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 108.895 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.16 -160.62 34.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.534 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 16.2 tt0 -83.71 7.63 17.05 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.11 -1.229 . . . . 0.0 109.428 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -108.29 -16.19 14.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -54.67 113.42 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.069 -1.02 . . . . 0.0 109.651 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.09 121.0 6.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -133.54 160.19 38.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.099 -1.236 . . . . 0.0 110.678 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 4.7 mmtp -144.51 -178.28 5.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.53 121.98 7.92 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.987 -1.07 . . . . 0.0 110.851 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -85.35 98.52 10.59 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 6.4 m-20 4.82 65.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.338 0.589 . . . . 0.0 111.452 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.39 -44.14 0.18 Allowed Glycine 0 N--CA 1.483 1.804 0 C-N-CA 119.746 -1.216 . . . . 0.0 111.3 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.5 mttt -153.26 160.48 42.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.477 -1.602 . . . . 0.0 109.929 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.565 ' HB2' HD11 ' A' ' 3' ' ' ILE . 71.9 m -88.04 178.81 6.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.65 0.738 . . . . 0.0 110.126 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.691 ' HG3' HG22 ' A' ' 2' ' ' ILE . 16.8 ttmt -150.4 124.09 9.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 1' ' ' THR . 33.9 m -102.75 127.12 50.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 111.354 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.498 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 27.6 m-85 -119.67 96.91 49.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 1' ' ' THR . 3.1 Cg_exo -60.95 138.22 77.35 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.107 1.871 . . . . 0.0 110.24 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.778 HG21 ' CB ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 35' ' ' LYS . 44.9 mt -107.42 -56.68 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.846 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -85.01 171.74 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.154 -0.966 . . . . 0.0 109.215 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.545 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -113.75 56.94 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.846 ' HB ' HD11 ' A' ' 3' ' ' ILE . 96.6 t -139.2 153.31 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 109.731 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -88.44 164.19 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.093 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.12 156.88 35.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 111.178 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.4 p -112.5 -10.23 13.74 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.48 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 64.6 p -168.16 137.19 1.97 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.703 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.2 Cg_exo -59.32 -14.27 23.94 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.534 1.49 . . . . 0.0 109.878 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -66.31 -45.83 79.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 108.616 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 4.8 mt-30 -72.5 -4.76 32.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.434 -0.791 . . . . 0.0 109.027 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.8 m -89.26 -23.37 22.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.385 -0.822 . . . . 0.0 110.463 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -58.48 -46.15 99.63 Favored Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 112.148 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.2 Cg_exo -58.94 -56.28 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.626 1.551 . . . . 0.0 111.868 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.68 -51.28 2.53 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.936 1.757 . . . . 0.0 110.586 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.98 -17.05 64.32 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.465 -0.772 . . . . 0.0 109.401 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 12.4 ttmm -81.01 -10.87 59.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.388 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.11 33.22 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.756 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.81 -61.18 0.9 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.401 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.2 m-85 -84.91 -65.76 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.546 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 178.41 -168.67 39.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 2.6 tt0 -69.67 -10.73 59.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.329 . . . . 0.0 109.393 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -89.84 -8.4 52.09 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.194 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . . . -54.93 122.06 10.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.012 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.88 120.55 6.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -128.45 157.27 41.56 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.952 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -139.01 -177.16 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.508 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.89 122.27 7.87 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.064 -1.022 . . . . 0.0 110.953 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.598 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -85.55 97.98 10.37 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.598 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.3 p30 4.81 65.84 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.348 0.594 . . . . 0.0 111.518 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.55 -44.12 0.18 Allowed Glycine 0 N--CA 1.484 1.892 0 C-N-CA 119.748 -1.215 . . . . 0.0 111.323 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.778 ' CB ' HG21 ' A' ' 1' ' ' THR . 76.7 mttt -153.44 159.9 42.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.424 -1.633 . . . . 0.0 109.764 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.675 ' HB2' HD13 ' A' ' 3' ' ' ILE . 55.5 m -88.21 178.28 6.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.608 -0.683 . . . . 0.0 110.236 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.594 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.47 132.58 15.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.325 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.99 119.61 35.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' OH ' ' HD2' ' A' ' 35' ' ' LYS . 32.4 m-85 -121.37 97.49 47.24 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.462 -0.774 . . . . 0.0 109.338 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.8 Cg_endo -61.55 140.92 89.61 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.089 1.859 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.6 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.437 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.29 0.567 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 36' ' ' CYS . 96.7 mt -88.8 -49.12 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.551 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -105.48 154.09 6.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.099 -1.0 . . . . 0.0 108.746 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.549 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p30 -111.08 78.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 108.976 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 4' ' ' ASN . 72.4 t -158.5 152.47 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG2' ' N ' ' A' ' 7' ' ' CYS . 32.7 tttm -91.77 162.13 14.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 108.798 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.531 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -156.02 158.59 38.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.949 -1.094 . . . . 0.0 111.353 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -113.49 -10.75 13.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 p -168.16 139.27 2.26 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.904 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.4 Cg_exo -59.78 -14.11 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 121.606 1.538 . . . . 0.0 109.919 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -63.76 -45.13 91.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.314 -0.867 . . . . 0.0 109.106 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 2.2 mt-30 -74.84 -5.03 41.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.5 m -88.68 -27.56 21.17 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.419 -0.801 . . . . 0.0 110.052 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -67.91 -45.2 42.64 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.227 -0.92 . . . . 0.0 112.225 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.66 -52.9 6.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.327 1.352 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.73 -44.63 10.19 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.768 1.645 . . . . 0.0 109.341 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 11.8 t -73.46 -8.65 56.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.79 -0.569 . . . . 0.0 109.776 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 3.1 ttpt -95.57 -9.58 31.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.71 -9.33 29.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -92.61 -58.73 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.904 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 9.1 m-85 -85.66 -60.95 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 168.44 -161.09 34.81 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 42.5 tt0 -84.72 10.05 12.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.246 . . . . 0.0 109.465 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -111.73 -15.55 13.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.337 -0.852 . . . . 0.0 109.79 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -55.31 123.23 13.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 109.787 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.69 117.14 5.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.733 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -125.88 165.46 18.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 110.412 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.9 mttp -154.7 179.32 9.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.243 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -150.32 124.75 9.58 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.888 -1.133 . . . . 0.0 110.948 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -88.94 98.67 11.88 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 7.1 m120 4.66 66.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.412 0.625 . . . . 0.0 111.542 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.47 -46.84 0.17 Allowed Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 2.5 mtmp? -153.33 160.44 42.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.561 -1.552 . . . . 0.0 109.522 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.613 ' HB2' HD13 ' A' ' 3' ' ' ILE . 57.2 m -88.13 -178.73 6.02 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 110.284 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.74 134.96 16.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.1 m -114.27 120.43 40.39 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.239 -0.913 . . . . 0.0 111.018 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.411 ' CE1' ' CD1' ' A' ' 2' ' ' ILE . 19.6 m-85 -113.23 98.99 47.94 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.57 141.48 95.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.146 1.898 . . . . 0.0 110.382 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.396 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.616 HD12 ' HZ3' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -111.57 -41.82 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 109.462 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -101.01 155.03 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.031 -1.043 . . . . 0.0 108.913 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.548 ' O ' HG23 ' A' ' 5' ' ' VAL . 23.7 t30 -106.9 81.72 1.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.086 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 4' ' ' ASN . 79.9 t -159.18 151.59 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -97.68 165.83 11.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 108.685 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.43 164.01 38.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.915 -1.116 . . . . 0.0 111.373 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.4 p -112.83 -10.71 13.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.494 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 31.8 p -167.33 141.87 3.16 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.614 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.9 Cg_endo -61.99 -10.24 17.06 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.793 1.662 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -77.17 -40.08 46.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.147 -0.971 . . . . 0.0 109.117 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.494 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 43.4 mt-30 -75.78 -4.71 42.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 56.4 m -89.55 -19.98 24.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.326 -0.859 . . . . 0.0 109.853 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.625 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -58.2 -44.41 99.22 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 112.37 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 6.2 Cg_exo -57.35 -56.31 1.91 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.633 1.555 . . . . 0.0 111.759 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -63.09 -49.82 4.46 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.71 1.607 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -70.18 -12.58 61.7 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.693 -0.629 . . . . 0.0 109.519 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.553 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -85.46 -9.93 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.439 -0.788 . . . . 0.0 109.071 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.65 41.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.264 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -106.88 -62.94 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-30 -84.22 -63.36 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.62 -156.72 18.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.553 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.7 tt0 -80.18 -9.99 59.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.037 -1.272 . . . . 0.0 109.346 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -95.75 -12.15 25.86 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.21 111.67 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -88.93 117.79 4.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.577 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.79 145.95 50.43 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 109.609 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.0 mttm -119.05 -168.3 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 6.0 t -150.61 123.98 8.96 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.282 -0.887 . . . . 0.0 109.658 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -95.18 -141.38 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.399 -0.813 . . . . 0.0 110.044 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.9 m-20 -38.43 -30.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 0.0 110.143 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 163.46 53.99 0.02 OUTLIER Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.344 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 29.1 mttt -152.62 144.39 23.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.023 -1.281 . . . . 0.0 108.628 178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.532 ' O ' HG23 ' A' ' 3' ' ' ILE . 73.0 m -85.82 159.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 109.526 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.616 ' HZ3' HD12 ' A' ' 2' ' ' ILE . 3.3 mttt -140.41 129.69 23.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 69.2 m -95.06 117.19 29.76 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.304 -0.872 . . . . 0.0 110.058 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CZ ' ' HD3' ' A' ' 35' ' ' LYS . 32.5 m-85 -120.88 99.99 46.56 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.507 -0.745 . . . . 0.0 109.041 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -60.55 141.95 96.65 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.008 1.805 . . . . 0.0 110.258 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.52 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 36' ' ' CYS . 9.9 mt -75.45 -28.07 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.511 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.542 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -103.55 154.0 5.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.095 -1.003 . . . . 0.0 108.721 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.542 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.5 t30 -108.45 83.38 1.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.063 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 96.7 t -158.65 149.0 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -86.89 158.48 19.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.47 157.91 37.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.978 -1.076 . . . . 0.0 111.24 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.6 p -113.45 -9.87 13.28 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.0 p -168.01 138.51 2.22 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.867 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.0 Cg_exo -59.59 -14.08 24.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 121.726 1.617 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -62.93 -46.79 86.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 108.981 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.497 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 15.2 mt-30 -72.28 -4.79 31.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.271 -0.893 . . . . 0.0 109.301 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.0 m -88.82 -29.2 19.89 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.382 -0.824 . . . . 0.0 109.985 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.3 mp -67.64 -45.35 45.73 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.903 . . . . 0.0 112.188 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.1 Cg_exo -55.69 -53.08 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.565 1.51 . . . . 0.0 110.727 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -63.03 -47.77 7.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.611 1.541 . . . . 0.0 109.349 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.2 t -69.66 -11.18 60.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.665 -0.647 . . . . 0.0 109.449 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 15.0 ttpp -89.39 -9.88 48.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.294 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.15 4.88 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -106.9 -61.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.626 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.5 m-30 -84.71 -56.86 3.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 108.762 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 171.87 -155.24 23.48 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.546 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 28.8 tt0 -90.37 7.01 40.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.24 . . . . 0.0 109.521 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -110.82 -12.24 14.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.124 -0.985 . . . . 0.0 109.869 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -50.27 122.31 6.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.81 115.66 5.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.59 156.26 41.18 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.239 -1.154 . . . . 0.0 110.267 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.7 mtmt -145.11 -179.89 6.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -150.96 124.76 9.14 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.997 -1.064 . . . . 0.0 110.856 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.596 ' O ' ' C ' ' A' ' 31' ' ' ASN . 37.1 mtp -89.17 98.52 11.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.0 t30 4.89 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 121.341 0.591 . . . . 0.0 111.426 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.26 -46.45 0.16 Allowed Glycine 0 N--CA 1.483 1.83 0 C-N-CA 119.799 -1.191 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 10.2 mtmm -153.51 160.15 42.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.587 -1.537 . . . . 0.0 109.556 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 65.0 m -88.18 -179.18 6.11 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.644 0.735 . . . . 0.0 110.338 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.564 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -150.46 140.8 22.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 29.4 m -118.28 124.66 48.39 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 111.075 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.35 102.51 48.12 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.92 107.69 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.97 1.78 . . . . 0.0 110.141 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.54 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.474 HG12 ' HD3' ' A' ' 35' ' ' LYS . 39.9 mm -73.89 -38.91 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.552 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -109.31 155.2 10.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.253 -0.904 . . . . 0.0 108.922 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.552 ' N ' HG13 ' A' ' 3' ' ' ILE . 42.9 t-20 -107.49 81.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 86.7 t -159.72 151.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.86 162.48 16.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.175 -0.953 . . . . 0.0 108.928 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.8 155.65 33.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 111.243 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -111.62 -10.27 14.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 88.5 p -167.99 139.24 2.33 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.788 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.0 Cg_exo -60.11 -12.98 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.648 1.566 . . . . 0.0 110.122 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -69.43 -44.42 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 108.861 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.467 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 9.4 mt-30 -73.59 -4.78 36.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.102 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 90.3 m -86.83 -22.73 25.64 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 109.969 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.5 mp -67.64 -45.52 45.85 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.334 -0.854 . . . . 0.0 112.27 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.69 -53.23 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.495 1.464 . . . . 0.0 110.612 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -64.34 -43.55 14.04 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.731 1.621 . . . . 0.0 109.068 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 11.7 t -75.2 -6.88 52.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.723 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.7 ttpt -98.58 -9.83 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.422 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.4 11.28 37.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.281 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.72 -57.89 2.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 7.8 m-85 -85.86 -61.86 1.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 108.77 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.08 -160.0 29.59 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.525 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 4.4 tt0 -88.06 9.75 21.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.048 -1.266 . . . . 0.0 109.364 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -111.62 -15.84 13.38 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -49.79 122.7 6.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.018 . . . . 0.0 109.66 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.42 122.52 7.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.602 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -130.91 169.65 15.49 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.236 . . . . 0.0 110.687 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 42.6 mttp -151.02 176.5 11.07 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.71 124.76 9.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.815 -1.178 . . . . 0.0 110.899 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.597 ' O ' ' C ' ' A' ' 31' ' ' ASN . 6.4 mtt -89.8 99.52 12.51 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 30' ' ' MET . 1.0 OUTLIER 4.99 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.337 0.589 . . . . 0.0 111.507 -177.36 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.19 -44.35 0.19 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 25.8 mttt -153.41 158.87 42.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.376 -1.661 . . . . 0.0 109.792 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 55.7 m -87.99 178.56 6.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.634 0.73 . . . . 0.0 110.154 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.568 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -147.64 125.05 11.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.7 m -104.09 122.13 44.64 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.29 -0.882 . . . . 0.0 111.222 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -117.65 99.59 52.35 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.24 159.82 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.06 1.84 . . . . 0.0 110.353 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.463 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 36' ' ' CYS . 4.8 mt -96.32 -35.23 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.27 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.757 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.53 154.75 6.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.257 -0.902 . . . . 0.0 108.766 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.539 ' N ' HG13 ' A' ' 3' ' ' ILE . 14.1 t-20 -112.18 66.85 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.073 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.757 ' HB ' HD11 ' A' ' 3' ' ' ILE . 74.3 t -146.77 152.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 14.2 ptmt -87.57 165.85 15.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.95 . . . . 0.0 109.005 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 3.1 p -155.98 151.79 27.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.973 -1.08 . . . . 0.0 111.666 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.44 -10.72 14.55 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -167.92 136.55 1.98 Allowed Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.7 ' O ' HD12 ' A' ' 14' ' ' LEU . 6.3 Cg_exo -58.39 -15.05 22.72 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.547 1.498 . . . . 0.0 109.943 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -63.6 -44.09 95.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.2 -4.89 41.5 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 87.4 m -88.28 -25.31 22.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.338 -0.851 . . . . 0.0 110.479 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -58.01 -46.29 99.7 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.888 -1.132 . . . . 0.0 112.543 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.12 -55.94 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.436 1.424 . . . . 0.0 111.844 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.96 -52.18 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.914 1.743 . . . . 0.0 110.719 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.72 -15.95 63.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.511 -0.743 . . . . 0.0 109.881 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 8.1 ttmm -90.4 -24.54 20.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 0.0 109.788 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.9 -3.66 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.763 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.14 -49.41 5.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.963 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 4.8 m-85 -96.65 -65.35 0.97 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.255 -0.903 . . . . 0.0 108.862 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.88 -172.42 42.01 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.564 ' HA ' ' HG3' ' A' ' 18' ' ' LYS . 5.6 tt0 -67.83 -6.81 23.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.987 -1.302 . . . . 0.0 109.621 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -90.64 -10.38 43.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.118 -0.988 . . . . 0.0 109.866 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.963 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -77.97 131.1 37.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 109.598 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -104.67 133.87 11.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -136.14 158.12 45.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.253 . . . . 0.0 109.791 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mmmt -142.25 -176.3 4.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.502 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -149.09 129.81 14.12 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.5 mtm -154.31 40.28 0.47 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.0 t30 179.87 39.73 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.98 21.24 69.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 40.2 mttt -153.08 152.2 31.06 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.256 -1.144 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.672 ' HB2' HD13 ' A' ' 3' ' ' ILE . 57.7 m -88.45 -177.22 5.57 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.361 0.601 . . . . 0.0 109.933 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 7.7 ttmt -150.82 128.12 11.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 40.4 m -95.31 124.46 39.36 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.482 ' OH ' ' HD2' ' A' ' 35' ' ' LYS . 58.3 m-85 -119.83 95.12 49.06 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.345 -0.847 . . . . 0.0 108.871 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.1 131.67 40.34 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.186 1.924 . . . . 0.0 110.261 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.5 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.732 HG21 ' HD3' ' A' ' 33' ' ' LYS . 5.7 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.343 0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.441 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 35.2 mt -59.08 -53.66 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 0.0 109.386 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.539 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -102.22 155.47 4.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.193 -0.942 . . . . 0.0 108.621 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.539 ' N ' HG13 ' A' ' 3' ' ' ILE . 11.5 m120 -104.68 82.83 1.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 63.2 t -159.32 148.3 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 109.594 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.65 159.2 20.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.263 -0.898 . . . . 0.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.9 p -156.0 154.58 31.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.014 -1.054 . . . . 0.0 111.388 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -113.8 -8.45 13.19 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.2 p -168.14 136.15 1.85 Allowed Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.791 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.7 Cg_exo -60.03 -13.95 25.79 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.567 1.511 . . . . 0.0 109.858 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -64.83 -37.44 87.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 108.913 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 7.5 mt-30 -80.83 -5.14 56.87 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.9 m -87.87 -30.37 20.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 109.98 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.791 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.2 -44.64 27.79 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 112.251 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.7 Cg_exo -55.11 -52.57 7.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.322 1.348 . . . . 0.0 110.624 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.9 Cg_endo -64.15 -47.22 6.64 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.669 1.58 . . . . 0.0 109.359 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 t -71.55 -8.12 52.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.609 -0.682 . . . . 0.0 109.586 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' HD2' ' CG ' ' A' ' 23' ' ' GLN . 1.4 ttpt -92.86 -11.29 33.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.6 2.18 44.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -105.19 -57.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.5 m-30 -84.86 -67.08 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 108.586 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -176.35 -156.56 15.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.559 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 3.8 tt0 -90.48 5.82 46.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.034 -1.274 . . . . 0.0 109.582 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 25' ' ' ALA . 6.8 p -108.94 -15.45 14.37 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.149 -0.97 . . . . 0.0 109.725 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.45 123.76 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.693 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.12 5.77 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.43 163.26 23.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.176 -1.19 . . . . 0.0 110.402 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.6 mttp -153.41 177.75 10.55 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.0 122.58 8.56 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.086 -1.009 . . . . 0.0 110.986 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -86.08 98.31 10.79 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.5 p30 4.77 65.89 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 121.289 0.566 . . . . 0.0 111.473 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.66 -43.84 0.18 Allowed Glycine 0 N--CA 1.485 1.931 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.228 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.732 ' HD3' HG21 ' A' ' 1' ' ' THR . 22.4 mttt -153.55 160.59 42.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.536 -1.567 . . . . 0.0 109.579 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.494 ' O ' HG23 ' A' ' 3' ' ' ILE . 83.0 m -88.24 -177.47 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.7 0.762 . . . . 0.0 110.482 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.548 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 4.4 mttt -150.19 142.5 24.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 27.4 m -122.19 123.64 41.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 111.011 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -117.78 97.55 50.86 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.73 131.98 40.44 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.126 1.884 . . . . 0.0 110.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.323 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.503 HG13 ' CG ' ' A' ' 35' ' ' LYS . 3.5 mt -119.21 -33.68 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.613 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -101.27 154.63 4.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.126 -0.984 . . . . 0.0 108.844 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.524 ' N ' HG13 ' A' ' 3' ' ' ILE . 2.4 m120 -105.07 78.44 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG23 ' C ' ' A' ' 4' ' ' ASN . 55.0 t -157.74 148.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.575 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 162.31 18.98 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.238 -0.914 . . . . 0.0 109.219 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 156.0 32.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.113 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 p -114.65 -7.84 12.72 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.5 p -167.83 136.57 2.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.771 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.1 Cg_exo -59.8 -14.44 27.08 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.562 1.508 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -66.13 -45.83 79.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 108.731 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -72.27 -4.8 31.72 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.381 -0.824 . . . . 0.0 109.047 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 87.5 m -89.39 -26.21 21.15 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 110.224 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.771 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.2 -46.5 99.83 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.421 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -57.97 -56.39 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.67 1.58 . . . . 0.0 111.854 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.77 -51.36 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.778 1.652 . . . . 0.0 110.259 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.641 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -67.91 -15.01 63.42 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.428 -0.795 . . . . 0.0 109.273 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.57 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 14.4 ttpp -86.29 -10.82 53.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.887 . . . . 0.0 109.264 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.71 15.12 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -61.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 109.476 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.697 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.7 m-30 -84.86 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.137 -0.977 . . . . 0.0 108.681 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -178.28 -166.19 34.2 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.57 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -73.33 -11.53 60.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.079 -1.248 . . . . 0.0 109.398 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -88.81 -21.56 23.68 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.269 -0.895 . . . . 0.0 109.45 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.79 129.56 7.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -108.1 125.95 8.08 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -132.12 153.89 50.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.296 . . . . 0.0 110.226 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 11.3 mttp -134.96 -177.14 4.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 109.496 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 122.89 8.46 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.024 -1.047 . . . . 0.0 110.795 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 2.5 mtp -85.0 97.55 9.88 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.7 OUTLIER 5.05 65.71 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 CA-C-O 121.336 0.589 . . . . 0.0 111.472 -177.207 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.28 -43.34 0.19 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 96.3 mttt -152.97 157.73 41.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.484 -1.597 . . . . 0.0 109.724 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' O ' HG23 ' A' ' 3' ' ' ILE . 57.9 m -87.75 178.1 6.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.568 -0.707 . . . . 0.0 110.074 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.8 128.13 11.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.498 -0.751 . . . . 0.0 109.28 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 m -93.25 119.69 32.7 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.481 -0.762 . . . . 0.0 109.469 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.9 m-85 -115.87 100.04 53.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.279 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.7 Cg_exo -60.04 158.08 31.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.115 1.876 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.481 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.011 HG23 ' HG3' ' A' ' 35' ' ' LYS . 3.5 mt -154.2 154.89 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.865 . . . . 0.0 109.346 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.579 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -124.55 138.22 54.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.103 -0.998 . . . . 0.0 109.659 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 23.6 p-10 -85.41 49.01 1.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.11 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 95.2 t -110.67 153.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.052 . . . . 0.0 109.464 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.78 157.96 20.84 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.162 -0.962 . . . . 0.0 109.457 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.5 p -156.54 155.7 32.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 111.188 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.1 p -112.49 -9.66 13.78 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.4 p -168.28 138.58 2.1 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.65 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.4 Cg_exo -59.81 -14.32 26.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.52 1.48 . . . . 0.0 109.892 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -46.01 84.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.923 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -4.74 34.33 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 87.5 m -87.46 -25.37 23.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.316 -0.865 . . . . 0.0 110.295 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -57.7 -46.39 99.75 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.024 -1.047 . . . . 0.0 112.333 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -57.23 -55.92 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.606 1.537 . . . . 0.0 111.78 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.2 Cg_endo -61.69 -47.57 10.92 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.755 1.637 . . . . 0.0 109.999 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.557 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -73.51 -11.13 60.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.3 ttpp -97.92 -13.67 21.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.291 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.38 8.92 12.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -115.98 -56.74 2.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.492 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.966 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.4 m-85 -85.94 -65.82 0.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -0.946 . . . . 0.0 108.676 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.51 -168.66 40.17 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -73.82 -6.22 45.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.989 -1.3 . . . . 0.0 109.407 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.7 p -89.5 -23.08 22.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.211 -0.931 . . . . 0.0 109.747 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.966 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -61.2 133.74 56.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -105.47 130.57 10.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -134.88 153.41 52.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.27 . . . . 0.0 109.677 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 18.2 mttt -138.25 -176.81 4.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.226 -0.921 . . . . 0.0 109.585 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.17 121.38 7.8 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.05 -1.031 . . . . 0.0 110.898 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.18 99.27 10.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.032 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 24.1 t30 4.76 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.288 0.566 . . . . 0.0 111.535 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.18 -44.51 0.19 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.349 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.2 mtmt -153.45 160.14 42.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.603 -1.528 . . . . 0.0 109.781 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.0 m -87.97 179.7 6.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.598 -0.689 . . . . 0.0 110.191 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 1.011 ' HG3' HG23 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -150.52 127.82 11.34 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.455 -0.778 . . . . 0.0 109.357 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.61 122.26 39.34 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.466 -0.772 . . . . 0.0 109.867 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.1 m-85 -119.38 94.5 48.43 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.64 164.7 10.94 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.126 1.884 . . . . 0.0 110.299 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.58 HG23 ' N ' ' A' ' 2' ' ' ILE . 4.9 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.684 HG23 ' HD2' ' A' ' 35' ' ' LYS . 13.9 mt -156.28 160.3 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.373 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.504 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -125.89 144.67 35.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.183 -0.948 . . . . 0.0 109.493 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -104.53 39.08 1.74 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 67.0 t -99.42 150.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.2 pttt -84.64 158.98 20.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.905 -1.122 . . . . 0.0 108.938 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.08 156.42 34.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 110.881 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 p -107.43 -3.94 19.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.1 p -166.36 140.7 3.54 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.713 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.2 Cg_endo -63.42 -9.93 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.962 1.775 . . . . 0.0 110.269 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 13.9 tttt -75.71 -40.34 55.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.61 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 19.4 mt-30 -72.27 -4.64 30.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.515 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 72.0 m -88.85 -29.3 19.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.255 -0.903 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.3 mp -66.94 -44.43 51.26 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 112.513 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -56.22 -53.33 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.403 1.402 . . . . 0.0 111.014 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -65.4 -45.43 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.744 1.629 . . . . 0.0 109.61 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.4 t -67.75 -16.59 64.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 110.0 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 32.5 ttmt -82.04 -9.55 59.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.142 -0.974 . . . . 0.0 109.43 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.14 21.44 2.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.36 -55.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.621 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.4 m-30 -85.01 -65.96 0.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 0.0 108.726 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.589 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 163.61 -170.63 39.04 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 18' ' ' LYS . 7.4 tt0 -68.66 -6.38 25.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.073 -1.251 . . . . 0.0 109.637 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -90.26 -8.84 49.98 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -59.27 124.28 19.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.891 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -112.92 118.55 4.61 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -128.6 166.47 18.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.368 -1.078 . . . . 0.0 109.687 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 49.1 mtmt -136.03 -169.51 2.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.865 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 27.3 t -151.44 115.64 5.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' GLY . 4.8 mmt -85.38 -140.07 0.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 109.609 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.6 m120 -41.22 -27.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.938 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 161.98 53.41 0.02 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.8 mtpp -153.39 139.68 18.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.083 -1.245 . . . . 0.0 108.167 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.485 ' O ' HG13 ' A' ' 3' ' ' ILE . 71.2 m -85.2 159.57 20.08 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 110.594 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.684 ' HD2' HG23 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -139.42 122.97 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 32.9 m -92.75 122.33 35.04 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 111.127 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.7 m-85 -122.18 93.35 48.6 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.43 147.67 93.31 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.063 1.842 . . . . 0.0 110.131 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.295 0.569 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.5 mt -121.44 -31.9 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.522 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -102.2 156.43 4.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.15 -0.969 . . . . 0.0 108.675 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 5' ' ' VAL . 3.9 t-20 -105.1 80.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 4' ' ' ASN . 75.7 t -159.53 153.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -90.13 160.61 16.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -155.96 157.95 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 110.797 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -9.45 13.17 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.4 p -168.06 137.72 2.08 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.754 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.6 Cg_exo -59.46 -14.42 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.672 1.581 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.4 -45.21 80.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.924 . . . . 0.0 108.779 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -73.92 -5.21 39.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.391 -0.818 . . . . 0.0 109.029 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.0 m -89.19 -22.09 22.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 110.117 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -57.75 -46.45 99.74 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 120.992 -1.067 . . . . 0.0 112.202 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.22 -56.28 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.73 -51.26 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.861 1.707 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -68.93 -14.62 63.15 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.487 -0.758 . . . . 0.0 109.219 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.558 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.5 ttpp -83.48 -9.8 58.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.352 -0.842 . . . . 0.0 109.205 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.58 15.6 13.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.945 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -109.26 -64.96 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.862 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-85 -84.2 -66.8 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 108.531 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -171.95 -157.22 13.35 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 29.1 tt0 -81.56 -12.52 58.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.284 . . . . 0.0 109.57 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.1 p -92.71 -13.09 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.345 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -43.5 118.13 1.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -90.12 122.06 6.43 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -128.47 161.17 30.14 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.155 -1.203 . . . . 0.0 110.234 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -144.78 178.06 8.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.837 . . . . 0.0 109.657 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.15 123.06 8.73 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.242 -0.911 . . . . 0.0 110.876 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.587 ' O ' ' C ' ' A' ' 31' ' ' ASN . 3.9 mtp -87.04 96.97 10.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.587 ' C ' ' O ' ' A' ' 30' ' ' MET . 11.2 m120 4.82 65.54 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.395 0.617 . . . . 0.0 111.505 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.5 -41.38 0.18 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 39.5 mttt -153.53 157.69 40.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.511 -1.582 . . . . 0.0 109.766 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' HG23 ' A' ' 3' ' ' ILE . 59.4 m -87.36 179.53 6.58 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 110.075 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.629 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 8.5 mttt -150.62 134.34 16.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 41.9 m -103.04 117.44 34.58 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.3 m-85 -118.9 106.1 44.22 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 Cg_exo -59.86 130.11 33.45 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.986 1.791 . . . . 0.0 110.223 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.537 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 2' ' ' ILE . 23.6 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.781 HD12 ' N ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -149.44 151.74 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.1 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.547 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -123.8 147.01 28.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.44 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.24 33.19 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.121 -0.987 . . . . 0.0 109.818 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 6' ' ' LYS . 50.4 t -82.46 162.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 109.116 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -84.12 153.6 23.64 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.133 -0.979 . . . . 0.0 109.08 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.552 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 165.22 37.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.092 -1.005 . . . . 0.0 111.557 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.1 p -122.31 -7.86 8.71 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -168.24 143.81 3.05 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -60.57 -16.13 40.84 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.899 1.733 . . . . 0.0 109.896 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.05 -43.2 88.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.26 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' O ' ' CD ' ' A' ' 16' ' ' PRO . 92.5 mt-30 -71.84 -4.68 29.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.238 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 73.5 m -84.84 -29.17 25.54 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.361 -0.837 . . . . 0.0 109.972 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.64 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mp -69.41 -45.17 27.22 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.343 -0.848 . . . . 0.0 112.584 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.1 Cg_exo -55.25 -54.28 4.58 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.429 1.419 . . . . 0.0 110.745 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -66.91 -44.18 5.78 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.543 1.495 . . . . 0.0 108.859 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.8 t -73.52 -5.03 37.52 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.189 0.519 . . . . 0.0 109.727 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.7 ttpp -98.64 -9.51 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.06 14.75 26.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.78 -57.03 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.059 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 9.2 m-85 -85.53 -35.75 20.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 108.713 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 139.46 -160.32 25.96 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.55 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 8.1 tt0 -86.69 8.66 21.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -1.231 . . . . 0.0 109.362 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 p -107.46 -18.15 13.93 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.059 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -53.61 119.72 5.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.04 117.12 5.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.556 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -125.01 169.9 11.67 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 110.638 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.2 mttt -155.09 177.23 11.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -149.61 128.2 12.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.98 -1.075 . . . . 0.0 110.515 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.601 ' O ' ' C ' ' A' ' 31' ' ' ASN . 38.3 mtt -95.61 104.03 15.92 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 30' ' ' MET . 35.8 m-20 4.86 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.321 0.581 . . . . 0.0 111.338 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 175.6 -54.98 0.12 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.248 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mppt? -152.99 165.33 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.753 -1.439 . . . . 0.0 109.968 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 68.4 m -88.35 177.59 6.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.634 0.73 . . . . 0.0 110.365 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.45 128.8 12.08 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.547 ' SG ' HD13 ' A' ' 3' ' ' ILE . 30.9 m -102.99 122.3 44.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 111.117 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.567 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.0 m-85 -113.41 98.56 46.94 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.99 90.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.983 1.789 . . . . 0.0 110.163 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.468 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 36' ' ' CYS . 9.0 t . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.82 HD12 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -152.88 145.88 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 0.0 108.9 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.785 HD11 ' HB2' ' A' ' 34' ' ' CYS . 12.6 pt -95.07 150.87 3.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.222 -0.924 . . . . 0.0 109.65 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.24 51.77 2.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 53.5 t -116.23 153.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.184 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.6 pttt -99.68 157.63 16.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 109.629 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -156.02 159.67 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.7 p -107.83 -6.22 16.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -166.74 140.02 3.12 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.889 ' O ' HD12 ' A' ' 14' ' ' LEU . 2.7 Cg_endo -60.33 -13.94 27.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.565 1.51 . . . . 0.0 109.733 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -73.41 -41.19 63.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.18 -4.95 38.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.282 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' CB ' ' A' ' 7' ' ' CYS . 69.5 m -91.15 -22.85 20.46 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.413 -0.805 . . . . 0.0 109.99 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.889 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -67.74 -45.16 44.51 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.162 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -56.98 -53.81 4.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.446 1.43 . . . . 0.0 111.022 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -65.17 -44.92 8.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.756 1.638 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 24.6 t -67.28 -16.68 64.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.8 -0.562 . . . . 0.0 109.922 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.599 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 29.6 ttmt -85.75 -9.98 56.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.35 15.69 15.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -118.13 -59.72 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.86 . . . . 0.0 109.61 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 7.0 m-85 -87.01 -67.69 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 108.908 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 177.07 -169.03 41.21 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.599 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 19.5 tt0 -69.72 -4.87 21.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -1.234 . . . . 0.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 p -95.82 -8.23 34.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -59.39 123.85 18.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.015 -1.053 . . . . 0.0 109.689 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.11 127.36 7.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -137.22 158.79 43.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.24 . . . . 0.0 110.381 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 68.0 mttm -123.1 -168.92 1.84 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.42 -0.8 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 36.1 t -151.08 117.23 5.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' GLY . 8.9 mtm -84.56 -140.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.495 -0.753 . . . . 0.0 109.283 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m-80 -41.7 -28.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . 162.13 54.69 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 25.5 mttm -152.69 135.98 15.81 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.157 -1.202 . . . . 0.0 108.239 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.785 ' HB2' HD11 ' A' ' 3' ' ' ILE . 31.7 m -85.07 148.69 26.02 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.042 -1.036 . . . . 0.0 111.005 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.568 ' HD3' HG23 ' A' ' 2' ' ' ILE . 3.4 ttpm? -123.47 117.39 25.03 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.655 ' O ' HG23 ' A' ' 1' ' ' THR . 33.6 m -94.06 123.31 37.35 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.628 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.522 ' OH ' ' CE ' ' A' ' 35' ' ' LYS . 13.1 m-85 -117.99 104.7 48.34 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.96 140.2 91.63 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.077 1.851 . . . . 0.0 110.221 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.413 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.575 HG22 ' H ' ' A' ' 36' ' ' CYS . 3.5 tt -124.02 -38.6 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 109.445 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -87.68 153.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' N ' HG13 ' A' ' 3' ' ' ILE . 39.4 t-20 -109.45 76.2 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.244 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 3' ' ' ILE . 71.9 t -153.64 151.8 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.837 . . . . 0.0 109.428 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -85.02 164.4 18.28 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 154.94 32.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 0.0 111.72 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -114.27 -10.66 12.68 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -168.08 141.75 2.72 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.6 Cg_exo -60.41 -17.27 46.6 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.728 1.619 . . . . 0.0 109.849 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.82 -44.89 91.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.074 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 47.6 mt-30 -71.31 -4.81 28.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.283 -0.886 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.491 ' SG ' ' HA ' ' A' ' 10' ' ' PRO . 74.1 m -85.86 -26.7 25.51 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.235 -0.915 . . . . 0.0 109.982 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.626 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.6 mm? -71.89 -45.77 11.93 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.458 -0.776 . . . . 0.0 112.017 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -54.84 -53.4 6.09 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.329 1.353 . . . . 0.0 110.437 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -66.67 -44.38 6.06 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.661 1.574 . . . . 0.0 109.041 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 12.7 t -73.31 -5.06 37.18 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.179 0.514 . . . . 0.0 109.832 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 9.5 ttpt -99.9 -9.43 22.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.986 -1.071 . . . . 0.0 109.341 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.1 11.89 38.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -120.13 -54.65 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.133 -0.979 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.4 m-85 -87.21 -46.33 9.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 108.702 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 154.53 -159.79 29.15 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -88.14 9.52 22.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.247 . . . . 0.0 109.46 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -108.4 -17.84 13.89 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.778 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.849 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -54.39 112.01 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -95.42 119.74 6.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.589 ' O ' HD21 ' A' ' 14' ' ' LEU . . . -126.52 170.7 11.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.074 -1.25 . . . . 0.0 110.859 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 7.4 mttt -155.31 -177.81 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -149.79 131.95 15.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' A' ' 29' ' ' CYS . 27.8 mtp -155.39 28.86 0.39 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.992 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -167.53 43.43 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 63.85 19.66 63.45 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.0 mtpt -153.21 155.81 37.33 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.17 -1.194 . . . . 0.0 109.604 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 28' ' ' LYS . 93.5 m -89.27 -178.91 5.75 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.513 0.673 . . . . 0.0 109.871 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.0 tmtt? -150.89 128.25 11.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.575 ' H ' HG22 ' A' ' 2' ' ' ILE . 33.0 m -103.42 125.59 50.1 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 111.338 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 62.9 m-85 -114.89 96.59 45.14 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.66 154.2 56.49 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.062 1.841 . . . . 0.0 110.385 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 35' ' ' LYS . 22.2 mm -117.79 -55.92 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -84.26 158.74 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.017 -1.052 . . . . 0.0 109.647 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -91.76 64.43 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.572 ' HB ' HD11 ' A' ' 3' ' ' ILE . 72.8 t -145.72 148.71 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 1.9 ptpp? -95.6 162.12 13.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.231 -0.918 . . . . 0.0 109.45 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -155.71 158.14 37.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 111.113 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -8.38 16.51 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.462 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 73.8 p -166.6 139.83 3.18 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 14' ' ' LEU . 3.9 Cg_exo -59.87 -14.35 27.0 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.747 1.631 . . . . 0.0 109.97 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -75.17 -39.83 60.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.295 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 2.4 mt-30 -73.5 -5.84 42.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 95.4 m -91.65 -21.51 20.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 109.89 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -64.89 -44.78 73.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 112.467 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.5 Cg_exo -55.86 -53.87 4.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.441 1.427 . . . . 0.0 110.875 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -63.79 -46.24 9.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.628 1.552 . . . . 0.0 109.372 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.1 t -70.71 -10.68 59.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.75 -0.594 . . . . 0.0 109.622 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 7.0 ttpt -91.9 -10.39 39.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 109.334 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.23 4.19 44.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -104.47 -61.7 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.6 m-30 -84.45 -52.71 5.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.704 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.15 -155.6 26.47 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 1.7 tt0 -90.18 7.37 38.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.09 -1.241 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -110.76 -14.02 14.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.089 -1.007 . . . . 0.0 109.928 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -46.68 126.96 9.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.701 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.22 120.13 6.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -131.72 176.47 8.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -1.186 . . . . 0.0 110.274 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 33.4 mmtm -150.24 -166.49 2.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 109.214 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.555 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 25.0 t -151.08 103.56 3.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.042 -1.036 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -103.78 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.485 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 1.7 t-20 -80.96 67.02 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.544 -0.722 . . . . 0.0 110.06 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.13 46.1 94.81 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.6 mttp -154.12 137.33 15.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.109 -1.23 . . . . 0.0 108.399 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 32.8 m -85.79 149.61 25.14 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.584 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 17.4 mtmt -123.6 124.37 42.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.1 m -103.23 122.88 45.67 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.247 -0.908 . . . . 0.0 111.165 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.63 104.85 46.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -58.8 148.93 81.01 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.896 1.731 . . . . 0.0 109.999 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.561 -179.778 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 36' ' ' CYS . 4.6 mp -103.52 -33.7 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.93 . . . . 0.0 109.544 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -101.02 155.01 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.195 -0.941 . . . . 0.0 108.646 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.527 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -110.8 65.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.833 . . . . 0.0 109.354 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.712 ' HB ' HD11 ' A' ' 3' ' ' ILE . 89.2 t -142.34 150.61 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 109.333 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -89.93 163.46 14.96 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.128 -0.982 . . . . 0.0 109.107 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 160.89 39.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.672 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 p -110.68 -4.6 15.29 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 66.6 p -166.47 140.94 3.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.826 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.5 Cg_endo -62.12 -12.19 25.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.798 1.665 . . . . 0.0 109.967 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -77.98 -38.57 44.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.426 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.416 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 6.0 mt-30 -73.09 -4.97 35.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -0.916 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 84.6 m -91.88 -27.19 18.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.358 -0.839 . . . . 0.0 110.041 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -65.56 -44.79 66.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.237 -0.914 . . . . 0.0 112.27 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.8 -53.5 5.47 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.492 1.462 . . . . 0.0 110.956 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 3.1 Cg_exo -62.21 -46.51 12.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.742 1.628 . . . . 0.0 109.638 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.11 -14.65 63.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.554 -0.716 . . . . 0.0 109.482 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.4 ttmp? -81.3 -9.69 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.167 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.72 14.31 19.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.46 -0.775 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.408 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tt0 -126.65 -57.27 1.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.627 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.626 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.7 m-30 -84.67 -66.76 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 108.739 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 169.05 -169.69 42.03 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.589 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -70.13 -4.59 22.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.015 -1.286 . . . . 0.0 109.728 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.47 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 7.3 p -94.23 -8.07 40.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.226 -0.922 . . . . 0.0 109.587 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -58.34 122.2 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.941 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.54 121.11 6.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -131.85 157.16 44.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.98 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -126.39 -168.21 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.614 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 28.0 t -151.42 120.19 6.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.963 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' GLY . 28.9 mtp -84.72 -143.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.368 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 30' ' ' MET . 28.4 t-20 -43.7 -26.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' LYS . . . 164.38 55.24 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 27.0 mttt -152.9 138.51 17.78 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.103 -1.234 . . . . 0.0 108.358 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' O ' HG23 ' A' ' 3' ' ' ILE . 81.5 m -85.11 156.17 21.17 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 110.702 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 12.3 mttm -135.1 127.44 30.28 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 30.4 m -100.62 124.48 46.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.874 0.845 . . . . 0.0 111.452 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -125.82 96.53 37.61 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.48 147.45 94.25 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.116 1.877 . . . . 0.0 110.081 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.47 ' CD2' ' HB2' ' A' ' 24' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.549 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 2' ' ' ILE . 16.3 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.754 HD12 ' N ' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -148.7 147.34 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 109.232 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 4.9 pt -100.27 160.5 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.21 -0.931 . . . . 0.0 109.433 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.14 63.1 5.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.41 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' A' ' 3' ' ' ILE . 72.6 t -143.48 151.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.609 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 5.8 mtpp -95.31 166.77 11.73 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.305 -0.872 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.21 159.96 39.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 110.66 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.464 ' OG1' ' OE1' ' A' ' 12' ' ' GLN . 13.3 p -111.77 -8.71 14.14 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 p -167.06 137.93 2.54 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.926 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.3 Cg_exo -59.38 -14.66 25.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.71 1.607 . . . . 0.0 109.939 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -70.9 -42.03 70.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.295 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.464 ' OE1' ' OG1' ' A' ' 8' ' ' THR . 63.8 mt-30 -74.16 -4.63 36.92 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 68.8 m -91.47 -23.78 19.88 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.275 -0.89 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.926 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER -66.77 -44.54 53.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.319 -0.863 . . . . 0.0 112.402 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.71 -53.51 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.483 1.455 . . . . 0.0 110.951 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.59 -46.39 7.18 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.643 1.562 . . . . 0.0 109.251 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.5 t -70.22 -10.72 59.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.725 -0.61 . . . . 0.0 109.725 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 16.2 ttpp -91.71 -9.91 42.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.424 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.16 -6.32 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.288 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -93.93 -61.86 1.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.609 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 1.7 m-30 -84.34 -66.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 108.85 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -179.57 -155.87 16.25 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.54 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 2.6 tt0 -88.49 5.97 40.02 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.086 -1.244 . . . . 0.0 109.524 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.0 p -109.34 -13.1 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.177 -0.952 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -45.25 123.9 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.29 116.73 5.63 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -132.53 172.29 12.7 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.094 -1.239 . . . . 0.0 110.666 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 38.9 mttp -154.09 -167.03 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 6.6 t -151.14 121.07 7.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.88 -1.138 . . . . 0.0 109.721 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.507 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.5 mmt -98.52 -135.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.108 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m120 -35.28 -31.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.9 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 158.37 49.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.499 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.1 mtpp -153.61 150.38 28.58 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.972 -1.311 . . . . 0.0 108.147 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 58.3 m -86.76 152.25 22.67 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 110.132 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 5.8 mmtm -122.98 121.63 36.58 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 28.8 m -104.09 119.45 38.97 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.102 -0.999 . . . . 0.0 111.159 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 35.3 m-85 -110.85 93.98 18.76 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 2.5 Cg_endo -61.56 152.19 75.11 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.122 1.881 . . . . 0.0 110.303 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 p80 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 3' ' ' ILE . 46.2 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 36' ' ' CYS . 82.1 mt -97.33 -42.01 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.902 . . . . 0.0 109.611 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -100.82 154.5 4.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.173 -0.954 . . . . 0.0 108.7 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.516 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p-10 -103.22 77.3 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.512 HG23 ' C ' ' A' ' 4' ' ' ASN . 21.5 t -157.46 145.24 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 7.7 mttm -84.8 164.06 18.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.046 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.4 159.76 39.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.11 -0.994 . . . . 0.0 111.384 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -111.98 -12.51 13.73 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p -168.32 139.3 2.19 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.943 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.3 Cg_exo -59.01 -14.29 22.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.642 1.561 . . . . 0.0 109.893 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -64.57 -46.87 80.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.249 -0.907 . . . . 0.0 108.823 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 mt-30 -72.71 -4.98 34.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.112 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.6 m -89.06 -26.71 21.25 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.88 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.943 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -65.95 -44.98 63.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 112.537 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.9 Cg_exo -55.21 -53.23 6.18 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.356 1.37 . . . . 0.0 110.751 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.39 -44.15 12.34 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.702 1.601 . . . . 0.0 109.614 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 10.4 t -72.74 -10.39 59.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.71 -0.618 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.3 ttpt -96.9 -9.58 28.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.523 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.4 8.86 44.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.33 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.31 -58.09 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.824 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.7 m-85 -84.88 -62.81 1.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 108.575 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.27 -159.73 29.01 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.55 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 61.0 tt0 -86.91 4.77 40.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.265 . . . . 0.0 109.366 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -107.83 -13.89 14.9 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.166 -0.959 . . . . 0.0 110.191 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.824 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -52.06 119.32 4.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.563 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.29 117.85 5.28 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.724 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -126.63 163.39 23.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.127 -1.22 . . . . 0.0 110.563 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.9 mtmt -153.64 178.97 9.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 0.0 109.272 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -150.6 124.55 9.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.011 -1.055 . . . . 0.0 110.861 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 5.8 mtp -90.53 98.45 11.78 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.8 OUTLIER 4.93 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.393 -177.208 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.84 -47.45 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.153 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 19.7 mtmm -153.86 161.97 41.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.543 -1.563 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' O ' HG23 ' A' ' 3' ' ' ILE . 55.9 m -88.52 -179.96 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 110.393 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.5 mttt -150.57 140.41 21.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 36.2 m -119.71 131.08 55.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.229 -0.92 . . . . 0.0 110.806 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -122.0 95.17 47.73 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.79 148.67 91.3 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.147 1.898 . . . . 0.0 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.368 179.86 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.5 mt -73.59 -36.44 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -101.59 155.08 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.141 -0.975 . . . . 0.0 108.747 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.525 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 1.1 t-20 -105.25 78.78 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 61.8 t -158.7 148.46 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.633 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -84.58 161.02 20.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.201 -0.937 . . . . 0.0 109.184 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -155.78 156.11 34.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 111.084 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -8.05 12.65 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.472 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 80.2 p -167.91 138.87 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.707 ' O ' HD12 ' A' ' 14' ' ' LEU . 2.7 Cg_endo -61.35 -13.3 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.704 1.603 . . . . 0.0 109.813 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -44.84 76.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.768 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.472 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 10.9 mt-30 -74.29 -4.55 36.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.416 -0.802 . . . . 0.0 109.273 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 94.6 m -88.84 -23.95 22.68 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.44 -46.96 99.75 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.404 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.3 Cg_exo -57.33 -56.21 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 121.665 1.577 . . . . 0.0 111.799 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.4 Cg_endo -61.24 -49.98 6.79 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.657 1.572 . . . . 0.0 110.032 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -70.34 -12.38 61.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 16.6 ttpp -94.94 -9.81 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.36 11.79 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -119.46 -56.81 2.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.747 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.1 m-85 -85.15 -66.2 0.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 108.723 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.05 -172.25 42.08 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.538 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 15.8 tt0 -69.91 -4.9 22.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.016 -1.285 . . . . 0.0 109.55 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 p -92.25 -21.49 20.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 109.794 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.977 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -62.0 133.91 55.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.988 . . . . 0.0 109.568 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -106.41 129.96 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -133.95 147.02 51.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.968 -1.313 . . . . 0.0 109.867 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.4 mttt -129.44 -176.16 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 123.18 8.62 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.072 -1.017 . . . . 0.0 110.764 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.589 ' O ' ' C ' ' A' ' 31' ' ' ASN . 82.2 mtp -86.28 99.8 11.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 30' ' ' MET . 4.9 m120 4.6 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.222 0.534 . . . . 0.0 111.516 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 170.82 -44.84 0.19 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.423 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 11.2 mtmm -153.34 159.9 42.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.49 -1.594 . . . . 0.0 109.715 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 57.3 m -87.72 179.61 6.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.518 0.675 . . . . 0.0 110.238 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 3.1 ttpt -150.63 128.86 11.96 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.426 -0.796 . . . . 0.0 109.26 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 38.6 m -95.3 120.11 34.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.59 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 30.2 m-85 -115.16 94.08 37.62 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.405 -0.809 . . . . 0.0 108.99 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -61.45 140.97 90.42 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.205 1.937 . . . . 0.0 110.043 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.483 -179.96 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 89.1 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.61 HD12 ' HE3' ' A' ' 35' ' ' LYS . 2.7 mp -100.3 -41.17 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.315 -0.865 . . . . 0.0 109.463 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.589 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -102.61 154.52 5.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 O-C-N 121.091 -1.006 . . . . 0.0 108.836 179.78 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.534 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.7 m-20 -109.45 69.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 0.0 109.215 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.589 ' HB ' HD11 ' A' ' 3' ' ' ILE . 49.5 t -143.56 146.87 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -86.32 159.95 19.26 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.219 -0.926 . . . . 0.0 109.596 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.5 p -156.06 145.6 20.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.141 -0.974 . . . . 0.0 110.575 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.33 -5.44 40.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.6 p -167.05 140.48 3.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.671 ' O ' HD23 ' A' ' 14' ' ' LEU . 2.3 Cg_endo -62.22 -11.26 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -41.45 62.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.365 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 5.4 mt-30 -74.46 -4.72 38.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 90.4 m -88.56 -21.14 24.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 10' ' ' PRO . 2.1 mm? -70.71 -45.15 17.01 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 111.892 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -55.24 -52.46 7.75 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.303 1.336 . . . . 0.0 110.627 -178.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.8 Cg_endo -67.47 -44.23 4.86 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.724 1.616 . . . . 0.0 109.229 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 14.6 t -72.22 -7.53 49.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.797 -0.565 . . . . 0.0 109.886 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.1 ttpt -97.26 -9.35 27.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.96 5.84 45.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.917 . . . . 0.0 109.54 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.95 -54.48 2.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.7 m-85 -89.47 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.44 -156.63 18.81 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.534 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.8 tt0 -90.16 4.69 49.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.17 -1.194 . . . . 0.0 109.376 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -106.72 -16.35 14.51 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.105 -0.997 . . . . 0.0 109.953 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -47.83 119.43 2.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.984 -1.072 . . . . 0.0 109.445 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.81 124.0 8.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -135.54 166.73 22.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.257 . . . . 0.0 110.683 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 3.5 mtmp? -139.94 -166.2 2.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.341 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 29.9 t -150.49 116.7 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 32' ' ' GLY . 5.1 mtp -84.67 -140.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.1 OUTLIER -41.09 -27.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.111 -179.637 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 162.11 52.7 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -153.13 140.98 20.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.038 -1.272 . . . . 0.0 108.185 178.35 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.52 ' O ' HG23 ' A' ' 3' ' ' ILE . 56.4 m -85.15 151.04 24.41 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.091 -1.005 . . . . 0.0 110.296 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.61 ' HE3' HD12 ' A' ' 2' ' ' ILE . 10.9 tttt -126.7 118.74 25.34 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 43.2 m -97.26 124.92 41.5 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.37 -0.831 . . . . 0.0 111.133 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.582 ' CE2' ' HG2' ' A' ' 35' ' ' LYS . 29.1 m-85 -116.15 99.57 52.77 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.02 104.61 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.054 1.836 . . . . 0.0 110.034 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.486 -179.794 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.615 HG23 ' HG2' ' A' ' 35' ' ' LYS . 1.3 mt -156.88 148.63 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.16 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -118.99 -176.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.253 -0.904 . . . . 0.0 109.604 -179.927 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -132.09 40.35 3.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 41.6 t -106.91 156.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' N ' HG12 ' A' ' 5' ' ' VAL . 10.9 pttp -85.02 158.16 20.55 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.08 156.07 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 111.33 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.2 p -112.78 -10.44 13.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.53 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 p -168.27 137.87 2.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.809 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.4 Cg_exo -58.95 -15.12 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 121.505 1.47 . . . . 0.0 109.843 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -45.58 84.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 108.732 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 62.8 mm-40 -72.47 -5.61 37.94 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.336 -0.853 . . . . 0.0 109.192 179.304 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.5 m -89.62 -25.77 21.12 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.32 -0.863 . . . . 0.0 110.337 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.72 -46.12 99.77 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 112.356 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.4 Cg_exo -57.53 -56.06 2.03 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.547 1.498 . . . . 0.0 111.654 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.576 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -61.45 -50.18 6.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.682 1.588 . . . . 0.0 109.945 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -69.11 -13.43 62.42 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.521 -0.737 . . . . 0.0 109.138 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.0 ttpt -95.58 -10.6 29.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.352 -0.842 . . . . 0.0 109.524 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.04 16.88 5.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -123.07 -55.87 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.945 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 7.2 m-85 -85.92 -63.37 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 108.855 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.13 -171.83 42.0 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.546 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 24.4 tt0 -73.21 -1.68 18.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.958 -1.319 . . . . 0.0 109.592 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -95.58 -21.01 18.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.919 . . . . 0.0 109.814 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.945 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -60.92 129.04 39.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -101.83 129.46 9.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -131.2 159.34 38.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.101 -1.235 . . . . 0.0 109.748 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.3 mttm -143.57 -176.77 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.39 122.25 8.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.969 -1.082 . . . . 0.0 110.678 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.07 97.54 9.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.058 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 5.1 p-10 4.99 65.62 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.472 0.653 . . . . 0.0 111.449 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.12 -44.05 0.18 Allowed Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.8 -1.191 . . . . 0.0 111.162 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 38.3 mttt -153.42 160.41 42.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.509 -1.583 . . . . 0.0 109.828 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.556 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.2 m -87.69 177.77 6.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.619 -0.675 . . . . 0.0 110.123 -179.135 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.627 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 5.6 mtmt -150.95 131.04 13.46 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.5 m -98.21 118.55 35.09 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.459 -0.775 . . . . 0.0 109.896 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.5 m-85 -116.59 90.55 31.37 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 108.927 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.503 ' CD ' ' OG1' ' A' ' 1' ' ' THR . 3.4 Cg_exo -59.9 105.71 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.331 2.021 . . . . 0.0 110.23 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.471 -179.988 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.483 ' C ' ' CG1' ' A' ' 2' ' ' ILE . 2.4 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.686 HG23 ' HG2' ' A' ' 35' ' ' LYS . 1.2 mt -157.78 147.6 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 109.024 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 34' ' ' CYS . 1.2 pt -111.8 149.39 14.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.49 23.18 14.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 53.6 t -74.83 158.2 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 0.0 109.123 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' N ' HG12 ' A' ' 5' ' ' VAL . 50.4 tttp -84.39 158.59 21.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.132 -0.98 . . . . 0.0 109.075 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.17 159.91 39.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 111.619 -178.268 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -115.53 -9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -168.02 138.3 2.18 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.782 ' O ' HD12 ' A' ' 14' ' ' LEU . 3.6 Cg_exo -60.26 -13.23 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.524 1.482 . . . . 0.0 109.958 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 3.8 tptm -65.56 -46.2 80.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.218 -0.926 . . . . 0.0 108.74 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 29.6 mt-30 -72.5 -4.53 30.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.436 -0.79 . . . . 0.0 109.132 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.4 m -87.47 -27.81 22.44 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.296 -0.877 . . . . 0.0 110.336 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.68 -44.75 24.51 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 112.437 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.79 -53.33 5.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.361 1.374 . . . . 0.0 110.636 -178.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -67.0 -43.58 6.39 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.708 1.605 . . . . 0.0 109.261 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 43.2 t -71.13 -10.59 60.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.862 -0.524 . . . . 0.0 110.129 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 25.8 ttmt -95.47 -9.51 32.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 0.0 109.639 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.16 10.97 8.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.97 -56.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.63 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.036 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.2 m-85 -84.92 -63.13 1.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 108.816 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 158.3 -171.68 35.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -67.98 -6.11 20.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.078 -1.248 . . . . 0.0 109.725 179.848 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -92.91 -9.12 41.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.036 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -70.37 122.72 20.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.41 122.38 7.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.712 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -127.43 161.89 27.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -1.156 . . . . 0.0 109.893 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 13.4 mttt -146.53 177.91 8.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.58 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.58 124.56 9.29 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -179.775 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.7 100.14 13.05 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.103 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.593 ' C ' ' O ' ' A' ' 30' ' ' MET . 33.2 m-20 4.88 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.398 0.618 . . . . 0.0 111.349 -177.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 174.28 -49.59 0.14 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.233 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.3 mptt -153.38 162.54 41.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.568 -1.548 . . . . 0.0 109.776 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.627 ' HB2' HD12 ' A' ' 3' ' ' ILE . 62.8 m -88.49 179.81 6.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.672 0.749 . . . . 0.0 110.655 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.686 ' HG2' HG23 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -150.38 133.36 16.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.878 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.8 m -108.08 120.49 42.48 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.391 -0.818 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -118.36 101.53 51.05 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.11 108.26 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.953 1.768 . . . . 0.0 110.242 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.495 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 34' ' ' CYS . 4.3 pt . . . . . 0 C--O 1.214 -0.763 0 CA-C-O 121.269 0.557 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -88.4 31.93 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 16.7 t -74.72 159.01 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 108.911 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.416 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -87.47 156.11 19.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.53 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.59 158.04 36.38 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.174 0.988 . . . . 0.0 111.727 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -113.7 -12.1 12.85 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.8 p -168.43 138.22 1.99 Allowed Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.696 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.7 Cg_exo -58.82 -14.61 22.95 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.633 1.555 . . . . 0.0 110.103 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -42.61 93.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.157 -0.964 . . . . 0.0 108.774 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 42.0 mt-30 -75.34 -5.05 42.8 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.39 -0.818 . . . . 0.0 109.349 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 94.4 m -85.06 -26.38 27.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.345 -0.847 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.87 -46.58 23.81 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.359 -0.838 . . . . 0.0 112.279 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.01 -53.26 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.358 1.372 . . . . 0.0 110.449 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.95 -44.27 10.3 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.602 1.535 . . . . 0.0 108.863 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 10.2 t -75.27 -3.79 35.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.4 ttpt -100.26 -9.64 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.235 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.48 -10.18 28.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.339 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -95.38 -56.67 2.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.871 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.8 m-85 -86.98 -61.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 108.895 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.16 -160.62 34.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.534 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 16.2 tt0 -83.71 7.63 17.05 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.11 -1.229 . . . . 0.0 109.428 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -108.29 -16.19 14.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -54.67 113.42 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.069 -1.02 . . . . 0.0 109.651 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.09 121.0 6.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -133.54 160.19 38.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.099 -1.236 . . . . 0.0 110.678 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 4.7 mmtp -144.51 -178.28 5.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.53 121.98 7.92 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.987 -1.07 . . . . 0.0 110.851 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -85.35 98.52 10.59 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.8 OUTLIER 4.82 65.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.338 0.589 . . . . 0.0 111.452 -177.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.39 -44.14 0.18 Allowed Glycine 0 N--CA 1.483 1.804 0 C-N-CA 119.746 -1.216 . . . . 0.0 111.3 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.5 mttt -153.26 160.48 42.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.477 -1.602 . . . . 0.0 109.929 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.565 ' HB2' HD11 ' A' ' 3' ' ' ILE . 71.9 m -88.04 178.81 6.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.65 0.738 . . . . 0.0 110.126 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 16.8 ttmt -150.4 124.09 9.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.9 m -102.75 127.12 50.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 111.354 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.498 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 27.6 m-85 -119.67 96.91 49.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.95 138.22 77.35 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.107 1.871 . . . . 0.0 110.24 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.846 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.545 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -113.75 56.94 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.846 ' HB ' HD11 ' A' ' 3' ' ' ILE . 96.6 t -139.2 153.31 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 109.731 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -88.44 164.19 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.093 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.12 156.88 35.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 111.178 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.4 p -112.5 -10.23 13.74 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.48 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 64.6 p -168.16 137.19 1.97 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.703 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.2 Cg_exo -59.32 -14.27 23.94 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.534 1.49 . . . . 0.0 109.878 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -66.31 -45.83 79.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 108.616 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 4.8 mt-30 -72.5 -4.76 32.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.434 -0.791 . . . . 0.0 109.027 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.8 m -89.26 -23.37 22.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.385 -0.822 . . . . 0.0 110.463 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -58.48 -46.15 99.63 Favored Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 112.148 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.2 Cg_exo -58.94 -56.28 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.626 1.551 . . . . 0.0 111.868 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.68 -51.28 2.53 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.936 1.757 . . . . 0.0 110.586 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.98 -17.05 64.32 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.465 -0.772 . . . . 0.0 109.401 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 12.4 ttmm -81.01 -10.87 59.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.388 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.11 33.22 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.756 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.81 -61.18 0.9 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.401 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.2 m-85 -84.91 -65.76 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.546 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 178.41 -168.67 39.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 2.6 tt0 -69.67 -10.73 59.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.329 . . . . 0.0 109.393 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -89.84 -8.4 52.09 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.194 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . . . -54.93 122.06 10.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.012 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.88 120.55 6.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -128.45 157.27 41.56 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.952 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -139.01 -177.16 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.508 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.89 122.27 7.87 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.064 -1.022 . . . . 0.0 110.953 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.598 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -85.55 97.98 10.37 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.598 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.3 p30 4.81 65.84 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.348 0.594 . . . . 0.0 111.518 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.55 -44.12 0.18 Allowed Glycine 0 N--CA 1.484 1.892 0 C-N-CA 119.748 -1.215 . . . . 0.0 111.323 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 76.7 mttt -153.44 159.9 42.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.424 -1.633 . . . . 0.0 109.764 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.675 ' HB2' HD13 ' A' ' 3' ' ' ILE . 55.5 m -88.21 178.28 6.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.608 -0.683 . . . . 0.0 110.236 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.594 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.47 132.58 15.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.325 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.99 119.61 35.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.484 ' OH ' ' HD2' ' A' ' 35' ' ' LYS . 32.4 m-85 -121.37 97.49 47.24 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.462 -0.774 . . . . 0.0 109.338 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.8 Cg_endo -61.55 140.92 89.61 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.089 1.859 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.6 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.437 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.549 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p30 -111.08 78.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 108.976 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 4' ' ' ASN . 72.4 t -158.5 152.47 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG2' ' N ' ' A' ' 7' ' ' CYS . 32.7 tttm -91.77 162.13 14.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 108.798 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.531 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -156.02 158.59 38.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.949 -1.094 . . . . 0.0 111.353 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -113.49 -10.75 13.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 p -168.16 139.27 2.26 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.904 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.4 Cg_exo -59.78 -14.11 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 121.606 1.538 . . . . 0.0 109.919 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -63.76 -45.13 91.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.314 -0.867 . . . . 0.0 109.106 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 2.2 mt-30 -74.84 -5.03 41.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.5 m -88.68 -27.56 21.17 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.419 -0.801 . . . . 0.0 110.052 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -67.91 -45.2 42.64 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.227 -0.92 . . . . 0.0 112.225 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.66 -52.9 6.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.327 1.352 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.73 -44.63 10.19 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.768 1.645 . . . . 0.0 109.341 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 11.8 t -73.46 -8.65 56.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.79 -0.569 . . . . 0.0 109.776 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 3.1 ttpt -95.57 -9.58 31.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.71 -9.33 29.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -92.61 -58.73 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.904 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 9.1 m-85 -85.66 -60.95 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 168.44 -161.09 34.81 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 42.5 tt0 -84.72 10.05 12.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.246 . . . . 0.0 109.465 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -111.73 -15.55 13.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.337 -0.852 . . . . 0.0 109.79 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -55.31 123.23 13.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 109.787 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.69 117.14 5.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.733 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -125.88 165.46 18.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 110.412 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.9 mttp -154.7 179.32 9.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.243 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -150.32 124.75 9.58 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.888 -1.133 . . . . 0.0 110.948 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -88.94 98.67 11.88 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 7.1 m120 4.66 66.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.412 0.625 . . . . 0.0 111.542 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.47 -46.84 0.17 Allowed Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 2.5 mtmp? -153.33 160.44 42.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.561 -1.552 . . . . 0.0 109.522 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.613 ' HB2' HD13 ' A' ' 3' ' ' ILE . 57.2 m -88.13 -178.73 6.02 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 110.284 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.74 134.96 16.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.1 m -114.27 120.43 40.39 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.239 -0.913 . . . . 0.0 111.018 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -113.23 98.99 47.94 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.57 141.48 95.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.146 1.898 . . . . 0.0 110.382 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.396 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.548 ' O ' HG23 ' A' ' 5' ' ' VAL . 23.7 t30 -106.9 81.72 1.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.086 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 4' ' ' ASN . 79.9 t -159.18 151.59 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -97.68 165.83 11.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 108.685 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.43 164.01 38.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.915 -1.116 . . . . 0.0 111.373 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.4 p -112.83 -10.71 13.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.494 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 31.8 p -167.33 141.87 3.16 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.614 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.9 Cg_endo -61.99 -10.24 17.06 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.793 1.662 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -77.17 -40.08 46.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.147 -0.971 . . . . 0.0 109.117 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.494 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 19.2 mt-30 -75.78 -4.71 42.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 56.4 m -89.55 -19.98 24.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.326 -0.859 . . . . 0.0 109.853 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.625 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -58.2 -44.41 99.22 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 112.37 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 6.2 Cg_exo -57.35 -56.31 1.91 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.633 1.555 . . . . 0.0 111.759 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -63.09 -49.82 4.46 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.71 1.607 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -70.18 -12.58 61.7 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.693 -0.629 . . . . 0.0 109.519 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.553 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -85.46 -9.93 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.439 -0.788 . . . . 0.0 109.071 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.65 41.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.264 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -106.88 -62.94 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-30 -84.22 -63.36 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.62 -156.72 18.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.553 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.7 tt0 -80.18 -9.99 59.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.037 -1.272 . . . . 0.0 109.346 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -95.75 -12.15 25.86 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.21 111.67 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -88.93 117.79 4.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.577 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.79 145.95 50.43 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 109.609 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.0 mttm -119.05 -168.3 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 6.0 t -150.61 123.98 8.96 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.282 -0.887 . . . . 0.0 109.658 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -95.18 -141.38 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.399 -0.813 . . . . 0.0 110.044 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.9 m-20 -38.43 -30.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 0.0 110.143 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 163.46 53.99 0.02 OUTLIER Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.344 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 29.1 mttt -152.62 144.39 23.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.023 -1.281 . . . . 0.0 108.628 178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.532 ' O ' HG23 ' A' ' 3' ' ' ILE . 73.0 m -85.82 159.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 109.526 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.577 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.3 mttt -140.41 129.69 23.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 69.2 m -95.06 117.19 29.76 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.304 -0.872 . . . . 0.0 110.058 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CZ ' ' HD3' ' A' ' 35' ' ' LYS . 32.5 m-85 -120.88 99.99 46.56 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.507 -0.745 . . . . 0.0 109.041 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -60.55 141.95 96.65 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.008 1.805 . . . . 0.0 110.258 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.52 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.542 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.542 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.5 t30 -108.45 83.38 1.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.063 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 96.7 t -158.65 149.0 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -86.89 158.48 19.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.47 157.91 37.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.978 -1.076 . . . . 0.0 111.24 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.6 p -113.45 -9.87 13.28 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.0 p -168.01 138.51 2.22 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.867 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.0 Cg_exo -59.59 -14.08 24.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 121.726 1.617 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -62.93 -46.79 86.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 108.981 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.497 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 5.0 mt-30 -72.28 -4.79 31.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.271 -0.893 . . . . 0.0 109.301 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.0 m -88.82 -29.2 19.89 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.382 -0.824 . . . . 0.0 109.985 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.3 mp -67.64 -45.35 45.73 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.903 . . . . 0.0 112.188 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.1 Cg_exo -55.69 -53.08 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.565 1.51 . . . . 0.0 110.727 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -63.03 -47.77 7.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.611 1.541 . . . . 0.0 109.349 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.2 t -69.66 -11.18 60.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.665 -0.647 . . . . 0.0 109.449 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 15.0 ttpp -89.39 -9.88 48.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.294 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.15 4.88 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -106.9 -61.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.626 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.5 m-30 -84.71 -56.86 3.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 108.762 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 171.87 -155.24 23.48 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.546 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 28.8 tt0 -90.37 7.01 40.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.24 . . . . 0.0 109.521 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -110.82 -12.24 14.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.124 -0.985 . . . . 0.0 109.869 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -50.27 122.31 6.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.81 115.66 5.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.59 156.26 41.18 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.239 -1.154 . . . . 0.0 110.267 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.7 mtmt -145.11 -179.89 6.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -150.96 124.76 9.14 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.997 -1.064 . . . . 0.0 110.856 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.596 ' O ' ' C ' ' A' ' 31' ' ' ASN . 37.1 mtp -89.17 98.52 11.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.0 t30 4.89 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 121.341 0.591 . . . . 0.0 111.426 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.26 -46.45 0.16 Allowed Glycine 0 N--CA 1.483 1.83 0 C-N-CA 119.799 -1.191 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 10.2 mtmm -153.51 160.15 42.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.587 -1.537 . . . . 0.0 109.556 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 65.0 m -88.18 -179.18 6.11 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.644 0.735 . . . . 0.0 110.338 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.564 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -150.46 140.8 22.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 29.4 m -118.28 124.66 48.39 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 111.075 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.35 102.51 48.12 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.92 107.69 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.97 1.78 . . . . 0.0 110.141 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.54 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.552 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.552 ' N ' HG13 ' A' ' 3' ' ' ILE . 42.9 t-20 -107.49 81.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 86.7 t -159.72 151.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.86 162.48 16.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.175 -0.953 . . . . 0.0 108.928 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.8 155.65 33.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 111.243 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -111.62 -10.27 14.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 88.5 p -167.99 139.24 2.33 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.788 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.0 Cg_exo -60.11 -12.98 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.648 1.566 . . . . 0.0 110.122 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -69.43 -44.42 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 108.861 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.467 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 7.2 mt-30 -73.59 -4.78 36.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.102 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 90.3 m -86.83 -22.73 25.64 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 109.969 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.5 mp -67.64 -45.52 45.85 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.334 -0.854 . . . . 0.0 112.27 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.69 -53.23 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.495 1.464 . . . . 0.0 110.612 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -64.34 -43.55 14.04 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.731 1.621 . . . . 0.0 109.068 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 11.7 t -75.2 -6.88 52.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.723 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.7 ttpt -98.58 -9.83 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.422 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.4 11.28 37.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.281 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.72 -57.89 2.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 7.8 m-85 -85.86 -61.86 1.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 108.77 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.08 -160.0 29.59 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.525 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 4.4 tt0 -88.06 9.75 21.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.048 -1.266 . . . . 0.0 109.364 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -111.62 -15.84 13.38 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -49.79 122.7 6.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.018 . . . . 0.0 109.66 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.42 122.52 7.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.602 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -130.91 169.65 15.49 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.236 . . . . 0.0 110.687 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 42.6 mttp -151.02 176.5 11.07 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.71 124.76 9.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.815 -1.178 . . . . 0.0 110.899 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.597 ' O ' ' C ' ' A' ' 31' ' ' ASN . 6.4 mtt -89.8 99.52 12.51 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 30' ' ' MET . 1.0 OUTLIER 4.99 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.337 0.589 . . . . 0.0 111.507 -177.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.19 -44.35 0.19 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 25.8 mttt -153.41 158.87 42.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.376 -1.661 . . . . 0.0 109.792 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 55.7 m -87.99 178.56 6.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.634 0.73 . . . . 0.0 110.154 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.568 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -147.64 125.05 11.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.7 m -104.09 122.13 44.64 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.29 -0.882 . . . . 0.0 111.222 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -117.65 99.59 52.35 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.24 159.82 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.06 1.84 . . . . 0.0 110.353 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.463 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.757 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.539 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -112.18 66.85 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.073 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.757 ' HB ' HD11 ' A' ' 3' ' ' ILE . 74.3 t -146.77 152.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 14.2 ptmt -87.57 165.85 15.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.95 . . . . 0.0 109.005 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 3.1 p -155.98 151.79 27.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.973 -1.08 . . . . 0.0 111.666 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.44 -10.72 14.55 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -167.92 136.55 1.98 Allowed Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.7 ' O ' HD12 ' A' ' 14' ' ' LEU . 6.3 Cg_exo -58.39 -15.05 22.72 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.547 1.498 . . . . 0.0 109.943 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -63.6 -44.09 95.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.2 -4.89 41.5 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 87.4 m -88.28 -25.31 22.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.338 -0.851 . . . . 0.0 110.479 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -58.01 -46.29 99.7 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.888 -1.132 . . . . 0.0 112.543 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.12 -55.94 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.436 1.424 . . . . 0.0 111.844 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.96 -52.18 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.914 1.743 . . . . 0.0 110.719 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.72 -15.95 63.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.511 -0.743 . . . . 0.0 109.881 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 8.1 ttmm -90.4 -24.54 20.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 0.0 109.788 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.9 -3.66 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.763 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.14 -49.41 5.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.963 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 4.8 m-85 -96.65 -65.35 0.97 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.255 -0.903 . . . . 0.0 108.862 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.88 -172.42 42.01 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.564 ' HA ' ' HG3' ' A' ' 18' ' ' LYS . 5.6 tt0 -67.83 -6.81 23.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.987 -1.302 . . . . 0.0 109.621 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -90.64 -10.38 43.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.118 -0.988 . . . . 0.0 109.866 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.963 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -77.97 131.1 37.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 109.598 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -104.67 133.87 11.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -136.14 158.12 45.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.253 . . . . 0.0 109.791 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mmmt -142.25 -176.3 4.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.502 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -149.09 129.81 14.12 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.5 mtm -154.31 40.28 0.47 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.0 t30 179.87 39.73 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.98 21.24 69.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 40.2 mttt -153.08 152.2 31.06 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.256 -1.144 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.672 ' HB2' HD13 ' A' ' 3' ' ' ILE . 57.7 m -88.45 -177.22 5.57 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.361 0.601 . . . . 0.0 109.933 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 7.7 ttmt -150.82 128.12 11.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 40.4 m -95.31 124.46 39.36 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.482 ' OH ' ' HD2' ' A' ' 35' ' ' LYS . 58.3 m-85 -119.83 95.12 49.06 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.345 -0.847 . . . . 0.0 108.871 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.1 131.67 40.34 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.186 1.924 . . . . 0.0 110.261 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.5 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.539 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.539 ' N ' HG13 ' A' ' 3' ' ' ILE . 11.5 m120 -104.68 82.83 1.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 63.2 t -159.32 148.3 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 109.594 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.65 159.2 20.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.263 -0.898 . . . . 0.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.9 p -156.0 154.58 31.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.014 -1.054 . . . . 0.0 111.388 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -113.8 -8.45 13.19 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.2 p -168.14 136.15 1.85 Allowed Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.791 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.7 Cg_exo -60.03 -13.95 25.79 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.567 1.511 . . . . 0.0 109.858 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -64.83 -37.44 87.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 108.913 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 7.5 mt-30 -80.83 -5.14 56.87 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.9 m -87.87 -30.37 20.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 109.98 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.791 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.2 -44.64 27.79 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 112.251 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.7 Cg_exo -55.11 -52.57 7.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.322 1.348 . . . . 0.0 110.624 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.9 Cg_endo -64.15 -47.22 6.64 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.669 1.58 . . . . 0.0 109.359 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 t -71.55 -8.12 52.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.609 -0.682 . . . . 0.0 109.586 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' HD2' ' CG ' ' A' ' 23' ' ' GLN . 1.4 ttpt -92.86 -11.29 33.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.6 2.18 44.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -105.19 -57.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.5 m-30 -84.86 -67.08 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 108.586 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -176.35 -156.56 15.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.559 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 3.8 tt0 -90.48 5.82 46.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.034 -1.274 . . . . 0.0 109.582 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 25' ' ' ALA . 6.8 p -108.94 -15.45 14.37 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.149 -0.97 . . . . 0.0 109.725 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.45 123.76 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.693 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.12 5.77 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.43 163.26 23.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.176 -1.19 . . . . 0.0 110.402 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.6 mttp -153.41 177.75 10.55 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.0 122.58 8.56 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.086 -1.009 . . . . 0.0 110.986 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -86.08 98.31 10.79 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.5 p30 4.77 65.89 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 121.289 0.566 . . . . 0.0 111.473 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.66 -43.84 0.18 Allowed Glycine 0 N--CA 1.485 1.931 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.228 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 22.4 mttt -153.55 160.59 42.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.536 -1.567 . . . . 0.0 109.579 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.494 ' O ' HG23 ' A' ' 3' ' ' ILE . 83.0 m -88.24 -177.47 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.7 0.762 . . . . 0.0 110.482 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.548 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 4.4 mttt -150.19 142.5 24.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 27.4 m -122.19 123.64 41.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 111.011 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -117.78 97.55 50.86 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.73 131.98 40.44 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.126 1.884 . . . . 0.0 110.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.323 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.524 ' N ' HG13 ' A' ' 3' ' ' ILE . 2.4 m120 -105.07 78.44 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG23 ' C ' ' A' ' 4' ' ' ASN . 55.0 t -157.74 148.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.575 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 162.31 18.98 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.238 -0.914 . . . . 0.0 109.219 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 156.0 32.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.113 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 p -114.65 -7.84 12.72 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.5 p -167.83 136.57 2.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.771 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.1 Cg_exo -59.8 -14.44 27.08 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.562 1.508 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -66.13 -45.83 79.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 108.731 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -72.27 -4.8 31.72 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.381 -0.824 . . . . 0.0 109.047 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 87.5 m -89.39 -26.21 21.15 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 110.224 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.771 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.2 -46.5 99.83 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.421 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -57.97 -56.39 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.67 1.58 . . . . 0.0 111.854 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.77 -51.36 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.778 1.652 . . . . 0.0 110.259 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.641 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -67.91 -15.01 63.42 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.428 -0.795 . . . . 0.0 109.273 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.57 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 14.4 ttpp -86.29 -10.82 53.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.887 . . . . 0.0 109.264 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.71 15.12 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -61.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 109.476 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.697 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.7 m-30 -84.86 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.137 -0.977 . . . . 0.0 108.681 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -178.28 -166.19 34.2 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.57 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -73.33 -11.53 60.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.079 -1.248 . . . . 0.0 109.398 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -88.81 -21.56 23.68 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.269 -0.895 . . . . 0.0 109.45 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.79 129.56 7.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -108.1 125.95 8.08 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -132.12 153.89 50.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.296 . . . . 0.0 110.226 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 11.3 mttp -134.96 -177.14 4.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 109.496 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 122.89 8.46 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.024 -1.047 . . . . 0.0 110.795 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 2.5 mtp -85.0 97.55 9.88 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.7 OUTLIER 5.05 65.71 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 CA-C-O 121.336 0.589 . . . . 0.0 111.472 -177.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.28 -43.34 0.19 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 96.3 mttt -152.97 157.73 41.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.484 -1.597 . . . . 0.0 109.724 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.487 ' O ' HG23 ' A' ' 3' ' ' ILE . 57.9 m -87.75 178.1 6.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.568 -0.707 . . . . 0.0 110.074 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.8 128.13 11.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.498 -0.751 . . . . 0.0 109.28 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 m -93.25 119.69 32.7 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.481 -0.762 . . . . 0.0 109.469 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.9 m-85 -115.87 100.04 53.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.279 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.7 Cg_exo -60.04 158.08 31.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.115 1.876 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' A' ' 39' ' ' HIS . 9.6 p80 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.481 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.579 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.258 0.551 . . . . 0.0 109.659 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -85.41 49.01 1.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.11 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 95.2 t -110.67 153.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.052 . . . . 0.0 109.464 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.78 157.96 20.84 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.162 -0.962 . . . . 0.0 109.457 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.5 p -156.54 155.7 32.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 111.188 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.1 p -112.49 -9.66 13.78 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.4 p -168.28 138.58 2.1 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.65 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.4 Cg_exo -59.81 -14.32 26.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.52 1.48 . . . . 0.0 109.892 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -46.01 84.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.923 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -4.74 34.33 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 87.5 m -87.46 -25.37 23.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.316 -0.865 . . . . 0.0 110.295 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -57.7 -46.39 99.75 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.024 -1.047 . . . . 0.0 112.333 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -57.23 -55.92 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.606 1.537 . . . . 0.0 111.78 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.2 Cg_endo -61.69 -47.57 10.92 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.755 1.637 . . . . 0.0 109.999 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.557 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -73.51 -11.13 60.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.3 ttpp -97.92 -13.67 21.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.291 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.38 8.92 12.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -115.98 -56.74 2.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.492 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.966 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.4 m-85 -85.94 -65.82 0.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -0.946 . . . . 0.0 108.676 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.51 -168.66 40.17 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -73.82 -6.22 45.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.989 -1.3 . . . . 0.0 109.407 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.7 p -89.5 -23.08 22.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.211 -0.931 . . . . 0.0 109.747 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.966 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -61.2 133.74 56.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -105.47 130.57 10.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -134.88 153.41 52.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.27 . . . . 0.0 109.677 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 18.2 mttt -138.25 -176.81 4.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.226 -0.921 . . . . 0.0 109.585 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.17 121.38 7.8 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.05 -1.031 . . . . 0.0 110.898 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.18 99.27 10.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 24.1 t30 4.76 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.288 0.566 . . . . 0.0 111.535 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.18 -44.51 0.19 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.349 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.2 mtmt -153.45 160.14 42.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.603 -1.528 . . . . 0.0 109.781 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.0 m -87.97 179.7 6.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.598 -0.689 . . . . 0.0 110.191 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -150.52 127.82 11.34 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.455 -0.778 . . . . 0.0 109.357 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.61 122.26 39.34 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.466 -0.772 . . . . 0.0 109.867 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.1 m-85 -119.38 94.5 48.43 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.64 164.7 10.94 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.126 1.884 . . . . 0.0 110.299 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.504 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.277 0.56 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -104.53 39.08 1.74 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 67.0 t -99.42 150.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.2 pttt -84.64 158.98 20.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.905 -1.122 . . . . 0.0 108.938 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.08 156.42 34.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 110.881 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 p -107.43 -3.94 19.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.1 p -166.36 140.7 3.54 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.713 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.2 Cg_endo -63.42 -9.93 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.962 1.775 . . . . 0.0 110.269 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 13.9 tttt -75.71 -40.34 55.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.61 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 19.4 mt-30 -72.27 -4.64 30.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.515 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 72.0 m -88.85 -29.3 19.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.255 -0.903 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.3 mp -66.94 -44.43 51.26 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 112.513 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -56.22 -53.33 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.403 1.402 . . . . 0.0 111.014 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -65.4 -45.43 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.744 1.629 . . . . 0.0 109.61 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.4 t -67.75 -16.59 64.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 110.0 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 32.5 ttmt -82.04 -9.55 59.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.142 -0.974 . . . . 0.0 109.43 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.14 21.44 2.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.36 -55.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.621 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.4 m-30 -85.01 -65.96 0.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 0.0 108.726 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.589 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 163.61 -170.63 39.04 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 18' ' ' LYS . 7.4 tt0 -68.66 -6.38 25.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.073 -1.251 . . . . 0.0 109.637 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -90.26 -8.84 49.98 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -59.27 124.28 19.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.891 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -112.92 118.55 4.61 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -128.6 166.47 18.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.368 -1.078 . . . . 0.0 109.687 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 49.1 mtmt -136.03 -169.51 2.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.865 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 27.3 t -151.44 115.64 5.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' GLY . 4.8 mmt -85.38 -140.07 0.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 109.609 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.6 m120 -41.22 -27.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.938 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 161.98 53.41 0.02 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.8 mtpp -153.39 139.68 18.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.083 -1.245 . . . . 0.0 108.167 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.485 ' O ' HG13 ' A' ' 3' ' ' ILE . 71.2 m -85.2 159.57 20.08 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 110.594 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -139.42 122.97 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 32.9 m -92.75 122.33 35.04 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 111.127 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.7 m-85 -122.18 93.35 48.6 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.43 147.67 93.31 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.063 1.842 . . . . 0.0 110.131 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.522 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 5' ' ' VAL . 3.9 t-20 -105.1 80.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 4' ' ' ASN . 75.7 t -159.53 153.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -90.13 160.61 16.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -155.96 157.95 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 110.797 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -9.45 13.17 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.4 p -168.06 137.72 2.08 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.754 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.6 Cg_exo -59.46 -14.42 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.672 1.581 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.4 -45.21 80.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.924 . . . . 0.0 108.779 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -73.92 -5.21 39.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.391 -0.818 . . . . 0.0 109.029 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.0 m -89.19 -22.09 22.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 110.117 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -57.75 -46.45 99.74 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 120.992 -1.067 . . . . 0.0 112.202 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.22 -56.28 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.73 -51.26 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.861 1.707 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -68.93 -14.62 63.15 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.487 -0.758 . . . . 0.0 109.219 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.558 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.5 ttpp -83.48 -9.8 58.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.352 -0.842 . . . . 0.0 109.205 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.58 15.6 13.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.945 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -109.26 -64.96 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.862 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-85 -84.2 -66.8 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 108.531 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -171.95 -157.22 13.35 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 29.1 tt0 -81.56 -12.52 58.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.284 . . . . 0.0 109.57 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.1 p -92.71 -13.09 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.345 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -43.5 118.13 1.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -90.12 122.06 6.43 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -128.47 161.17 30.14 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.155 -1.203 . . . . 0.0 110.234 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -144.78 178.06 8.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.837 . . . . 0.0 109.657 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.15 123.06 8.73 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.242 -0.911 . . . . 0.0 110.876 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.587 ' O ' ' C ' ' A' ' 31' ' ' ASN . 3.9 mtp -87.04 96.97 10.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.587 ' C ' ' O ' ' A' ' 30' ' ' MET . 11.2 m120 4.82 65.54 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.395 0.617 . . . . 0.0 111.505 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.5 -41.38 0.18 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 39.5 mttt -153.53 157.69 40.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.511 -1.582 . . . . 0.0 109.766 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' HG23 ' A' ' 3' ' ' ILE . 59.4 m -87.36 179.53 6.58 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 110.075 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.629 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 8.5 mttt -150.62 134.34 16.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 41.9 m -103.04 117.44 34.58 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.3 m-85 -118.9 106.1 44.22 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 Cg_exo -59.86 130.11 33.45 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.986 1.791 . . . . 0.0 110.223 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.537 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.547 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.24 33.19 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.121 -0.987 . . . . 0.0 109.818 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 6' ' ' LYS . 50.4 t -82.46 162.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 109.116 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -84.12 153.6 23.64 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.133 -0.979 . . . . 0.0 109.08 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.552 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 165.22 37.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.092 -1.005 . . . . 0.0 111.557 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.1 p -122.31 -7.86 8.71 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -168.24 143.81 3.05 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -60.57 -16.13 40.84 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.899 1.733 . . . . 0.0 109.896 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.05 -43.2 88.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.26 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' O ' ' CD ' ' A' ' 16' ' ' PRO . 92.5 mt-30 -71.84 -4.68 29.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.238 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 73.5 m -84.84 -29.17 25.54 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.361 -0.837 . . . . 0.0 109.972 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.64 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mp -69.41 -45.17 27.22 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.343 -0.848 . . . . 0.0 112.584 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.1 Cg_exo -55.25 -54.28 4.58 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.429 1.419 . . . . 0.0 110.745 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -66.91 -44.18 5.78 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.543 1.495 . . . . 0.0 108.859 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.8 t -73.52 -5.03 37.52 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.189 0.519 . . . . 0.0 109.727 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.7 ttpp -98.64 -9.51 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.06 14.75 26.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.78 -57.03 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.059 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 9.2 m-85 -85.53 -35.75 20.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 108.713 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 139.46 -160.32 25.96 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.55 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 8.1 tt0 -86.69 8.66 21.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -1.231 . . . . 0.0 109.362 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 p -107.46 -18.15 13.93 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.059 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -53.61 119.72 5.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.04 117.12 5.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.556 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -125.01 169.9 11.67 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 110.638 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.2 mttt -155.09 177.23 11.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -149.61 128.2 12.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.98 -1.075 . . . . 0.0 110.515 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.601 ' O ' ' C ' ' A' ' 31' ' ' ASN . 38.3 mtt -95.61 104.03 15.92 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 30' ' ' MET . 35.8 m-20 4.86 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.321 0.581 . . . . 0.0 111.338 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 175.6 -54.98 0.12 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.248 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.552 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mppt? -152.99 165.33 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.753 -1.439 . . . . 0.0 109.968 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 68.4 m -88.35 177.59 6.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.634 0.73 . . . . 0.0 110.365 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.45 128.8 12.08 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.547 ' SG ' HD13 ' A' ' 3' ' ' ILE . 30.9 m -102.99 122.3 44.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 111.117 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.567 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.0 m-85 -113.41 98.56 46.94 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.99 90.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.983 1.789 . . . . 0.0 110.163 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.468 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.785 HD11 ' HB2' ' A' ' 34' ' ' CYS . 12.6 pt . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 121.201 0.524 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.24 51.77 2.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 53.5 t -116.23 153.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.184 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.6 pttt -99.68 157.63 16.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 109.629 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -156.02 159.67 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.7 p -107.83 -6.22 16.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -166.74 140.02 3.12 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.889 ' O ' HD12 ' A' ' 14' ' ' LEU . 2.7 Cg_endo -60.33 -13.94 27.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.565 1.51 . . . . 0.0 109.733 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -73.41 -41.19 63.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.18 -4.95 38.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.282 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' CB ' ' A' ' 7' ' ' CYS . 69.5 m -91.15 -22.85 20.46 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.413 -0.805 . . . . 0.0 109.99 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.889 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -67.74 -45.16 44.51 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.162 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -56.98 -53.81 4.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.446 1.43 . . . . 0.0 111.022 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -65.17 -44.92 8.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.756 1.638 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 24.6 t -67.28 -16.68 64.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.8 -0.562 . . . . 0.0 109.922 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.599 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 29.6 ttmt -85.75 -9.98 56.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.35 15.69 15.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.434 ' NE2' ' CZ ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -118.13 -59.72 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.86 . . . . 0.0 109.61 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 7.0 m-85 -87.01 -67.69 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 108.908 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 177.07 -169.03 41.21 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.599 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 19.5 tt0 -69.72 -4.87 21.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -1.234 . . . . 0.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 p -95.82 -8.23 34.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -59.39 123.85 18.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.015 -1.053 . . . . 0.0 109.689 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.11 127.36 7.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -137.22 158.79 43.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.24 . . . . 0.0 110.381 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 68.0 mttm -123.1 -168.92 1.84 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.42 -0.8 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 36.1 t -151.08 117.23 5.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' GLY . 8.9 mtm -84.56 -140.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.495 -0.753 . . . . 0.0 109.283 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m-80 -41.7 -28.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . 162.13 54.69 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 25.5 mttm -152.69 135.98 15.81 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.157 -1.202 . . . . 0.0 108.239 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.785 ' HB2' HD11 ' A' ' 3' ' ' ILE . 31.7 m -85.07 148.69 26.02 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.042 -1.036 . . . . 0.0 111.005 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.4 ttpm? -123.47 117.39 25.03 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.6 m -94.06 123.31 37.35 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.628 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.522 ' OH ' ' CE ' ' A' ' 35' ' ' LYS . 13.1 m-85 -117.99 104.7 48.34 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.96 140.2 91.63 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.077 1.851 . . . . 0.0 110.221 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.413 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.521 ' N ' HG13 ' A' ' 3' ' ' ILE . 39.4 t-20 -109.45 76.2 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.244 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 3' ' ' ILE . 71.9 t -153.64 151.8 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.837 . . . . 0.0 109.428 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -85.02 164.4 18.28 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 154.94 32.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 0.0 111.72 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -114.27 -10.66 12.68 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -168.08 141.75 2.72 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.6 Cg_exo -60.41 -17.27 46.6 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.728 1.619 . . . . 0.0 109.849 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.82 -44.89 91.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.074 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 47.6 mt-30 -71.31 -4.81 28.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.283 -0.886 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.491 ' SG ' ' HA ' ' A' ' 10' ' ' PRO . 74.1 m -85.86 -26.7 25.51 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.235 -0.915 . . . . 0.0 109.982 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.626 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.6 mm? -71.89 -45.77 11.93 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.458 -0.776 . . . . 0.0 112.017 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -54.84 -53.4 6.09 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.329 1.353 . . . . 0.0 110.437 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -66.67 -44.38 6.06 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.661 1.574 . . . . 0.0 109.041 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 12.7 t -73.31 -5.06 37.18 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.179 0.514 . . . . 0.0 109.832 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 9.5 ttpt -99.9 -9.43 22.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.986 -1.071 . . . . 0.0 109.341 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.1 11.89 38.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -120.13 -54.65 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.133 -0.979 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.4 m-85 -87.21 -46.33 9.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 108.702 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 154.53 -159.79 29.15 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -88.14 9.52 22.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.247 . . . . 0.0 109.46 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -108.4 -17.84 13.89 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.778 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.849 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -54.39 112.01 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -95.42 119.74 6.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.589 ' O ' HD21 ' A' ' 14' ' ' LEU . . . -126.52 170.7 11.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.074 -1.25 . . . . 0.0 110.859 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 7.4 mttt -155.31 -177.81 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -149.79 131.95 15.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' A' ' 29' ' ' CYS . 27.8 mtp -155.39 28.86 0.39 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.992 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -167.53 43.43 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 63.85 19.66 63.45 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.0 mtpt -153.21 155.81 37.33 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.17 -1.194 . . . . 0.0 109.604 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 28' ' ' LYS . 93.5 m -89.27 -178.91 5.75 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.513 0.673 . . . . 0.0 109.871 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.0 tmtt? -150.89 128.25 11.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 33.0 m -103.42 125.59 50.1 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 111.338 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 62.9 m-85 -114.89 96.59 45.14 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.66 154.2 56.49 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.062 1.841 . . . . 0.0 110.385 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.283 0.563 . . . . 0.0 109.647 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -91.76 64.43 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.572 ' HB ' HD11 ' A' ' 3' ' ' ILE . 72.8 t -145.72 148.71 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 1.9 ptpp? -95.6 162.12 13.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.231 -0.918 . . . . 0.0 109.45 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -155.71 158.14 37.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 111.113 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -8.38 16.51 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.462 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 73.8 p -166.6 139.83 3.18 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 14' ' ' LEU . 3.9 Cg_exo -59.87 -14.35 27.0 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.747 1.631 . . . . 0.0 109.97 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -75.17 -39.83 60.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.295 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 2.4 mt-30 -73.5 -5.84 42.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 95.4 m -91.65 -21.51 20.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 109.89 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -64.89 -44.78 73.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 112.467 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.5 Cg_exo -55.86 -53.87 4.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.441 1.427 . . . . 0.0 110.875 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -63.79 -46.24 9.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.628 1.552 . . . . 0.0 109.372 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.1 t -70.71 -10.68 59.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.75 -0.594 . . . . 0.0 109.622 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 7.0 ttpt -91.9 -10.39 39.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 109.334 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.23 4.19 44.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -104.47 -61.7 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.6 m-30 -84.45 -52.71 5.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.704 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.15 -155.6 26.47 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 1.7 tt0 -90.18 7.37 38.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.09 -1.241 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -110.76 -14.02 14.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.089 -1.007 . . . . 0.0 109.928 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -46.68 126.96 9.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.701 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.22 120.13 6.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -131.72 176.47 8.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -1.186 . . . . 0.0 110.274 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 33.4 mmtm -150.24 -166.49 2.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 109.214 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.555 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 25.0 t -151.08 103.56 3.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.042 -1.036 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -103.78 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.485 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 1.7 t-20 -80.96 67.02 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.544 -0.722 . . . . 0.0 110.06 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.13 46.1 94.81 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.6 mttp -154.12 137.33 15.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.109 -1.23 . . . . 0.0 108.399 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 32.8 m -85.79 149.61 25.14 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.584 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 17.4 mtmt -123.6 124.37 42.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.1 m -103.23 122.88 45.67 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.247 -0.908 . . . . 0.0 111.165 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.63 104.85 46.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -58.8 148.93 81.01 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.896 1.731 . . . . 0.0 109.999 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.561 -179.778 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.527 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -110.8 65.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.833 . . . . 0.0 109.354 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.712 ' HB ' HD11 ' A' ' 3' ' ' ILE . 89.2 t -142.34 150.61 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 109.333 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -89.93 163.46 14.96 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.128 -0.982 . . . . 0.0 109.107 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 160.89 39.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.672 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 p -110.68 -4.6 15.29 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 66.6 p -166.47 140.94 3.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.826 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.5 Cg_endo -62.12 -12.19 25.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.798 1.665 . . . . 0.0 109.967 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -77.98 -38.57 44.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.426 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.416 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 6.0 mt-30 -73.09 -4.97 35.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -0.916 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 84.6 m -91.88 -27.19 18.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.358 -0.839 . . . . 0.0 110.041 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -65.56 -44.79 66.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.237 -0.914 . . . . 0.0 112.27 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.8 -53.5 5.47 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.492 1.462 . . . . 0.0 110.956 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 3.1 Cg_exo -62.21 -46.51 12.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.742 1.628 . . . . 0.0 109.638 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.11 -14.65 63.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.554 -0.716 . . . . 0.0 109.482 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.4 ttmp? -81.3 -9.69 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.167 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.72 14.31 19.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.46 -0.775 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.408 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tt0 -126.65 -57.27 1.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.627 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.626 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.7 m-30 -84.67 -66.76 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 108.739 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 169.05 -169.69 42.03 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.589 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.13 -4.59 22.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.015 -1.286 . . . . 0.0 109.728 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 p -94.23 -8.07 40.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.226 -0.922 . . . . 0.0 109.587 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -58.34 122.2 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.941 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.54 121.11 6.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -131.85 157.16 44.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.98 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -126.39 -168.21 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.614 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 28.0 t -151.42 120.19 6.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.963 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' GLY . 28.9 mtp -84.72 -143.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.368 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 30' ' ' MET . 28.4 t-20 -43.7 -26.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' LYS . . . 164.38 55.24 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 27.0 mttt -152.9 138.51 17.78 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.103 -1.234 . . . . 0.0 108.358 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.506 ' O ' HG23 ' A' ' 3' ' ' ILE . 81.5 m -85.11 156.17 21.17 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 110.702 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 12.3 mttm -135.1 127.44 30.28 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 30.4 m -100.62 124.48 46.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.874 0.845 . . . . 0.0 111.452 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -125.82 96.53 37.61 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.48 147.45 94.25 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.116 1.877 . . . . 0.0 110.081 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 4.9 pt . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.14 63.1 5.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.41 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' A' ' 3' ' ' ILE . 72.6 t -143.48 151.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.609 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 5.8 mtpp -95.31 166.77 11.73 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.305 -0.872 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.21 159.96 39.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 110.66 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.464 ' OG1' ' OE1' ' A' ' 12' ' ' GLN . 13.3 p -111.77 -8.71 14.14 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 p -167.06 137.93 2.54 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.926 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.3 Cg_exo -59.38 -14.66 25.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.71 1.607 . . . . 0.0 109.939 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -70.9 -42.03 70.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.295 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.464 ' OE1' ' OG1' ' A' ' 8' ' ' THR . 63.8 mt-30 -74.16 -4.63 36.92 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 68.8 m -91.47 -23.78 19.88 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.275 -0.89 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.926 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER -66.77 -44.54 53.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.319 -0.863 . . . . 0.0 112.402 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.71 -53.51 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.483 1.455 . . . . 0.0 110.951 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.59 -46.39 7.18 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.643 1.562 . . . . 0.0 109.251 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.5 t -70.22 -10.72 59.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.725 -0.61 . . . . 0.0 109.725 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 16.2 ttpp -91.71 -9.91 42.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.424 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.16 -6.32 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.288 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -93.93 -61.86 1.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.609 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 1.7 m-30 -84.34 -66.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 108.85 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -179.57 -155.87 16.25 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.54 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 2.6 tt0 -88.49 5.97 40.02 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.086 -1.244 . . . . 0.0 109.524 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.0 p -109.34 -13.1 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.177 -0.952 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -45.25 123.9 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.29 116.73 5.63 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -132.53 172.29 12.7 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.094 -1.239 . . . . 0.0 110.666 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 38.9 mttp -154.09 -167.03 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 6.6 t -151.14 121.07 7.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.88 -1.138 . . . . 0.0 109.721 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.507 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.5 mmt -98.52 -135.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.108 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m120 -35.28 -31.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.9 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 158.37 49.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.499 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.1 mtpp -153.61 150.38 28.58 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.972 -1.311 . . . . 0.0 108.147 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 58.3 m -86.76 152.25 22.67 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 110.132 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 5.8 mmtm -122.98 121.63 36.58 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 28.8 m -104.09 119.45 38.97 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.102 -0.999 . . . . 0.0 111.159 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 35.3 m-85 -110.85 93.98 18.76 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 2.5 Cg_endo -61.56 152.19 75.11 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.122 1.881 . . . . 0.0 110.303 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 p80 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.516 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p-10 -103.22 77.3 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.512 HG23 ' C ' ' A' ' 4' ' ' ASN . 21.5 t -157.46 145.24 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 7.7 mttm -84.8 164.06 18.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.046 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.4 159.76 39.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.11 -0.994 . . . . 0.0 111.384 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -111.98 -12.51 13.73 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p -168.32 139.3 2.19 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.943 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.3 Cg_exo -59.01 -14.29 22.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.642 1.561 . . . . 0.0 109.893 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -64.57 -46.87 80.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.249 -0.907 . . . . 0.0 108.823 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 mt-30 -72.71 -4.98 34.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.112 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.6 m -89.06 -26.71 21.25 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.88 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.943 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -65.95 -44.98 63.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 112.537 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.9 Cg_exo -55.21 -53.23 6.18 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.356 1.37 . . . . 0.0 110.751 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.39 -44.15 12.34 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.702 1.601 . . . . 0.0 109.614 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 10.4 t -72.74 -10.39 59.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.71 -0.618 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.3 ttpt -96.9 -9.58 28.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.523 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.4 8.86 44.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.33 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.31 -58.09 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.824 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.7 m-85 -84.88 -62.81 1.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 108.575 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.27 -159.73 29.01 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.55 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 61.0 tt0 -86.91 4.77 40.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.265 . . . . 0.0 109.366 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -107.83 -13.89 14.9 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.166 -0.959 . . . . 0.0 110.191 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.824 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -52.06 119.32 4.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.563 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.29 117.85 5.28 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.724 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -126.63 163.39 23.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.127 -1.22 . . . . 0.0 110.563 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.9 mtmt -153.64 178.97 9.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 0.0 109.272 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.509 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -150.6 124.55 9.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.011 -1.055 . . . . 0.0 110.861 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 5.8 mtp -90.53 98.45 11.78 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.8 OUTLIER 4.93 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.393 -177.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.84 -47.45 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.153 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 19.7 mtmm -153.86 161.97 41.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.543 -1.563 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' O ' HG23 ' A' ' 3' ' ' ILE . 55.9 m -88.52 -179.96 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 110.393 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.5 mttt -150.57 140.41 21.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 36.2 m -119.71 131.08 55.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.229 -0.92 . . . . 0.0 110.806 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -122.0 95.17 47.73 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.79 148.67 91.3 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.147 1.898 . . . . 0.0 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.368 179.86 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.525 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 1.1 t-20 -105.25 78.78 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 61.8 t -158.7 148.46 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.633 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -84.58 161.02 20.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.201 -0.937 . . . . 0.0 109.184 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -155.78 156.11 34.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 111.084 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -8.05 12.65 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.472 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 80.2 p -167.91 138.87 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.707 ' O ' HD12 ' A' ' 14' ' ' LEU . 2.7 Cg_endo -61.35 -13.3 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.704 1.603 . . . . 0.0 109.813 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -44.84 76.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.768 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.472 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 10.9 mt-30 -74.29 -4.55 36.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.416 -0.802 . . . . 0.0 109.273 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 94.6 m -88.84 -23.95 22.68 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.44 -46.96 99.75 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.404 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.3 Cg_exo -57.33 -56.21 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 121.665 1.577 . . . . 0.0 111.799 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.4 Cg_endo -61.24 -49.98 6.79 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.657 1.572 . . . . 0.0 110.032 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -70.34 -12.38 61.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 16.6 ttpp -94.94 -9.81 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.36 11.79 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -119.46 -56.81 2.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.747 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.1 m-85 -85.15 -66.2 0.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 108.723 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.05 -172.25 42.08 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.538 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 15.8 tt0 -69.91 -4.9 22.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.016 -1.285 . . . . 0.0 109.55 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 p -92.25 -21.49 20.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 109.794 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.977 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -62.0 133.91 55.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.988 . . . . 0.0 109.568 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -106.41 129.96 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -133.95 147.02 51.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.968 -1.313 . . . . 0.0 109.867 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.4 mttt -129.44 -176.16 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 123.18 8.62 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.072 -1.017 . . . . 0.0 110.764 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.589 ' O ' ' C ' ' A' ' 31' ' ' ASN . 82.2 mtp -86.28 99.8 11.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 30' ' ' MET . 4.9 m120 4.6 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.222 0.534 . . . . 0.0 111.516 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 170.82 -44.84 0.19 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.423 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 11.2 mtmm -153.34 159.9 42.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.49 -1.594 . . . . 0.0 109.715 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 57.3 m -87.72 179.61 6.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.518 0.675 . . . . 0.0 110.238 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 3.1 ttpt -150.63 128.86 11.96 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.426 -0.796 . . . . 0.0 109.26 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 38.6 m -95.3 120.11 34.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.59 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 30.2 m-85 -115.16 94.08 37.62 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.405 -0.809 . . . . 0.0 108.99 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -61.45 140.97 90.42 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.205 1.937 . . . . 0.0 110.043 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.483 -179.96 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.589 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.534 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.7 m-20 -109.45 69.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 0.0 109.215 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.589 ' HB ' HD11 ' A' ' 3' ' ' ILE . 49.5 t -143.56 146.87 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -86.32 159.95 19.26 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.219 -0.926 . . . . 0.0 109.596 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.5 p -156.06 145.6 20.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.141 -0.974 . . . . 0.0 110.575 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.33 -5.44 40.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.6 p -167.05 140.48 3.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.671 ' O ' HD23 ' A' ' 14' ' ' LEU . 2.3 Cg_endo -62.22 -11.26 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -41.45 62.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.365 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.429 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 5.4 mt-30 -74.46 -4.72 38.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 90.4 m -88.56 -21.14 24.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 10' ' ' PRO . 2.1 mm? -70.71 -45.15 17.01 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 111.892 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -55.24 -52.46 7.75 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.303 1.336 . . . . 0.0 110.627 -178.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.8 Cg_endo -67.47 -44.23 4.86 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.724 1.616 . . . . 0.0 109.229 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 14.6 t -72.22 -7.53 49.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.797 -0.565 . . . . 0.0 109.886 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.1 ttpt -97.26 -9.35 27.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.96 5.84 45.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.917 . . . . 0.0 109.54 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.95 -54.48 2.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.7 m-85 -89.47 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.44 -156.63 18.81 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.534 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.8 tt0 -90.16 4.69 49.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.17 -1.194 . . . . 0.0 109.376 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -106.72 -16.35 14.51 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.105 -0.997 . . . . 0.0 109.953 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -47.83 119.43 2.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.984 -1.072 . . . . 0.0 109.445 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.81 124.0 8.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -135.54 166.73 22.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.257 . . . . 0.0 110.683 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 3.5 mtmp? -139.94 -166.2 2.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.341 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 29.9 t -150.49 116.7 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 32' ' ' GLY . 5.1 mtp -84.67 -140.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.1 OUTLIER -41.09 -27.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.111 -179.637 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 162.11 52.7 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -153.13 140.98 20.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.038 -1.272 . . . . 0.0 108.185 178.35 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.52 ' O ' HG23 ' A' ' 3' ' ' ILE . 56.4 m -85.15 151.04 24.41 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.091 -1.005 . . . . 0.0 110.296 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.582 ' HG2' ' CE2' ' A' ' 37' ' ' TYR . 10.9 tttt -126.7 118.74 25.34 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 43.2 m -97.26 124.92 41.5 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.37 -0.831 . . . . 0.0 111.133 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.582 ' CE2' ' HG2' ' A' ' 35' ' ' LYS . 29.1 m-85 -116.15 99.57 52.77 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.02 104.61 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.054 1.836 . . . . 0.0 110.034 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.486 -179.794 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 121.194 0.521 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -132.09 40.35 3.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 41.6 t -106.91 156.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' N ' HG12 ' A' ' 5' ' ' VAL . 10.9 pttp -85.02 158.16 20.55 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.08 156.07 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 111.33 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.2 p -112.78 -10.44 13.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 p -168.27 137.87 2.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.809 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.4 Cg_exo -58.95 -15.12 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 121.505 1.47 . . . . 0.0 109.843 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -45.58 84.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 108.732 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 62.8 mm-40 -72.47 -5.61 37.94 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.336 -0.853 . . . . 0.0 109.192 179.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.5 m -89.62 -25.77 21.12 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.32 -0.863 . . . . 0.0 110.337 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.72 -46.12 99.77 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 112.356 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.4 Cg_exo -57.53 -56.06 2.03 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.547 1.498 . . . . 0.0 111.654 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.576 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -61.45 -50.18 6.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.682 1.588 . . . . 0.0 109.945 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -69.11 -13.43 62.42 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.521 -0.737 . . . . 0.0 109.138 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.0 ttpt -95.58 -10.6 29.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.352 -0.842 . . . . 0.0 109.524 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.04 16.88 5.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -123.07 -55.87 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.945 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 7.2 m-85 -85.92 -63.37 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 108.855 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.13 -171.83 42.0 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.546 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 24.4 tt0 -73.21 -1.68 18.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.958 -1.319 . . . . 0.0 109.592 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -95.58 -21.01 18.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.919 . . . . 0.0 109.814 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.945 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -60.92 129.04 39.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -101.83 129.46 9.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -131.2 159.34 38.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.101 -1.235 . . . . 0.0 109.748 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.3 mttm -143.57 -176.77 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.39 122.25 8.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.969 -1.082 . . . . 0.0 110.678 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.07 97.54 9.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.058 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 5.1 p-10 4.99 65.62 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.472 0.653 . . . . 0.0 111.449 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.12 -44.05 0.18 Allowed Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.8 -1.191 . . . . 0.0 111.162 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 38.3 mttt -153.42 160.41 42.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.509 -1.583 . . . . 0.0 109.828 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.556 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.2 m -87.69 177.77 6.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.619 -0.675 . . . . 0.0 110.123 -179.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.627 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 5.6 mtmt -150.95 131.04 13.46 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.5 m -98.21 118.55 35.09 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.459 -0.775 . . . . 0.0 109.896 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.5 m-85 -116.59 90.55 31.37 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 108.927 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 3.4 Cg_exo -59.9 105.71 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.331 2.021 . . . . 0.0 110.23 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.471 -179.988 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 34' ' ' CYS . 1.2 pt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.49 23.18 14.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 53.6 t -74.83 158.2 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 0.0 109.123 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.441 ' N ' HG12 ' A' ' 5' ' ' VAL . 50.4 tttp -84.39 158.59 21.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.132 -0.98 . . . . 0.0 109.075 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.17 159.91 39.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 111.619 -178.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -115.53 -9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -168.02 138.3 2.18 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.782 ' O ' HD12 ' A' ' 14' ' ' LEU . 3.6 Cg_exo -60.26 -13.23 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.524 1.482 . . . . 0.0 109.958 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 3.8 tptm -65.56 -46.2 80.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.218 -0.926 . . . . 0.0 108.74 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 29.6 mt-30 -72.5 -4.53 30.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.436 -0.79 . . . . 0.0 109.132 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.4 m -87.47 -27.81 22.44 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.296 -0.877 . . . . 0.0 110.336 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.68 -44.75 24.51 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 112.437 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.79 -53.33 5.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.361 1.374 . . . . 0.0 110.636 -178.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -67.0 -43.58 6.39 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.708 1.605 . . . . 0.0 109.261 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 43.2 t -71.13 -10.59 60.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.862 -0.524 . . . . 0.0 110.129 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 25.8 ttmt -95.47 -9.51 32.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 0.0 109.639 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.16 10.97 8.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.97 -56.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.63 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.036 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.2 m-85 -84.92 -63.13 1.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 108.816 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 158.3 -171.68 35.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 3.8 tm0? -67.98 -6.11 20.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.078 -1.248 . . . . 0.0 109.725 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -92.91 -9.12 41.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.036 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -70.37 122.72 20.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.41 122.38 7.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.712 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -127.43 161.89 27.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -1.156 . . . . 0.0 109.893 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 13.4 mttt -146.53 177.91 8.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.58 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.58 124.56 9.29 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -179.775 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.7 100.14 13.05 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.103 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.593 ' C ' ' O ' ' A' ' 30' ' ' MET . 33.2 m-20 4.88 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.398 0.618 . . . . 0.0 111.349 -177.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 174.28 -49.59 0.14 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.233 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.3 mptt -153.38 162.54 41.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.568 -1.548 . . . . 0.0 109.776 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.627 ' HB2' HD12 ' A' ' 3' ' ' ILE . 62.8 m -88.49 179.81 6.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.672 0.749 . . . . 0.0 110.655 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.568 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -150.38 133.36 16.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.878 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.8 m -108.08 120.49 42.48 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.391 -0.818 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -118.36 101.53 51.05 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.11 108.26 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.953 1.768 . . . . 0.0 110.242 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.495 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.534 ' HG1' ' HZ ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.691 HG22 ' HG3' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -47.5 119.16 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.229 -0.919 . . . . 0.0 109.199 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 34' ' ' CYS . 4.3 pt -103.38 138.74 26.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 110.118 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -88.4 31.93 0.8 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.866 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 16.7 t -74.72 159.01 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 108.911 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -87.47 156.11 19.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.59 158.04 36.38 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.174 0.988 . . . . 0.0 111.727 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 p -113.7 -12.1 12.85 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.8 p -168.43 138.22 1.99 Allowed Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.696 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.7 Cg_exo -58.82 -14.61 22.95 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.633 1.555 . . . . 0.0 110.103 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -42.61 93.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.157 -0.964 . . . . 0.0 108.774 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 42.0 mt-30 -75.34 -5.05 42.8 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.39 -0.818 . . . . 0.0 109.349 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 94.4 m -85.06 -26.38 27.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.345 -0.847 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.87 -46.58 23.81 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.359 -0.838 . . . . 0.0 112.279 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.01 -53.26 6.24 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.358 1.372 . . . . 0.0 110.449 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.95 -44.27 10.3 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.602 1.535 . . . . 0.0 108.863 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 10.2 t -75.27 -3.79 35.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.4 ttpt -100.26 -9.64 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.939 . . . . 0.0 109.235 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.48 -10.18 28.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.339 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -95.38 -56.67 2.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.579 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.871 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.8 m-85 -86.98 -61.95 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -0.9 . . . . 0.0 108.895 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.16 -160.62 34.35 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.534 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 16.2 tt0 -83.71 7.63 17.05 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.11 -1.229 . . . . 0.0 109.428 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -108.29 -16.19 14.3 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.868 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -54.67 113.42 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.069 -1.02 . . . . 0.0 109.651 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.09 121.0 6.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -133.54 160.19 38.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.099 -1.236 . . . . 0.0 110.678 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 4.7 mmtp -144.51 -178.28 5.91 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.53 121.98 7.92 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.987 -1.07 . . . . 0.0 110.851 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -85.35 98.52 10.59 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.8 OUTLIER 4.82 65.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 121.338 0.589 . . . . 0.0 111.452 -177.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.39 -44.14 0.18 Allowed Glycine 0 N--CA 1.483 1.804 0 C-N-CA 119.746 -1.216 . . . . 0.0 111.3 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.5 mttt -153.26 160.48 42.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.477 -1.602 . . . . 0.0 109.929 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.565 ' HB2' HD11 ' A' ' 3' ' ' ILE . 71.9 m -88.04 178.81 6.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.65 0.738 . . . . 0.0 110.126 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.691 ' HG3' HG22 ' A' ' 2' ' ' ILE . 16.8 ttmt -150.4 124.09 9.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 1' ' ' THR . 33.9 m -102.75 127.12 50.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 111.354 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.498 ' OH ' ' HD3' ' A' ' 35' ' ' LYS . 27.6 m-85 -119.67 96.91 49.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 1' ' ' THR . 3.1 Cg_exo -60.95 138.22 77.35 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.107 1.871 . . . . 0.0 110.24 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.035 -0.984 . . . . 0.0 109.474 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.778 HG21 ' CB ' ' A' ' 33' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 35' ' ' LYS . 44.9 mt -107.42 -56.68 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.938 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.846 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -85.01 171.74 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.154 -0.966 . . . . 0.0 109.215 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.545 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -113.75 56.94 0.69 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.213 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.846 ' HB ' HD11 ' A' ' 3' ' ' ILE . 96.6 t -139.2 153.31 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -0.927 . . . . 0.0 109.731 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -88.44 164.19 15.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.093 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.12 156.88 35.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 111.178 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 50.4 p -112.5 -10.23 13.74 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.48 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 64.6 p -168.16 137.19 1.97 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.703 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.2 Cg_exo -59.32 -14.27 23.94 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.534 1.49 . . . . 0.0 109.878 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -66.31 -45.83 79.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.885 . . . . 0.0 108.616 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 4.8 mt-30 -72.5 -4.76 32.39 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.434 -0.791 . . . . 0.0 109.027 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.8 m -89.26 -23.37 22.34 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.385 -0.822 . . . . 0.0 110.463 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -58.48 -46.15 99.63 Favored Pre-proline 0 C--N 1.296 -1.739 0 O-C-N 120.921 -1.112 . . . . 0.0 112.148 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.2 Cg_exo -58.94 -56.28 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.626 1.551 . . . . 0.0 111.868 -178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.68 -51.28 2.53 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.936 1.757 . . . . 0.0 110.586 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.98 -17.05 64.32 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.465 -0.772 . . . . 0.0 109.401 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 12.4 ttmm -81.01 -10.87 59.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.375 -0.828 . . . . 0.0 109.388 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.11 33.22 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.756 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.81 -61.18 0.9 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.401 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.2 m-85 -84.91 -65.76 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.546 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 178.41 -168.67 39.95 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.532 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 2.6 tt0 -69.67 -10.73 59.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.941 -1.329 . . . . 0.0 109.393 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -89.84 -8.4 52.09 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.29 -0.881 . . . . 0.0 109.194 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 18' ' ' LYS . . . -54.93 122.06 10.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -0.878 . . . . 0.0 110.012 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.88 120.55 6.89 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -128.45 157.27 41.56 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.952 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -139.01 -177.16 4.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.348 -0.845 . . . . 0.0 109.508 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.89 122.27 7.87 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.064 -1.022 . . . . 0.0 110.953 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.598 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.6 OUTLIER -85.55 97.98 10.37 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 176.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.598 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.3 p30 4.81 65.84 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.348 0.594 . . . . 0.0 111.518 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.55 -44.12 0.18 Allowed Glycine 0 N--CA 1.484 1.892 0 C-N-CA 119.748 -1.215 . . . . 0.0 111.323 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.778 ' CB ' HG21 ' A' ' 1' ' ' THR . 76.7 mttt -153.44 159.9 42.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.424 -1.633 . . . . 0.0 109.764 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.675 ' HB2' HD13 ' A' ' 3' ' ' ILE . 55.5 m -88.21 178.28 6.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.608 -0.683 . . . . 0.0 110.236 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.594 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -150.47 132.58 15.32 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.477 -0.765 . . . . 0.0 109.325 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.99 119.61 35.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 110.137 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' OH ' ' HD2' ' A' ' 35' ' ' LYS . 32.4 m-85 -121.37 97.49 47.24 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.462 -0.774 . . . . 0.0 109.338 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 2.8 Cg_endo -61.55 140.92 89.61 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.089 1.859 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.6 m80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.437 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.29 0.567 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.431 HG21 ' O ' ' A' ' 36' ' ' CYS . 96.7 mt -88.8 -49.12 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.551 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.613 HD13 ' HB2' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -105.48 154.09 6.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.099 -1.0 . . . . 0.0 108.746 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.549 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p30 -111.08 78.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.389 -0.819 . . . . 0.0 108.976 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 4' ' ' ASN . 72.4 t -158.5 152.47 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG2' ' N ' ' A' ' 7' ' ' CYS . 32.7 tttm -91.77 162.13 14.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.91 . . . . 0.0 108.798 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.531 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -156.02 158.59 38.1 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.949 -1.094 . . . . 0.0 111.353 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -113.49 -10.75 13.17 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 p -168.16 139.27 2.26 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.904 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.4 Cg_exo -59.78 -14.11 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 121.606 1.538 . . . . 0.0 109.919 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -63.76 -45.13 91.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.314 -0.867 . . . . 0.0 109.106 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 2.2 mt-30 -74.84 -5.03 41.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.5 m -88.68 -27.56 21.17 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.419 -0.801 . . . . 0.0 110.052 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -67.91 -45.2 42.64 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.227 -0.92 . . . . 0.0 112.225 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.66 -52.9 6.52 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 121.327 1.352 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.7 Cg_endo -64.73 -44.63 10.19 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.768 1.645 . . . . 0.0 109.341 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 11.8 t -73.46 -8.65 56.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.79 -0.569 . . . . 0.0 109.776 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 3.1 ttpt -95.57 -9.58 31.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.71 -9.33 29.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -92.61 -58.73 2.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.505 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.904 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 9.1 m-85 -85.66 -60.95 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 108.879 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 168.44 -161.09 34.81 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 42.5 tt0 -84.72 10.05 12.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.246 . . . . 0.0 109.465 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.5 p -111.73 -15.55 13.39 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.337 -0.852 . . . . 0.0 109.79 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -55.31 123.23 13.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 109.787 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.69 117.14 5.66 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.733 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -125.88 165.46 18.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 110.412 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.572 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.9 mttp -154.7 179.32 9.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.243 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.511 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -150.32 124.75 9.58 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.888 -1.133 . . . . 0.0 110.948 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -88.94 98.67 11.88 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 7.1 m120 4.66 66.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 121.412 0.625 . . . . 0.0 111.542 -177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.47 -46.84 0.17 Allowed Glycine 0 N--CA 1.484 1.872 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.208 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 2.5 mtmp? -153.33 160.44 42.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.561 -1.552 . . . . 0.0 109.522 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.613 ' HB2' HD13 ' A' ' 3' ' ' ILE . 57.2 m -88.13 -178.73 6.02 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.465 -0.772 . . . . 0.0 110.284 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -150.74 134.96 16.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.1 m -114.27 120.43 40.39 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.239 -0.913 . . . . 0.0 111.018 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.411 ' CE1' ' CD1' ' A' ' 2' ' ' ILE . 19.6 m-85 -113.23 98.99 47.94 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.57 141.48 95.39 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.146 1.898 . . . . 0.0 110.382 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.069 -0.967 . . . . 0.0 109.396 179.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.616 HD12 ' HZ3' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -111.57 -41.82 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -0.956 . . . . 0.0 109.462 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -101.01 155.03 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.031 -1.043 . . . . 0.0 108.913 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.548 ' O ' HG23 ' A' ' 5' ' ' VAL . 23.7 t30 -106.9 81.72 1.6 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.086 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 4' ' ' ASN . 79.9 t -159.18 151.59 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -97.68 165.83 11.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.324 -0.86 . . . . 0.0 108.685 179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.627 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.43 164.01 38.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.915 -1.116 . . . . 0.0 111.373 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.4 p -112.83 -10.71 13.55 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.494 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 31.8 p -167.33 141.87 3.16 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.614 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.9 Cg_endo -61.99 -10.24 17.06 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.793 1.662 . . . . 0.0 110.171 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -77.17 -40.08 46.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.147 -0.971 . . . . 0.0 109.117 179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.494 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 19.2 mt-30 -75.78 -4.71 42.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 109.375 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 56.4 m -89.55 -19.98 24.33 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.326 -0.859 . . . . 0.0 109.853 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.625 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.2 mp -58.2 -44.41 99.22 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 112.37 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 6.2 Cg_exo -57.35 -56.31 1.91 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.633 1.555 . . . . 0.0 111.759 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -63.09 -49.82 4.46 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.71 1.607 . . . . 0.0 110.125 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -70.18 -12.58 61.7 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.693 -0.629 . . . . 0.0 109.519 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.553 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 0.8 OUTLIER -85.46 -9.93 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.439 -0.788 . . . . 0.0 109.071 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.95 6.65 41.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.264 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -106.88 -62.94 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.915 . . . . 0.0 110.137 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-30 -84.22 -63.36 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.62 -156.72 18.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.553 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.7 tt0 -80.18 -9.99 59.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.037 -1.272 . . . . 0.0 109.346 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.1 p -95.75 -12.15 25.86 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.555 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.21 111.67 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.228 -0.92 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -88.93 117.79 4.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.577 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.79 145.95 50.43 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.307 -1.114 . . . . 0.0 109.609 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.0 mttm -119.05 -168.3 1.54 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.183 -0.948 . . . . 0.0 110.314 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 6.0 t -150.61 123.98 8.96 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.282 -0.887 . . . . 0.0 109.658 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.475 ' O ' ' N ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -95.18 -141.38 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.399 -0.813 . . . . 0.0 110.044 -179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 30' ' ' MET . 3.9 m-20 -38.43 -30.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.486 -0.759 . . . . 0.0 110.143 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 163.46 53.99 0.02 OUTLIER Glycine 0 N--CA 1.485 1.924 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.344 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.627 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 29.1 mttt -152.62 144.39 23.58 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.023 -1.281 . . . . 0.0 108.628 178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.532 ' O ' HG23 ' A' ' 3' ' ' ILE . 73.0 m -85.82 159.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 109.526 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.616 ' HZ3' HD12 ' A' ' 2' ' ' ILE . 3.3 mttt -140.41 129.69 23.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 69.2 m -95.06 117.19 29.76 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.304 -0.872 . . . . 0.0 110.058 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CZ ' ' HD3' ' A' ' 35' ' ' LYS . 32.5 m-85 -120.88 99.99 46.56 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.507 -0.745 . . . . 0.0 109.041 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -60.55 141.95 96.65 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.008 1.805 . . . . 0.0 110.258 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.52 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 36' ' ' CYS . 9.9 mt -75.45 -28.07 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.511 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.542 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -103.55 154.0 5.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.095 -1.003 . . . . 0.0 108.721 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.542 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.5 t30 -108.45 83.38 1.77 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 109.063 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 96.7 t -158.65 149.0 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.929 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -86.89 158.48 19.31 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.47 157.91 37.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.978 -1.076 . . . . 0.0 111.24 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.6 p -113.45 -9.87 13.28 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.0 p -168.01 138.51 2.22 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.867 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.0 Cg_exo -59.59 -14.08 24.37 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 121.726 1.617 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -62.93 -46.79 86.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 108.981 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.497 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 5.0 mt-30 -72.28 -4.79 31.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.271 -0.893 . . . . 0.0 109.301 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.0 m -88.82 -29.2 19.89 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.382 -0.824 . . . . 0.0 109.985 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.867 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.3 mp -67.64 -45.35 45.73 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.903 . . . . 0.0 112.188 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.1 Cg_exo -55.69 -53.08 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.565 1.51 . . . . 0.0 110.727 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -63.03 -47.77 7.74 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.611 1.541 . . . . 0.0 109.349 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.2 t -69.66 -11.18 60.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.665 -0.647 . . . . 0.0 109.449 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 15.0 ttpp -89.39 -9.88 48.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.294 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.15 4.88 44.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.249 -0.907 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -106.9 -61.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.925 . . . . 0.0 109.585 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.626 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.5 m-30 -84.71 -56.86 3.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 108.762 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 171.87 -155.24 23.48 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.546 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 28.8 tt0 -90.37 7.01 40.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.092 -1.24 . . . . 0.0 109.521 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -110.82 -12.24 14.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.124 -0.985 . . . . 0.0 109.869 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -50.27 122.31 6.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.091 -1.006 . . . . 0.0 109.704 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.81 115.66 5.21 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.59 156.26 41.18 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.239 -1.154 . . . . 0.0 110.267 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.7 mtmt -145.11 -179.89 6.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -0.762 . . . . 0.0 109.286 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -150.96 124.76 9.14 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.997 -1.064 . . . . 0.0 110.856 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.596 ' O ' ' C ' ' A' ' 31' ' ' ASN . 37.1 mtp -89.17 98.52 11.81 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.0 t30 4.89 65.98 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 CA-C-O 121.341 0.591 . . . . 0.0 111.426 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.26 -46.45 0.16 Allowed Glycine 0 N--CA 1.483 1.83 0 C-N-CA 119.799 -1.191 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 10.2 mtmm -153.51 160.15 42.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.587 -1.537 . . . . 0.0 109.556 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 65.0 m -88.18 -179.18 6.11 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.644 0.735 . . . . 0.0 110.338 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.564 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -150.46 140.8 22.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 29.4 m -118.28 124.66 48.39 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.21 -0.931 . . . . 0.0 111.075 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -119.35 102.51 48.12 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.92 107.69 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.97 1.78 . . . . 0.0 110.141 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.54 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.474 HG12 ' HD3' ' A' ' 35' ' ' LYS . 39.9 mm -73.89 -38.91 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.552 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -109.31 155.2 10.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.253 -0.904 . . . . 0.0 108.922 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.552 ' N ' HG13 ' A' ' 3' ' ' ILE . 42.9 t-20 -107.49 81.17 1.49 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.345 -0.847 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 86.7 t -159.72 151.35 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.329 -0.857 . . . . 0.0 109.539 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.86 162.48 16.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.175 -0.953 . . . . 0.0 108.928 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.515 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.8 p -155.8 155.65 33.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.06 -1.025 . . . . 0.0 111.243 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -111.62 -10.27 14.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.467 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 88.5 p -167.99 139.24 2.33 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.788 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.0 Cg_exo -60.11 -12.98 21.38 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 121.648 1.566 . . . . 0.0 110.122 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -69.43 -44.42 71.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 0.0 108.861 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.467 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 7.2 mt-30 -73.59 -4.78 36.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.375 -0.828 . . . . 0.0 109.102 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 90.3 m -86.83 -22.73 25.64 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 109.969 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.5 mp -67.64 -45.52 45.85 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.334 -0.854 . . . . 0.0 112.27 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.69 -53.23 5.93 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.495 1.464 . . . . 0.0 110.612 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -64.34 -43.55 14.04 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.731 1.621 . . . . 0.0 109.068 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 11.7 t -75.2 -6.88 52.03 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.247 0.546 . . . . 0.0 109.723 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.7 ttpt -98.58 -9.83 24.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.354 -0.841 . . . . 0.0 109.422 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.4 11.28 37.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.281 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -116.72 -57.89 2.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -0.87 . . . . 0.0 109.508 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.727 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 7.8 m-85 -85.86 -61.86 1.66 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 108.77 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.08 -160.0 29.59 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.525 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 4.4 tt0 -88.06 9.75 21.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.048 -1.266 . . . . 0.0 109.364 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -111.62 -15.84 13.38 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -49.79 122.7 6.82 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.07 -1.018 . . . . 0.0 109.66 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.42 122.52 7.55 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.602 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -130.91 169.65 15.49 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.1 -1.236 . . . . 0.0 110.687 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.564 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 42.6 mttp -151.02 176.5 11.07 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.71 124.76 9.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.815 -1.178 . . . . 0.0 110.899 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.597 ' O ' ' C ' ' A' ' 31' ' ' ASN . 6.4 mtt -89.8 99.52 12.51 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.597 ' C ' ' O ' ' A' ' 30' ' ' MET . 1.0 OUTLIER 4.99 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.337 0.589 . . . . 0.0 111.507 -177.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.19 -44.35 0.19 Allowed Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.487 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 25.8 mttt -153.41 158.87 42.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.376 -1.661 . . . . 0.0 109.792 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 55.7 m -87.99 178.56 6.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.634 0.73 . . . . 0.0 110.154 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.568 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -147.64 125.05 11.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.7 m -104.09 122.13 44.64 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.29 -0.882 . . . . 0.0 111.222 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -117.65 99.59 52.35 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.24 159.82 21.36 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.06 1.84 . . . . 0.0 110.353 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.463 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 36' ' ' CYS . 4.8 mt -96.32 -35.23 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.27 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.757 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -104.53 154.75 6.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.257 -0.902 . . . . 0.0 108.766 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.539 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -112.18 66.85 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.392 -0.817 . . . . 0.0 109.073 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.757 ' HB ' HD11 ' A' ' 3' ' ' ILE . 74.3 t -146.77 152.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.297 -0.877 . . . . 0.0 109.449 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 14.2 ptmt -87.57 165.85 15.16 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.181 -0.95 . . . . 0.0 109.005 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 3.1 p -155.98 151.79 27.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.973 -1.08 . . . . 0.0 111.666 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.44 -10.72 14.55 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.7 p -167.92 136.55 1.98 Allowed Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.7 ' O ' HD12 ' A' ' 14' ' ' LEU . 6.3 Cg_exo -58.39 -15.05 22.72 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.547 1.498 . . . . 0.0 109.943 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -63.6 -44.09 95.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.2 -4.89 41.5 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 87.4 m -88.28 -25.31 22.89 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.338 -0.851 . . . . 0.0 110.479 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -58.01 -46.29 99.7 Favored Pre-proline 0 C--N 1.297 -1.707 0 O-C-N 120.888 -1.132 . . . . 0.0 112.543 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.12 -55.94 1.94 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.436 1.424 . . . . 0.0 111.844 -178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -63.96 -52.18 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.914 1.743 . . . . 0.0 110.719 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -67.72 -15.95 63.89 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.511 -0.743 . . . . 0.0 109.881 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 8.1 ttmm -90.4 -24.54 20.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.175 -0.953 . . . . 0.0 109.788 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.9 -3.66 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.763 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -94.14 -49.41 5.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.116 -0.99 . . . . 0.0 109.619 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.963 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 4.8 m-85 -96.65 -65.35 0.97 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.255 -0.903 . . . . 0.0 108.862 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.88 -172.42 42.01 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.564 ' HA ' ' HG3' ' A' ' 18' ' ' LYS . 5.6 tt0 -67.83 -6.81 23.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.987 -1.302 . . . . 0.0 109.621 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p -90.64 -10.38 43.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.118 -0.988 . . . . 0.0 109.866 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.963 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -77.97 131.1 37.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.116 -0.99 . . . . 0.0 109.598 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -104.67 133.87 11.74 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.116 -1.593 . . . . 0.0 109.116 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -136.14 158.12 45.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.253 . . . . 0.0 109.791 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mmmt -142.25 -176.3 4.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.188 -0.945 . . . . 0.0 109.661 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.502 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -149.09 129.81 14.12 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.5 mtm -154.31 40.28 0.47 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.917 . . . . 0.0 109.805 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.0 t30 179.87 39.73 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 65.98 21.24 69.5 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 40.2 mttt -153.08 152.2 31.06 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.256 -1.144 . . . . 0.0 109.505 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.672 ' HB2' HD13 ' A' ' 3' ' ' ILE . 57.7 m -88.45 -177.22 5.57 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.361 0.601 . . . . 0.0 109.933 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 7.7 ttmt -150.82 128.12 11.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.614 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 40.4 m -95.31 124.46 39.36 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.398 -0.814 . . . . 0.0 110.193 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.482 ' OH ' ' HD2' ' A' ' 35' ' ' LYS . 58.3 m-85 -119.83 95.12 49.06 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.345 -0.847 . . . . 0.0 108.871 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.1 131.67 40.34 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.186 1.924 . . . . 0.0 110.261 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.5 -179.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.732 HG21 ' HD3' ' A' ' 33' ' ' LYS . 5.7 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.343 0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.441 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 35.2 mt -59.08 -53.66 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 0.0 109.386 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.539 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -102.22 155.47 4.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.193 -0.942 . . . . 0.0 108.621 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.539 ' N ' HG13 ' A' ' 3' ' ' ILE . 11.5 m120 -104.68 82.83 1.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.589 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 63.2 t -159.32 148.3 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 109.594 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.65 159.2 20.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.263 -0.898 . . . . 0.0 109.059 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.9 p -156.0 154.58 31.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.014 -1.054 . . . . 0.0 111.388 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.9 t -113.8 -8.45 13.19 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.2 p -168.14 136.15 1.85 Allowed Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.791 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.7 Cg_exo -60.03 -13.95 25.79 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.567 1.511 . . . . 0.0 109.858 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.6 OUTLIER -64.83 -37.44 87.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 108.913 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 7.5 mt-30 -80.83 -5.14 56.87 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.326 -0.859 . . . . 0.0 109.313 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 71.9 m -87.87 -30.37 20.2 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.474 -0.766 . . . . 0.0 109.98 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.791 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.2 -44.64 27.79 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 112.251 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 2.7 Cg_exo -55.11 -52.57 7.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.322 1.348 . . . . 0.0 110.624 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.9 Cg_endo -64.15 -47.22 6.64 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 121.669 1.58 . . . . 0.0 109.359 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 t -71.55 -8.12 52.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.609 -0.682 . . . . 0.0 109.586 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' HD2' ' CG ' ' A' ' 23' ' ' GLN . 1.4 ttpt -92.86 -11.29 33.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.06 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.6 2.18 44.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.404 -0.81 . . . . 0.0 109.189 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -105.19 -57.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 109.348 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.5 m-30 -84.86 -67.08 0.83 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.135 -0.978 . . . . 0.0 108.586 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -176.35 -156.56 15.57 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.559 ' CG ' ' HD2' ' A' ' 18' ' ' LYS . 3.8 tt0 -90.48 5.82 46.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.034 -1.274 . . . . 0.0 109.582 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 25' ' ' ALA . 6.8 p -108.94 -15.45 14.37 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.149 -0.97 . . . . 0.0 109.725 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.45 123.76 3.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.693 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.97 117.12 5.77 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -126.43 163.26 23.71 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.176 -1.19 . . . . 0.0 110.402 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.6 mttp -153.41 177.75 10.55 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.0 122.58 8.56 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.086 -1.009 . . . . 0.0 110.986 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.592 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -86.08 98.31 10.79 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.592 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.5 p30 4.77 65.89 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.335 0 CA-C-O 121.289 0.566 . . . . 0.0 111.473 -177.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.66 -43.84 0.18 Allowed Glycine 0 N--CA 1.485 1.931 0 C-N-CA 119.75 -1.214 . . . . 0.0 111.228 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.732 ' HD3' HG21 ' A' ' 1' ' ' THR . 22.4 mttt -153.55 160.59 42.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.536 -1.567 . . . . 0.0 109.579 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.494 ' O ' HG23 ' A' ' 3' ' ' ILE . 83.0 m -88.24 -177.47 5.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.7 0.762 . . . . 0.0 110.482 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.548 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 4.4 mttt -150.19 142.5 24.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 27.4 m -122.19 123.64 41.96 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.102 -0.999 . . . . 0.0 111.011 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -117.78 97.55 50.86 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.73 131.98 40.44 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.126 1.884 . . . . 0.0 110.306 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.323 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.503 HG13 ' CG ' ' A' ' 35' ' ' LYS . 3.5 mt -119.21 -33.68 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.613 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.524 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -101.27 154.63 4.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 O-C-N 121.126 -0.984 . . . . 0.0 108.844 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.524 ' N ' HG13 ' A' ' 3' ' ' ILE . 2.4 m120 -105.07 78.44 1.4 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 0.0 109.387 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG23 ' C ' ' A' ' 4' ' ' ASN . 55.0 t -157.74 148.11 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 0.0 109.575 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 162.31 18.98 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.238 -0.914 . . . . 0.0 109.219 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.52 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 156.0 32.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 111.113 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.5 p -114.65 -7.84 12.72 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.5 p -167.83 136.57 2.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.771 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.1 Cg_exo -59.8 -14.44 27.08 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.562 1.508 . . . . 0.0 109.93 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -66.13 -45.83 79.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 108.731 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -72.27 -4.8 31.72 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.381 -0.824 . . . . 0.0 109.047 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 87.5 m -89.39 -26.21 21.15 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.353 -0.842 . . . . 0.0 110.224 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.771 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.2 -46.5 99.83 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.005 -1.059 . . . . 0.0 112.421 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -57.97 -56.39 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.67 1.58 . . . . 0.0 111.854 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.77 -51.36 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.778 1.652 . . . . 0.0 110.259 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.641 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -67.91 -15.01 63.42 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.428 -0.795 . . . . 0.0 109.273 -179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.57 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 14.4 ttpp -86.29 -10.82 53.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.887 . . . . 0.0 109.264 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.71 15.12 11.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.421 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.51 -61.45 1.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 109.476 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.697 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.7 m-30 -84.86 -65.97 0.95 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.137 -0.977 . . . . 0.0 108.681 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -178.28 -166.19 34.2 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.57 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -73.33 -11.53 60.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.079 -1.248 . . . . 0.0 109.398 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -88.81 -21.56 23.68 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.269 -0.895 . . . . 0.0 109.45 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -44.79 129.56 7.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.307 -0.871 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -108.1 125.95 8.08 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -132.12 153.89 50.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.296 . . . . 0.0 110.226 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 11.3 mttp -134.96 -177.14 4.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.826 . . . . 0.0 109.496 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 122.89 8.46 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.024 -1.047 . . . . 0.0 110.795 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 2.5 mtp -85.0 97.55 9.88 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.7 OUTLIER 5.05 65.71 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.329 0 CA-C-O 121.336 0.589 . . . . 0.0 111.472 -177.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.28 -43.34 0.19 Allowed Glycine 0 N--CA 1.484 1.848 0 C-N-CA 119.816 -1.183 . . . . 0.0 111.389 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 96.3 mttt -152.97 157.73 41.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.484 -1.597 . . . . 0.0 109.724 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.487 ' O ' HG23 ' A' ' 3' ' ' ILE . 57.9 m -87.75 178.1 6.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.568 -0.707 . . . . 0.0 110.074 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -150.8 128.13 11.33 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.498 -0.751 . . . . 0.0 109.28 -179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 m -93.25 119.69 32.7 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.481 -0.762 . . . . 0.0 109.469 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 40.9 m-85 -115.87 100.04 53.15 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.279 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.7 Cg_exo -60.04 158.08 31.44 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.115 1.876 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' A' ' 39' ' ' HIS . 9.6 p80 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.481 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.011 HG23 ' HG3' ' A' ' 35' ' ' LYS . 3.5 mt -154.2 154.89 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.865 . . . . 0.0 109.346 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.579 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -124.55 138.22 54.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.103 -0.998 . . . . 0.0 109.659 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -85.41 49.01 1.67 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 110.11 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 95.2 t -110.67 153.32 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.052 . . . . 0.0 109.464 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.78 157.96 20.84 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.162 -0.962 . . . . 0.0 109.457 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.521 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.5 p -156.54 155.7 32.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 0.0 111.188 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.1 p -112.49 -9.66 13.78 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.4 p -168.28 138.58 2.1 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.65 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.4 Cg_exo -59.81 -14.32 26.57 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 121.52 1.48 . . . . 0.0 109.892 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -46.01 84.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.923 . . . . 0.0 108.784 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -4.74 34.33 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.4 -0.813 . . . . 0.0 109.213 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 87.5 m -87.46 -25.37 23.77 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.316 -0.865 . . . . 0.0 110.295 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -57.7 -46.39 99.75 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.024 -1.047 . . . . 0.0 112.333 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -57.23 -55.92 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.606 1.537 . . . . 0.0 111.78 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.2 Cg_endo -61.69 -47.57 10.92 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.755 1.637 . . . . 0.0 109.999 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.557 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -73.51 -11.13 60.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.3 ttpp -97.92 -13.67 21.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.312 -0.867 . . . . 0.0 109.291 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.38 8.92 12.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.925 . . . . 0.0 109.432 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -115.98 -56.74 2.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.492 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.966 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.4 m-85 -85.94 -65.82 0.97 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -0.946 . . . . 0.0 108.676 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 166.51 -168.66 40.17 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 108.255 -1.938 . . . . 0.0 108.255 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -73.82 -6.22 45.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.989 -1.3 . . . . 0.0 109.407 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.7 p -89.5 -23.08 22.15 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.211 -0.931 . . . . 0.0 109.747 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.966 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -61.2 133.74 56.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -105.47 130.57 10.27 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -134.88 153.41 52.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.27 . . . . 0.0 109.677 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 18.2 mttt -138.25 -176.81 4.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.226 -0.921 . . . . 0.0 109.585 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.17 121.38 7.8 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.05 -1.031 . . . . 0.0 110.898 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.18 99.27 10.97 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 177.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 24.1 t30 4.76 65.81 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.288 0.566 . . . . 0.0 111.535 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.18 -44.51 0.19 Allowed Glycine 0 N--CA 1.484 1.863 0 C-N-CA 119.747 -1.216 . . . . 0.0 111.349 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 19.2 mtmt -153.45 160.14 42.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.603 -1.528 . . . . 0.0 109.781 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.0 m -87.97 179.7 6.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.598 -0.689 . . . . 0.0 110.191 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 1.011 ' HG3' HG23 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -150.52 127.82 11.34 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.455 -0.778 . . . . 0.0 109.357 -179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.0 m -96.61 122.26 39.34 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.466 -0.772 . . . . 0.0 109.867 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.1 m-85 -119.38 94.5 48.43 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 121.297 -0.877 . . . . 0.0 109.173 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.64 164.7 10.94 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.126 1.884 . . . . 0.0 110.299 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.58 HG23 ' N ' ' A' ' 2' ' ' ILE . 4.9 t . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.684 HG23 ' HD2' ' A' ' 35' ' ' LYS . 13.9 mt -156.28 160.3 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.373 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.504 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -125.89 144.67 35.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.183 -0.948 . . . . 0.0 109.493 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -104.53 39.08 1.74 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 67.0 t -99.42 150.59 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.1 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.2 pttt -84.64 158.98 20.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.905 -1.122 . . . . 0.0 108.938 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.08 156.42 34.31 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 110.881 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.7 p -107.43 -3.94 19.01 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.1 p -166.36 140.7 3.54 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.713 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.2 Cg_endo -63.42 -9.93 19.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.962 1.775 . . . . 0.0 110.269 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 13.9 tttt -75.71 -40.34 55.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.61 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 19.4 mt-30 -72.27 -4.64 30.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.515 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 72.0 m -88.85 -29.3 19.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.255 -0.903 . . . . 0.0 110.001 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.3 mp -66.94 -44.43 51.26 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 112.513 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -56.22 -53.33 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.403 1.402 . . . . 0.0 111.014 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -65.4 -45.43 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.744 1.629 . . . . 0.0 109.61 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.4 t -67.75 -16.59 64.2 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.682 -0.636 . . . . 0.0 110.0 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 32.5 ttmt -82.04 -9.55 59.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.142 -0.974 . . . . 0.0 109.43 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.14 21.44 2.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.36 -55.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.602 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.621 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.4 m-30 -85.01 -65.96 0.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 0.0 108.726 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.589 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 163.61 -170.63 39.04 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 107.874 -2.09 . . . . 0.0 107.874 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 18' ' ' LYS . 7.4 tt0 -68.66 -6.38 25.69 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.073 -1.251 . . . . 0.0 109.637 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -90.26 -8.84 49.98 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.269 -0.895 . . . . 0.0 109.456 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -59.27 124.28 19.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.891 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -112.92 118.55 4.61 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -128.6 166.47 18.8 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.368 -1.078 . . . . 0.0 109.687 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 49.1 mtmt -136.03 -169.51 2.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.865 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 27.3 t -151.44 115.64 5.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.694 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 32' ' ' GLY . 4.8 mmt -85.38 -140.07 0.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.307 -0.87 . . . . 0.0 109.609 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.6 m120 -41.22 -27.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.938 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 161.98 53.41 0.02 OUTLIER Glycine 0 N--CA 1.486 2.013 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 4.8 mtpp -153.39 139.68 18.51 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.083 -1.245 . . . . 0.0 108.167 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.485 ' O ' HG13 ' A' ' 3' ' ' ILE . 71.2 m -85.2 159.57 20.08 Favored 'General case' 0 C--N 1.293 -1.88 0 O-C-N 121.15 -0.969 . . . . 0.0 110.594 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.684 ' HD2' HG23 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -139.42 122.97 17.33 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 32.9 m -92.75 122.33 35.04 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.845 0.831 . . . . 0.0 111.127 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.7 m-85 -122.18 93.35 48.6 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.43 147.67 93.31 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.063 1.842 . . . . 0.0 110.131 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.295 0.569 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.5 mt -121.44 -31.9 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.522 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -102.2 156.43 4.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 121.15 -0.969 . . . . 0.0 108.675 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.593 ' O ' HG23 ' A' ' 5' ' ' VAL . 3.9 t-20 -105.1 80.74 1.64 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 4' ' ' ASN . 75.7 t -159.53 153.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -90.13 160.61 16.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.403 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -155.96 157.95 37.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 110.797 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -9.45 13.17 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.4 p -168.06 137.72 2.08 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.754 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.6 Cg_exo -59.46 -14.42 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.672 1.581 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.4 -45.21 80.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.924 . . . . 0.0 108.779 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -73.92 -5.21 39.77 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.391 -0.818 . . . . 0.0 109.029 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.0 m -89.19 -22.09 22.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 110.117 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.754 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -57.75 -46.45 99.74 Favored Pre-proline 0 C--N 1.297 -1.712 0 O-C-N 120.992 -1.067 . . . . 0.0 112.202 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.7 Cg_exo -58.22 -56.28 1.7 Allowed 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.619 1.546 . . . . 0.0 111.858 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.5 Cg_endo -62.73 -51.26 3.23 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.861 1.707 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -68.93 -14.62 63.15 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.487 -0.758 . . . . 0.0 109.219 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.558 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.5 ttpp -83.48 -9.8 58.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.352 -0.842 . . . . 0.0 109.205 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.58 15.6 13.92 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.187 -0.945 . . . . 0.0 109.407 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -109.26 -64.96 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.89 . . . . 0.0 109.862 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 2.7 m-85 -84.2 -66.8 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 108.531 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -171.95 -157.22 13.35 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 29.1 tt0 -81.56 -12.52 58.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.284 . . . . 0.0 109.57 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.1 p -92.71 -13.09 29.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.239 -0.913 . . . . 0.0 109.345 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -43.5 118.13 1.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -90.12 122.06 6.43 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -128.47 161.17 30.14 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.155 -1.203 . . . . 0.0 110.234 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -144.78 178.06 8.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.837 . . . . 0.0 109.657 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.15 123.06 8.73 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.242 -0.911 . . . . 0.0 110.876 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.587 ' O ' ' C ' ' A' ' 31' ' ' ASN . 3.9 mtp -87.04 96.97 10.47 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.587 ' C ' ' O ' ' A' ' 30' ' ' MET . 11.2 m120 4.82 65.54 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 121.395 0.617 . . . . 0.0 111.505 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 171.5 -41.38 0.18 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.229 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 39.5 mttt -153.53 157.69 40.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.511 -1.582 . . . . 0.0 109.766 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' HG23 ' A' ' 3' ' ' ILE . 59.4 m -87.36 179.53 6.58 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.505 -0.747 . . . . 0.0 110.075 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.629 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 8.5 mttt -150.62 134.34 16.59 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.546 -0.721 . . . . 0.0 109.512 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 41.9 m -103.04 117.44 34.58 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.435 -0.79 . . . . 0.0 110.057 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 6.3 m-85 -118.9 106.1 44.22 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.503 -0.748 . . . . 0.0 109.425 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 Cg_exo -59.86 130.11 33.45 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.986 1.791 . . . . 0.0 110.223 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.537 179.956 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 2' ' ' ILE . 23.6 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.781 HD12 ' N ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -149.44 151.74 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.1 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.547 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -123.8 147.01 28.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.44 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.24 33.19 5.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.121 -0.987 . . . . 0.0 109.818 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 6' ' ' LYS . 50.4 t -82.46 162.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 109.116 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -84.12 153.6 23.64 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.133 -0.979 . . . . 0.0 109.08 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.552 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 165.22 37.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.092 -1.005 . . . . 0.0 111.557 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.1 p -122.31 -7.86 8.71 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 97.0 p -168.24 143.81 3.05 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.4 Cg_exo -60.57 -16.13 40.84 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.899 1.733 . . . . 0.0 109.896 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -66.05 -43.2 88.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.26 179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' O ' ' CD ' ' A' ' 16' ' ' PRO . 92.5 mt-30 -71.84 -4.68 29.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.238 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 73.5 m -84.84 -29.17 25.54 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.361 -0.837 . . . . 0.0 109.972 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.64 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 1.3 mp -69.41 -45.17 27.22 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.343 -0.848 . . . . 0.0 112.584 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.1 Cg_exo -55.25 -54.28 4.58 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 121.429 1.419 . . . . 0.0 110.745 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -66.91 -44.18 5.78 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.543 1.495 . . . . 0.0 108.859 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.8 t -73.52 -5.03 37.52 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.189 0.519 . . . . 0.0 109.727 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.7 ttpp -98.64 -9.51 24.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.968 . . . . 0.0 109.222 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.06 14.75 26.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.481 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.78 -57.03 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.059 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 9.2 m-85 -85.53 -35.75 20.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 108.713 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 139.46 -160.32 25.96 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.55 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 8.1 tt0 -86.69 8.66 21.56 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -1.231 . . . . 0.0 109.362 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.4 p -107.46 -18.15 13.93 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.276 -0.89 . . . . 0.0 109.689 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.059 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -53.61 119.72 5.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.118 -0.989 . . . . 0.0 109.485 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.04 117.12 5.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.556 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -125.01 169.9 11.67 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.188 -1.184 . . . . 0.0 110.638 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 37.2 mttt -155.09 177.23 11.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.523 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -149.61 128.2 12.35 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.98 -1.075 . . . . 0.0 110.515 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.601 ' O ' ' C ' ' A' ' 31' ' ' ASN . 38.3 mtt -95.61 104.03 15.92 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 30' ' ' MET . 35.8 m-20 4.86 65.67 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 121.321 0.581 . . . . 0.0 111.338 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 175.6 -54.98 0.12 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 119.731 -1.223 . . . . 0.0 111.248 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 mppt? -152.99 165.33 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.753 -1.439 . . . . 0.0 109.968 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 68.4 m -88.35 177.59 6.8 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.634 0.73 . . . . 0.0 110.365 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.567 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.45 128.8 12.08 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.547 ' SG ' HD13 ' A' ' 3' ' ' ILE . 30.9 m -102.99 122.3 44.32 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 111.117 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.567 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 31.0 m-85 -113.41 98.56 46.94 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.99 90.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.983 1.789 . . . . 0.0 110.163 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.468 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 36' ' ' CYS . 9.0 t . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.82 HD12 ' N ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -152.88 145.88 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 0.0 108.9 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.785 HD11 ' HB2' ' A' ' 34' ' ' CYS . 12.6 pt -95.07 150.87 3.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.222 -0.924 . . . . 0.0 109.65 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.24 51.77 2.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 0.0 109.545 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 53.5 t -116.23 153.56 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.352 -0.842 . . . . 0.0 109.184 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 3.6 pttt -99.68 157.63 16.34 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.153 -0.967 . . . . 0.0 109.629 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.58 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -156.02 159.67 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.7 p -107.83 -6.22 16.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.9 p -166.74 140.02 3.12 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.889 ' O ' HD12 ' A' ' 14' ' ' LEU . 2.7 Cg_endo -60.33 -13.94 27.17 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.565 1.51 . . . . 0.0 109.733 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -73.41 -41.19 63.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.325 -0.859 . . . . 0.0 109.194 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.18 -4.95 38.95 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.259 -0.901 . . . . 0.0 109.282 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' ' CB ' ' A' ' 7' ' ' CYS . 69.5 m -91.15 -22.85 20.46 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.413 -0.805 . . . . 0.0 109.99 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.889 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -67.74 -45.16 44.51 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 112.162 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.7 Cg_exo -56.98 -53.81 4.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.446 1.43 . . . . 0.0 111.022 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -65.17 -44.92 8.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.756 1.638 . . . . 0.0 109.365 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 24.6 t -67.28 -16.68 64.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.8 -0.562 . . . . 0.0 109.922 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.599 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 29.6 ttmt -85.75 -9.98 56.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.152 -0.967 . . . . 0.0 109.599 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.35 15.69 15.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.434 ' NE2' ' CZ ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -118.13 -59.72 1.87 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.325 -0.86 . . . . 0.0 109.61 -179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 7.0 m-85 -87.01 -67.69 0.8 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 108.908 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 177.07 -169.03 41.21 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.599 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 19.5 tt0 -69.72 -4.87 21.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -1.234 . . . . 0.0 109.789 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 p -95.82 -8.23 34.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.211 -0.931 . . . . 0.0 109.665 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -59.39 123.85 18.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.015 -1.053 . . . . 0.0 109.689 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -113.11 127.36 7.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -137.22 158.79 43.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.24 . . . . 0.0 110.381 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 68.0 mttm -123.1 -168.92 1.84 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.42 -0.8 . . . . 0.0 109.532 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 36.1 t -151.08 117.23 5.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.781 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 32' ' ' GLY . 8.9 mtm -84.56 -140.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.495 -0.753 . . . . 0.0 109.283 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m-80 -41.7 -28.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 109.826 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . 162.13 54.69 0.02 OUTLIER Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 25.5 mttm -152.69 135.98 15.81 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.157 -1.202 . . . . 0.0 108.239 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.785 ' HB2' HD11 ' A' ' 3' ' ' ILE . 31.7 m -85.07 148.69 26.02 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.042 -1.036 . . . . 0.0 111.005 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.568 ' HD3' HG23 ' A' ' 2' ' ' ILE . 3.4 ttpm? -123.47 117.39 25.03 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.655 ' O ' HG23 ' A' ' 1' ' ' THR . 33.6 m -94.06 123.31 37.35 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.628 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.522 ' OH ' ' CE ' ' A' ' 35' ' ' LYS . 13.1 m-85 -117.99 104.7 48.34 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.96 140.2 91.63 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.077 1.851 . . . . 0.0 110.221 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.413 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.575 HG22 ' H ' ' A' ' 36' ' ' CYS . 3.5 tt -124.02 -38.6 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 109.445 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -87.68 153.18 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.521 ' N ' HG13 ' A' ' 3' ' ' ILE . 39.4 t-20 -109.45 76.2 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.244 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 3' ' ' ILE . 71.9 t -153.64 151.8 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.362 -0.837 . . . . 0.0 109.428 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -85.02 164.4 18.28 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.7 p -155.9 154.94 32.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.065 . . . . 0.0 111.72 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 t -114.27 -10.66 12.68 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.0 p -168.08 141.75 2.72 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 4.6 Cg_exo -60.41 -17.27 46.6 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.728 1.619 . . . . 0.0 109.849 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -63.82 -44.89 91.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.074 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.528 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 47.6 mt-30 -71.31 -4.81 28.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.283 -0.886 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.491 ' SG ' ' HA ' ' A' ' 10' ' ' PRO . 74.1 m -85.86 -26.7 25.51 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.235 -0.915 . . . . 0.0 109.982 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.626 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 2.6 mm? -71.89 -45.77 11.93 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.458 -0.776 . . . . 0.0 112.017 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -54.84 -53.4 6.09 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.329 1.353 . . . . 0.0 110.437 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.1 Cg_endo -66.67 -44.38 6.06 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.661 1.574 . . . . 0.0 109.041 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 12.7 t -73.31 -5.06 37.18 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.179 0.514 . . . . 0.0 109.832 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 9.5 ttpt -99.9 -9.43 22.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.986 -1.071 . . . . 0.0 109.341 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.1 11.89 38.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -120.13 -54.65 2.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.133 -0.979 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.849 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.4 m-85 -87.21 -46.33 9.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 108.702 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 154.53 -159.79 29.15 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -88.14 9.52 22.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.247 . . . . 0.0 109.46 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -108.4 -17.84 13.89 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.778 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.849 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -54.39 112.01 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -95.42 119.74 6.29 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.589 ' O ' HD21 ' A' ' 14' ' ' LEU . . . -126.52 170.7 11.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.074 -1.25 . . . . 0.0 110.859 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 7.4 mttt -155.31 -177.81 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -149.79 131.95 15.41 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' A' ' 29' ' ' CYS . 27.8 mtp -155.39 28.86 0.39 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.992 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -167.53 43.43 0.05 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 63.85 19.66 63.45 Favored Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.0 mtpt -153.21 155.81 37.33 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.17 -1.194 . . . . 0.0 109.604 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 28' ' ' LYS . 93.5 m -89.27 -178.91 5.75 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.513 0.673 . . . . 0.0 109.871 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 3.0 tmtt? -150.89 128.25 11.33 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.575 ' H ' HG22 ' A' ' 2' ' ' ILE . 33.0 m -103.42 125.59 50.1 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 111.338 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.476 ' CE2' ' HD2' ' A' ' 35' ' ' LYS . 62.9 m-85 -114.89 96.59 45.14 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.66 154.2 56.49 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.062 1.841 . . . . 0.0 110.385 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 35' ' ' LYS . 22.2 mm -117.79 -55.92 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -84.26 158.74 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 O-C-N 121.017 -1.052 . . . . 0.0 109.647 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -91.76 64.43 4.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.572 ' HB ' HD11 ' A' ' 3' ' ' ILE . 72.8 t -145.72 148.71 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.503 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 1.9 ptpp? -95.6 162.12 13.76 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.231 -0.918 . . . . 0.0 109.45 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.3 p -155.71 158.14 37.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 0.0 111.113 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.13 -8.38 16.51 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 177.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.462 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 73.8 p -166.6 139.83 3.18 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.887 ' O ' HD12 ' A' ' 14' ' ' LEU . 3.9 Cg_exo -59.87 -14.35 27.0 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 121.747 1.631 . . . . 0.0 109.97 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HA ' ' CD1' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -75.17 -39.83 60.0 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.295 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 2.4 mt-30 -73.5 -5.84 42.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.219 -0.926 . . . . 0.0 109.091 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 95.4 m -91.65 -21.51 20.75 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.379 -0.826 . . . . 0.0 109.89 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.887 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.1 mp -64.89 -44.78 73.43 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.267 -0.895 . . . . 0.0 112.467 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.5 Cg_exo -55.86 -53.87 4.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.441 1.427 . . . . 0.0 110.875 -178.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 2.0 Cg_endo -63.79 -46.24 9.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.628 1.552 . . . . 0.0 109.372 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.1 t -70.71 -10.68 59.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.75 -0.594 . . . . 0.0 109.622 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 7.0 ttpt -91.9 -10.39 39.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 109.334 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.23 4.19 44.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 109.393 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -104.47 -61.7 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.0 109.547 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.6 m-30 -84.45 -52.71 5.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.704 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.15 -155.6 26.47 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.548 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 1.7 tt0 -90.18 7.37 38.41 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.09 -1.241 . . . . 0.0 109.504 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -110.76 -14.02 14.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.089 -1.007 . . . . 0.0 109.928 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -46.68 126.96 9.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -0.976 . . . . 0.0 109.701 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.22 120.13 6.41 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -131.72 176.47 8.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -1.186 . . . . 0.0 110.274 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 33.4 mmtm -150.24 -166.49 2.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 109.214 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.555 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 25.0 t -151.08 103.56 3.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.042 -1.036 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -103.78 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.506 -0.746 . . . . 0.0 110.075 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.485 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 1.7 t-20 -80.96 67.02 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.544 -0.722 . . . . 0.0 110.06 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 60.13 46.1 94.81 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.6 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.6 mttp -154.12 137.33 15.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.109 -1.23 . . . . 0.0 108.399 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 32.8 m -85.79 149.61 25.14 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.144 -0.973 . . . . 0.0 110.584 -178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 17.4 mtmt -123.6 124.37 42.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 33.1 m -103.23 122.88 45.67 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.247 -0.908 . . . . 0.0 111.165 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.63 104.85 46.75 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -58.8 148.93 81.01 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.896 1.731 . . . . 0.0 109.999 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.561 -179.778 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 36' ' ' CYS . 4.6 mp -103.52 -33.7 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.93 . . . . 0.0 109.544 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -101.02 155.01 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 121.195 -0.941 . . . . 0.0 108.646 179.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.527 ' N ' HG13 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -110.8 65.74 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.366 -0.833 . . . . 0.0 109.354 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.712 ' HB ' HD11 ' A' ' 3' ' ' ILE . 89.2 t -142.34 150.61 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.397 -0.814 . . . . 0.0 109.333 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -89.93 163.46 14.96 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.128 -0.982 . . . . 0.0 109.107 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.6 p -156.49 160.89 39.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 110.672 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.4 p -110.68 -4.6 15.29 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 66.6 p -166.47 140.94 3.51 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.826 ' O ' HD12 ' A' ' 14' ' ' LEU . 1.5 Cg_endo -62.12 -12.19 25.44 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.798 1.665 . . . . 0.0 109.967 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -77.98 -38.57 44.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.426 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.416 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 6.0 mt-30 -73.09 -4.97 35.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.234 -0.916 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 84.6 m -91.88 -27.19 18.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.358 -0.839 . . . . 0.0 110.041 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -65.56 -44.79 66.96 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.237 -0.914 . . . . 0.0 112.27 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.0 Cg_exo -55.8 -53.5 5.47 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.492 1.462 . . . . 0.0 110.956 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 3.1 Cg_exo -62.21 -46.51 12.45 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.742 1.628 . . . . 0.0 109.638 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.11 -14.65 63.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.554 -0.716 . . . . 0.0 109.482 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 1.4 ttmp? -81.3 -9.69 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.366 -0.834 . . . . 0.0 109.167 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.72 14.31 19.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.46 -0.775 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.408 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tt0 -126.65 -57.27 1.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.896 . . . . 0.0 109.627 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.626 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 1.7 m-30 -84.67 -66.76 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 108.739 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.512 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 169.05 -169.69 42.03 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.589 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.13 -4.59 22.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.015 -1.286 . . . . 0.0 109.728 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 p -94.23 -8.07 40.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.226 -0.922 . . . . 0.0 109.587 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.626 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -58.34 122.2 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.941 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -108.54 121.11 6.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -131.85 157.16 44.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -1.164 . . . . 0.0 109.98 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.549 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -126.39 -168.21 1.83 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 109.614 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 28.0 t -151.42 120.19 6.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.116 -0.99 . . . . 0.0 109.963 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' GLY . 28.9 mtp -84.72 -143.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.442 -0.786 . . . . 0.0 109.368 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 30' ' ' MET . 28.4 t-20 -43.7 -26.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.64 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' LYS . . . 164.38 55.24 0.02 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 27.0 mttt -152.9 138.51 17.78 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.103 -1.234 . . . . 0.0 108.358 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.506 ' O ' HG23 ' A' ' 3' ' ' ILE . 81.5 m -85.11 156.17 21.17 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.13 -0.981 . . . . 0.0 110.702 -178.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 12.3 mttm -135.1 127.44 30.28 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 30.4 m -100.62 124.48 46.25 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.874 0.845 . . . . 0.0 111.452 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -125.82 96.53 37.61 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.48 147.45 94.25 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.116 1.877 . . . . 0.0 110.081 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 2' ' ' ILE . 16.3 m . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.754 HD12 ' N ' ' A' ' 2' ' ' ILE . 0.3 OUTLIER -148.7 147.34 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 109.232 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 4.9 pt -100.27 160.5 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.21 -0.931 . . . . 0.0 109.433 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.14 63.1 5.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.203 -0.935 . . . . 0.0 109.41 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' A' ' 3' ' ' ILE . 72.6 t -143.48 151.99 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.609 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 5.8 mtpp -95.31 166.77 11.73 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.305 -0.872 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.8 p -156.21 159.96 39.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 110.66 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.464 ' OG1' ' OE1' ' A' ' 12' ' ' GLN . 13.3 p -111.77 -8.71 14.14 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.5 p -167.06 137.93 2.54 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.926 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.3 Cg_exo -59.38 -14.66 25.95 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.71 1.607 . . . . 0.0 109.939 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -70.9 -42.03 70.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.87 . . . . 0.0 109.295 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.464 ' OE1' ' OG1' ' A' ' 8' ' ' THR . 63.8 mt-30 -74.16 -4.63 36.92 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.225 -0.922 . . . . 0.0 109.415 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 68.8 m -91.47 -23.78 19.88 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.275 -0.89 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.926 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER -66.77 -44.54 53.45 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.319 -0.863 . . . . 0.0 112.402 -179.339 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.3 Cg_exo -55.71 -53.51 5.51 Favored 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.483 1.455 . . . . 0.0 110.951 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.561 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.59 -46.39 7.18 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.643 1.562 . . . . 0.0 109.251 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 8.5 t -70.22 -10.72 59.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.725 -0.61 . . . . 0.0 109.725 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 16.2 ttpp -91.71 -9.91 42.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.9 . . . . 0.0 109.424 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.16 -6.32 35.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.288 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -93.93 -61.86 1.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.609 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 36' ' ' CYS . 1.7 m-30 -84.34 -66.3 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -0.975 . . . . 0.0 108.85 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . -179.57 -155.87 16.25 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.54 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 2.6 tt0 -88.49 5.97 40.02 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.086 -1.244 . . . . 0.0 109.524 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 25' ' ' ALA . 7.0 p -109.34 -13.1 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.177 -0.952 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -45.25 123.9 4.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.632 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -98.29 116.73 5.63 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -132.53 172.29 12.7 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.094 -1.239 . . . . 0.0 110.666 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 38.9 mttp -154.09 -167.03 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.519 -0.738 . . . . 0.0 109.427 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 6.6 t -151.14 121.07 7.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.88 -1.138 . . . . 0.0 109.721 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.507 ' O ' ' N ' ' A' ' 32' ' ' GLY . 1.5 mmt -98.52 -135.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 110.108 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 30' ' ' MET . 2.3 m120 -35.28 -31.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.9 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 158.37 49.08 0.01 OUTLIER Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.499 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 9.1 mtpp -153.61 150.38 28.58 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.972 -1.311 . . . . 0.0 108.147 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.559 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 58.3 m -86.76 152.25 22.67 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.011 -1.056 . . . . 0.0 110.132 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 5.8 mmtm -122.98 121.63 36.58 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 28.8 m -104.09 119.45 38.97 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.102 -0.999 . . . . 0.0 111.159 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 35.3 m-85 -110.85 93.98 18.76 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 2.5 Cg_endo -61.56 152.19 75.11 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.122 1.881 . . . . 0.0 110.303 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.6 p80 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.45 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 3' ' ' ILE . 46.2 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 36' ' ' CYS . 82.1 mt -97.33 -42.01 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.902 . . . . 0.0 109.611 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -100.82 154.5 4.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.173 -0.954 . . . . 0.0 108.7 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.516 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.1 p-10 -103.22 77.3 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.253 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.512 HG23 ' C ' ' A' ' 4' ' ' ASN . 21.5 t -157.46 145.24 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 7.7 mttm -84.8 164.06 18.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.046 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.7 p -156.4 159.76 39.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.11 -0.994 . . . . 0.0 111.384 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -111.98 -12.51 13.73 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.6 p -168.32 139.3 2.19 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.943 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.3 Cg_exo -59.01 -14.29 22.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.642 1.561 . . . . 0.0 109.893 179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -64.57 -46.87 80.9 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.249 -0.907 . . . . 0.0 108.823 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 4.8 mt-30 -72.71 -4.98 34.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.112 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.6 m -89.06 -26.71 21.25 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.88 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.943 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -65.95 -44.98 63.56 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.34 -0.85 . . . . 0.0 112.537 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.9 Cg_exo -55.21 -53.23 6.18 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.356 1.37 . . . . 0.0 110.751 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 1.6 Cg_endo -64.39 -44.15 12.34 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.702 1.601 . . . . 0.0 109.614 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 10.4 t -72.74 -10.39 59.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.71 -0.618 . . . . 0.0 110.178 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.3 ttpt -96.9 -9.58 28.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.523 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -98.4 8.86 44.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.33 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -114.31 -58.09 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.824 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.7 m-85 -84.88 -62.81 1.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.258 -0.901 . . . . 0.0 108.575 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 174.27 -159.73 29.01 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.55 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 61.0 tt0 -86.91 4.77 40.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.265 . . . . 0.0 109.366 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.7 p -107.83 -13.89 14.9 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.166 -0.959 . . . . 0.0 110.191 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.824 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -52.06 119.32 4.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.057 -1.027 . . . . 0.0 109.563 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.29 117.85 5.28 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.724 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -126.63 163.39 23.57 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.127 -1.22 . . . . 0.0 110.563 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 10.9 mtmt -153.64 178.97 9.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 0.0 109.272 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.509 ' N ' ' HB3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -150.6 124.55 9.27 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.011 -1.055 . . . . 0.0 110.861 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.591 ' O ' ' C ' ' A' ' 31' ' ' ASN . 5.8 mtp -90.53 98.45 11.78 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.591 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.8 OUTLIER 4.93 66.13 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.376 0.608 . . . . 0.0 111.393 -177.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 173.84 -47.45 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.153 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' CA ' ' SG ' ' A' ' 7' ' ' CYS . 19.7 mtmm -153.86 161.97 41.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.543 -1.563 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' O ' HG23 ' A' ' 3' ' ' ILE . 55.9 m -88.52 -179.96 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 110.393 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 3.5 mttt -150.57 140.41 21.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 36.2 m -119.71 131.08 55.3 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.229 -0.92 . . . . 0.0 110.806 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -122.0 95.17 47.73 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.79 148.67 91.3 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.147 1.898 . . . . 0.0 110.323 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.368 179.86 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.5 mt -73.59 -36.44 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -101.59 155.08 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.141 -0.975 . . . . 0.0 108.747 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.525 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 1.1 t-20 -105.25 78.78 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 0.0 109.273 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 4' ' ' ASN . 61.8 t -158.7 148.46 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.633 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -84.58 161.02 20.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.201 -0.937 . . . . 0.0 109.184 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -155.78 156.11 34.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 111.084 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -8.05 12.65 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.472 ' OG ' ' HG3' ' A' ' 12' ' ' GLN . 80.2 p -167.91 138.87 2.31 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.707 ' O ' HD12 ' A' ' 14' ' ' LEU . 2.7 Cg_endo -61.35 -13.3 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.704 1.603 . . . . 0.0 109.813 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.71 -44.84 76.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.768 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.472 ' HG3' ' OG ' ' A' ' 9' ' ' SER . 10.9 mt-30 -74.29 -4.55 36.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.416 -0.802 . . . . 0.0 109.273 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 94.6 m -88.84 -23.95 22.68 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.266 -0.896 . . . . 0.0 110.462 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.44 -46.96 99.75 Favored Pre-proline 0 C--N 1.297 -1.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.404 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.3 Cg_exo -57.33 -56.21 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 121.665 1.577 . . . . 0.0 111.799 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.4 Cg_endo -61.24 -49.98 6.79 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.657 1.572 . . . . 0.0 110.032 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -70.34 -12.38 61.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 16.6 ttpp -94.94 -9.81 32.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.36 11.79 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -119.46 -56.81 2.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 109.747 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.1 m-85 -85.15 -66.2 0.92 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 108.723 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.05 -172.25 42.08 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.538 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 15.8 tt0 -69.91 -4.9 22.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.016 -1.285 . . . . 0.0 109.55 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.3 p -92.25 -21.49 20.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.096 -1.003 . . . . 0.0 109.794 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.977 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -62.0 133.91 55.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.12 -0.988 . . . . 0.0 109.568 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -106.41 129.96 9.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . . . -133.95 147.02 51.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.968 -1.313 . . . . 0.0 109.867 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 28.4 mttt -129.44 -176.16 3.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.45 123.18 8.62 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.072 -1.017 . . . . 0.0 110.764 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.589 ' O ' ' C ' ' A' ' 31' ' ' ASN . 82.2 mtp -86.28 99.8 11.83 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.589 ' C ' ' O ' ' A' ' 30' ' ' MET . 4.9 m120 4.6 66.06 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.222 0.534 . . . . 0.0 111.516 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 170.82 -44.84 0.19 Allowed Glycine 0 N--CA 1.484 1.88 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.423 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 11.2 mtmm -153.34 159.9 42.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.49 -1.594 . . . . 0.0 109.715 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 57.3 m -87.72 179.61 6.47 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.518 0.675 . . . . 0.0 110.238 -179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HG2' ' CZ ' ' A' ' 37' ' ' TYR . 3.1 ttpt -150.63 128.86 11.96 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.426 -0.796 . . . . 0.0 109.26 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 38.6 m -95.3 120.11 34.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.313 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.59 ' CZ ' ' HG2' ' A' ' 35' ' ' LYS . 30.2 m-85 -115.16 94.08 37.62 Favored Pre-proline 0 C--N 1.305 -1.359 0 O-C-N 121.405 -0.809 . . . . 0.0 108.99 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 2.5 Cg_endo -61.45 140.97 90.42 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.205 1.937 . . . . 0.0 110.043 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.483 -179.96 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 89.1 m . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.61 HD12 ' HE3' ' A' ' 35' ' ' LYS . 2.7 mp -100.3 -41.17 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.315 -0.865 . . . . 0.0 109.463 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.589 HD11 ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -102.61 154.52 5.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 O-C-N 121.091 -1.006 . . . . 0.0 108.836 179.78 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.534 ' N ' HG13 ' A' ' 3' ' ' ILE . 1.7 m-20 -109.45 69.48 0.7 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 0.0 109.215 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.589 ' HB ' HD11 ' A' ' 3' ' ' ILE . 49.5 t -143.56 146.87 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -86.32 159.95 19.26 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.219 -0.926 . . . . 0.0 109.596 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 33' ' ' LYS . 2.5 p -156.06 145.6 20.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.141 -0.974 . . . . 0.0 110.575 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.33 -5.44 40.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 177.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 81.6 p -167.05 140.48 3.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.671 ' O ' HD23 ' A' ' 14' ' ' LEU . 2.3 Cg_endo -62.22 -11.26 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.899 1.733 . . . . 0.0 110.059 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -41.45 62.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.365 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' C ' ' HD2' ' A' ' 15' ' ' PRO . 5.4 mt-30 -74.46 -4.72 38.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 90.4 m -88.56 -21.14 24.23 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 -179.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 10' ' ' PRO . 2.1 mm? -70.71 -45.15 17.01 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 111.892 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 3.2 Cg_exo -55.24 -52.46 7.75 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.303 1.336 . . . . 0.0 110.627 -178.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 15' ' ' PRO . 1.8 Cg_endo -67.47 -44.23 4.86 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.724 1.616 . . . . 0.0 109.229 179.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 14.6 t -72.22 -7.53 49.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.797 -0.565 . . . . 0.0 109.886 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 2.1 ttpt -97.26 -9.35 27.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.167 -0.958 . . . . 0.0 109.459 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.96 5.84 45.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.917 . . . . 0.0 109.54 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.95 -54.48 2.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.913 . . . . 0.0 109.525 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.64 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.7 m-85 -89.47 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 179.44 -156.63 18.81 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.534 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 37.8 tt0 -90.16 4.69 49.71 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.17 -1.194 . . . . 0.0 109.376 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -106.72 -16.35 14.51 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.105 -0.997 . . . . 0.0 109.953 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -47.83 119.43 2.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.984 -1.072 . . . . 0.0 109.445 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.81 124.0 8.1 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 35' ' ' LYS . . . -135.54 166.73 22.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.063 -1.257 . . . . 0.0 110.683 -179.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.523 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 3.5 mtmp? -139.94 -166.2 2.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.587 -0.696 . . . . 0.0 109.341 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 29.9 t -150.49 116.7 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.089 -1.007 . . . . 0.0 109.882 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 32' ' ' GLY . 5.1 mtp -84.67 -140.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.478 -0.764 . . . . 0.0 109.424 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 30' ' ' MET . 0.1 OUTLIER -41.09 -27.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.111 -179.637 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 162.11 52.7 0.02 OUTLIER Glycine 0 N--CA 1.487 2.096 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.597 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -153.13 140.98 20.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.038 -1.272 . . . . 0.0 108.185 178.35 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.52 ' O ' HG23 ' A' ' 3' ' ' ILE . 56.4 m -85.15 151.04 24.41 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.091 -1.005 . . . . 0.0 110.296 -178.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.61 ' HE3' HD12 ' A' ' 2' ' ' ILE . 10.9 tttt -126.7 118.74 25.34 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 43.2 m -97.26 124.92 41.5 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.37 -0.831 . . . . 0.0 111.133 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.582 ' CE2' ' HG2' ' A' ' 35' ' ' LYS . 29.1 m-85 -116.15 99.57 52.77 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.02 104.61 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.054 1.836 . . . . 0.0 110.034 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.486 -179.794 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.529 HG22 ' H ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.615 HG23 ' HG2' ' A' ' 35' ' ' LYS . 1.3 mt -156.88 148.63 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.16 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 0.1 OUTLIER -118.99 -176.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.253 -0.904 . . . . 0.0 109.604 -179.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -132.09 40.35 3.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 41.6 t -106.91 156.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' N ' HG12 ' A' ' 5' ' ' VAL . 10.9 pttp -85.02 158.16 20.55 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.223 -0.923 . . . . 0.0 109.588 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.2 p -156.08 156.07 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 111.33 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.2 p -112.78 -10.44 13.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 61.7 p -168.27 137.87 2.01 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.809 ' O ' HD12 ' A' ' 14' ' ' LEU . 5.4 Cg_exo -58.95 -15.12 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 121.505 1.47 . . . . 0.0 109.843 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -45.58 84.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 108.732 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 62.8 mm-40 -72.47 -5.61 37.94 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.336 -0.853 . . . . 0.0 109.192 179.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 92.5 m -89.62 -25.77 21.12 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.32 -0.863 . . . . 0.0 110.337 -179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.809 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -57.72 -46.12 99.77 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 112.356 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 5.4 Cg_exo -57.53 -56.06 2.03 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.547 1.498 . . . . 0.0 111.654 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.576 ' HD2' ' CD ' ' A' ' 15' ' ' PRO . 2.5 Cg_endo -61.45 -50.18 6.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 121.682 1.588 . . . . 0.0 109.945 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -69.11 -13.43 62.42 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.521 -0.737 . . . . 0.0 109.138 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' CD ' ' HA ' ' A' ' 23' ' ' GLN . 8.0 ttpt -95.58 -10.6 29.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.352 -0.842 . . . . 0.0 109.524 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.04 16.88 5.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -123.07 -55.87 1.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.317 -0.864 . . . . 0.0 109.477 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.945 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 7.2 m-85 -85.92 -63.37 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 108.855 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 167.13 -171.83 42.0 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.546 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 24.4 tt0 -73.21 -1.68 18.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.958 -1.319 . . . . 0.0 109.592 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.6 p -95.58 -21.01 18.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.229 -0.919 . . . . 0.0 109.814 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.945 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -60.92 129.04 39.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -101.83 129.46 9.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 35' ' ' LYS . . . -131.2 159.34 38.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.101 -1.235 . . . . 0.0 109.748 -179.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 9.3 mttm -143.57 -176.77 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.72 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.39 122.25 8.14 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.969 -1.082 . . . . 0.0 110.678 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.594 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -85.07 97.54 9.91 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 177.058 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 30' ' ' MET . 5.1 p-10 4.99 65.62 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 121.472 0.653 . . . . 0.0 111.449 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 172.12 -44.05 0.18 Allowed Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.8 -1.191 . . . . 0.0 111.162 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 38.3 mttt -153.42 160.41 42.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.509 -1.583 . . . . 0.0 109.828 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.556 ' HB2' ' CD1' ' A' ' 3' ' ' ILE . 61.2 m -87.69 177.77 6.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.619 -0.675 . . . . 0.0 110.123 -179.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.627 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 5.6 mtmt -150.95 131.04 13.46 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.425 -0.797 . . . . 0.0 109.208 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 46.5 m -98.21 118.55 35.09 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.459 -0.775 . . . . 0.0 109.896 179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 26' ' ' GLY . 42.5 m-85 -116.59 90.55 31.37 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 108.927 179.101 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.503 ' CD ' ' OG1' ' A' ' 1' ' ' THR . 3.4 Cg_exo -59.9 105.71 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.331 2.021 . . . . 0.0 110.23 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.471 -179.988 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.483 ' C ' ' CG1' ' A' ' 2' ' ' ILE . 2.4 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.686 HG23 ' HG2' ' A' ' 35' ' ' LYS . 1.2 mt -157.78 147.6 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 0.0 109.024 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 34' ' ' CYS . 1.2 pt -111.8 149.39 14.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.49 23.18 14.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.156 -0.965 . . . . 0.0 109.931 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 53.6 t -74.83 158.2 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 0.0 109.123 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' N ' HG12 ' A' ' 5' ' ' VAL . 50.4 tttp -84.39 158.59 21.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.132 -0.98 . . . . 0.0 109.075 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' SG ' ' CA ' ' A' ' 33' ' ' LYS . 2.6 p -156.17 159.91 39.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.004 -1.06 . . . . 0.0 111.619 -178.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -115.53 -9.82 11.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -168.02 138.3 2.18 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.782 ' O ' HD12 ' A' ' 14' ' ' LEU . 3.6 Cg_exo -60.26 -13.23 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.524 1.482 . . . . 0.0 109.958 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 3.8 tptm -65.56 -46.2 80.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.218 -0.926 . . . . 0.0 108.74 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 16' ' ' PRO . 29.6 mt-30 -72.5 -4.53 30.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.436 -0.79 . . . . 0.0 109.132 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 29' ' ' CYS . 96.4 m -87.47 -27.81 22.44 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.296 -0.877 . . . . 0.0 110.336 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 10' ' ' PRO . 1.2 mp -69.68 -44.75 24.51 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 112.437 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 14' ' ' LEU . 4.4 Cg_exo -55.79 -53.33 5.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.361 1.374 . . . . 0.0 110.636 -178.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 15' ' ' PRO . 1.3 Cg_endo -67.0 -43.58 6.39 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.708 1.605 . . . . 0.0 109.261 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 43.2 t -71.13 -10.59 60.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.862 -0.524 . . . . 0.0 110.129 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 22' ' ' GLY . 25.8 ttmt -95.47 -9.51 32.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.013 -1.054 . . . . 0.0 109.639 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.16 10.97 8.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -121.97 -56.35 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.63 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.036 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.2 m-85 -84.92 -63.13 1.38 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -0.934 . . . . 0.0 108.816 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 18' ' ' LYS . . . 158.3 -171.68 35.21 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HA ' ' CD ' ' A' ' 18' ' ' LYS . 3.8 tm0? -67.98 -6.11 20.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.078 -1.248 . . . . 0.0 109.725 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.0 p -92.91 -9.12 41.24 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.036 ' HB2' ' HB2' ' A' ' 21' ' ' PHE . . . -70.37 122.72 20.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.031 -1.043 . . . . 0.0 109.785 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.41 122.38 7.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.712 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . . . -127.43 161.89 27.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -1.156 . . . . 0.0 109.893 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 13.4 mttt -146.53 177.91 8.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.367 -0.833 . . . . 0.0 109.58 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -150.58 124.56 9.29 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.014 -1.054 . . . . 0.0 110.815 -179.775 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.593 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.7 100.14 13.05 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 177.103 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.593 ' C ' ' O ' ' A' ' 30' ' ' MET . 33.2 m-20 4.88 65.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.398 0.618 . . . . 0.0 111.349 -177.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 30' ' ' MET . . . 174.28 -49.59 0.14 Allowed Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.852 -1.166 . . . . 0.0 111.233 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 29' ' ' CYS . 2.3 mptt -153.38 162.54 41.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.568 -1.548 . . . . 0.0 109.776 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.627 ' HB2' HD12 ' A' ' 3' ' ' ILE . 62.8 m -88.49 179.81 6.22 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.672 0.749 . . . . 0.0 110.655 -178.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.686 ' HG2' HG23 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -150.38 133.36 16.09 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.878 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 35.8 m -108.08 120.49 42.48 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.391 -0.818 . . . . 0.0 110.804 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -118.36 101.53 51.05 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.11 108.26 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.953 1.768 . . . . 0.0 110.242 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.495 -179.918 . . . . . . . . 1 1 . 1 stop_ save_